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Thesis Abstract 
Bioluminescence is the production of light by living organisms as a result of a 
number of enzyme catalysed reactions caused by enzymes termed luciferases. The 
lux genes responsible for the emission of light can be cloned from one 
bioluminescent microorganism into one that is not bioluminescent. The light emitted 
can be monitored and quantified and will provide information on the metabolic 
activity, quantity and location of cells in a particular environment, in real-time.  
The primary aim of this thesis was to investigate and identify several food industry 
related applications of lux-tagged microorganisms. Throughout this thesis, a variety 
of lux-tagged Gram negative and Gram positive bacteria were examined, under 
standard laboratory conditions and in complex food systems. Initial experiments 
investigated the effect of introducing the lux plasmid into Cronobacter sakazakii and 
found the lux genes had no negative effect on the growth characteristics of the strain. 
The potential of using the lux-tagged C. sakazakii strain to monitor growth of this 
bacterium in clear and opaque liquids was examined and results demonstrated that 
bacterial bioluminescence could be detected when the lux-tagged strain was grown in 
Luria-Bertani broth, skim milk, and infant milk formula. We also showed that 
bioluminescence of the strain could be detected when the lux-tagged strain was 
cultured in the presence of competing bacteria and that the effect of antimicrobial 
agents on growth of the lux-tagged C. sakazakii could be monitored by measuring 
bioluminescence. 
Following this, we investigated the use of a bioluminescence based early warning 
system for starter culture disruption by antimicrobial agents. To achieve this, a new 
conjugative lux-tagged plasmid (pRH001lux), capable of mobilisation between 
strains, was constructed. We subsequently transformed this plasmid into several 
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bacteria and developed a bank of bioluminescent cheese starter culture strains. When 
the effect of introducing this new lux plasmid into starter cultures it was was 
examined, it was determined that the lux plasmid had no negative effect on the 
growth characteristics of the strain. We used this bank to establish assays capable of 
rapidly monitoring antimicrobial agents, such as antibiotics, in laboratory media and 
milk.  
The final section of this thesis examined the activity of bioengineered Nisin 
derivatives, Nisin V and S29A, against foodborne pathogens in laboratory media and 
selected foods. For the first time, we report the enhanced antimicrobial activity of 
Nisin V against Gram negative bacteria in agarose assays and laboratory media. We 
have also highlighted the enhanced bioactivity of S29A and V against Listeria 
monocytogenes in a commercially produced frankfurter maintained under sub-
optimal conditions and demonstrated that Nisin V outperforms both the wild-type 
nisin and S29A, with respect to controlling growth of Listeria over a 24 hour period.  
When Nisin V and S29A was examined against Gram negative bacteria in powdered 
infant formula (PIF), apple juice and liquid whole egg no inhibitory effect was 
observed. 
In conclusion, this thesis demonstrates that there are many food related applications 
of lux-tagged microorganisms in the food industry. In particular, the lux system can 
be used to monitor growth of tagged micro-organisms in clear and opaque liquids, as 
an early warning system for starter culture disruption by antibiotic residues and as a 
real-time method for tracking the antimicrobial effect of Nisin variants in selected 
model food systems. 
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1. Abstract 
Bioluminescence is the production of light by living organisms. The luciferase genes 
responsible for the generation of light (lux genes) can be cloned from a 
bioluminescent microorganism into one that is not naturally bioluminescent. Light 
output can be monitored in real time and will provide information on the metabolic 
state, location and quantity of cells in a given environment. Herein we review the 
applications of lux-tagged microorganisms in the food industry including their uses 
in the development of novel food products and processes, for problem solving and 
for determining parameters important for the control of food quality and safety. 
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2. Introduction 
Bioluminescence is the emission of light by living organisms as a consequence of an 
enzymatic reaction catalysed by enzymes termed luciferases. Over 80% of 
luminescent organisms have been isolated from marine habitats and include bacteria, 
fungi, crustaceans, jellyfish, worms and beetles (Widder, 2010). The biological 
functions of light emission include communication, illumination, camouflage, 
attraction and repulsion (Meighen, 1993). The lux genes responsible for 
bioluminescence have been identified and can be transferred and expressed in several 
microorganisms including foodborne pathogens and food spoilage bacteria. Herein 
we briefly summarise approaches used to create bioluminescent bacteria and discuss 
the applications of bioluminescent technology to food microbiology. 
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3. Lux system 
While the majority of luciferases have been identified in marine organisms the most 
frequently used bioluminescent reporter system, the lux system, is derived from the 
Gram negative bacterium Photorhabdus luminescens that is found in terrestrial 
environments. In the presence of oxygen the luciferase enzyme catalyses the 
oxidation of reduced flavin mononucleotide (FMNH2) and a long chain aliphatic 
aldehyde to yield flavin mononucleotide (FMN) and a long chain fatty acid (Fig. 1).  
As a consequence of this reaction, light is emitted at a wavelength of 490nm (Baker 
et al., 1992, Dostalek and Branyik, 2005). The luciferase enzyme is encoded by the 
luxAB genes and the fatty acid reductase complex required for regeneration of the 
aldehyde is coded for by the luxCDE genes. The lux genes can be transferred from P. 
luminescens and expressed in other bacteria and the resulting lux-tagged bacteria 
emit light. A large number of bacteria of importance in food have been successfully 
lux-tagged (Table 1). Light output from Gram positive bacteria is usually lower than 
that from Gram negatives and it has been suggested that this is the result of poor 
expression of lux genes (Jacobs et al., 1995, Griffiths, 2000). This problem can be 
overcome by introducing translational signals optimized for Gram positive bacteria 
in front of luxA, luxC and luxE (Qazi et al., 2001). 
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 (A) 
 
 
 
 
(B)      (C) 
 
 
 
Fig 1. (A) Schematic of the lux reaction. (B) Lux-tagged C. sakazakii on Luria 
Bertani (LB) agar viewed with a Xenogen IVIS 100 Imager. (C) Growth of lux-
tagged C. sakazakii in LB broth. Relative light units (RLU) were measured with a 
Luminoskan luminometer. Inset picture on Fig. 1 (C) represent growth of the tagged 
strain over 8 h. Image was viewed with a Xenogen IVIS 100 Imager.  
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Table 1.  Summary of plasmids and transposons that have been used to lux-tag microorganisms 
of relevance to the food industry.  
Bacterium Plasmid/Transposon Relevant information References 
Listeria monocytogenes pPl2lux Contains luxABCDE from P. 
luminescens and phelp promoter 
for the constitutive expression of 
light. Integrates into tRNA
ARG
 
locus on chromosome.  
(Riedel et al., 
2007b) 
Staphlyococcas aureus pMK4 luxABCDE 
(Also known as p-XEN-
1) 
Contains the luxABCDE derived 
from P. luminescens. Functional in 
Gram positive and negative 
bacteria. Random host DNA 
fragments were used as 
promoters.  
 
(Francis et al., 2000, 
Moulton et al., 
2009) 
 
Streptococcus 
thermophilus 
PLux72 & pTCLux72 
 
LuxAB genes derived from V. 
harveyi.   Exogenous aldehyde 
(decanal) must be added. 
(Jacobs et al., 1995) 
Bacillus cereus B. cereus F4810/ 
72(pMDX[P1/LuxABCDE
]) 
Contains the LuxABCDE from P. 
luminescens under the control of 
the ces promoter.  
 
(Dommel et al., 
2010) 
Bacillus subtilus pSB357-sspB:: LuxAB Contains LuxAB genes from V. 
harveyi under the control of the 
B. subtilus sspB promoter. The 
promoter encodes small acid 
soluble proteins which only 
induce bioluminescence upon 
germination of the Bacillus 
spores. Exogenous aldehyde must 
be added to the reaction. 
(Hill et al., 1994) 
Bacillus anthracis pSB357 containing lux 
genes 
Contains the LuxABCDE from P. 
luminescens and is under the 
control of the spore small acid-
soluble protein promoter sspB. 
Bioluminescence is induced upon 
germination of the Bacillus 
spores.  
(Sanz et al., 2008) 
Escherichia coli, 
Cronobacter sakazakii, 
Citrobacter rodentium, 
Salmonella enterica, 
Yersinia enterocolitica, 
Pseudomonas 
aeruginosa, Shigella 
flexneri 
p16Slux 
 
Contains LuxABCDE genes from P. 
luminescens. Contains phelp 
promoter for the constitutive 
expression of light. Plasmid 
integrates into 16S region of 
Gram negative bacterial 
chromosome. 
(Riedel et al., 
2007a) 
Salmonella enterica pBEN276 LuxCDABE genes from P. 
luminescens are under control of 
constitutive E. coli frr promoter 
(Howe et al., 2010) 
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which encodes the genes 
responsible for the ribosome 
recycling factor. Also contains 
tnsABCD genes required for 
transposition. The plasmid inserts 
at the attTn7 site in the genome. 
Escherichia coli 
 
Lux pCGLS1 and 
pCGLS1R 
 
LuxABCDE genes come from X. 
luminescens. Under the control of 
the lac promoter.  
(Frackman et al., 
1990) 
Salmonella enterica pAK1-Lux1 
 
Contains luxCDABE genes from P. 
luminescens controlled by the 
lacZ promoter. Strains carrying 
pAK1-Lux1 constitutively 
expressed the lux operon.  
(Karsi et al., 2008) 
Salmonella enterica pSB230 LuxAB 
 
Contains the Lux genes LuxAB and 
contains trp pol (promoter 
operator leader). The lux genes 
are derived from V. harveyi 
Exogenous substrate dodecanal 
must be added. 
(Hill et al., 1991) 
Lactococcus lactis pNZ8048 containing 
lux genes 
 
Contains the modified lux genes 
ABCDE from P. luminescens under 
the control of nisin inducible 
promoter nisA in pNZ8048. 
Induces luminescence upon 
detection of nisin.   
(Immonen and 
Karp, 2007) 
Bifidobacterium breve pLuxMC1 
 
Contains the LuxABCDE genes 
derived from P. luminescens. 
Integrates into the chromosome 
and allows for the constitutive 
expression of light with the aid of 
either the Prep or the Phelp 
promoter. 
(Cronin et al., 2008) 
Lactococcus lactis PNZ5519 
 
Contains LuxAB derived from V. 
harveyi. FMN or riboflavin is 
added as the luminous reaction is 
dependent on intracellular 
FMNH2 concentration. Exogenous 
substrate is added in the form of 
nonanal. 
(Bachmann et al., 
2007) 
Mycobacterium 
tuberculosis 
pMV306hsp +LuxAB Contains the genes LuxABCDE 
derived from P. luminescens 
under the control of the inducible 
promoter Phsp60. Exogenous 
aldehyde in the form of decanal 
must be added. 
(Andreu et al., 
2010) 
Pseudomonas syringae pJFLux1 Contains LuxCDABE from P. 
luminescens and under the 
control of a constitutive TT4 
(Fan et al., 2008) 
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promoter.  
Salmonella enteritdis pDB30 (GCDE/GCDE)  LuxAB genes from V. harveyi are 
carried by the Tn-5 containing 
plasmid pDB30. 
The bioluminescence marker was 
expressed in the presence of n-
decanal. 
(Chen and Griffiths, 
1996a) 
Yersinia enterocolitica pUT-mini-Tn5 
luxCDABE-Km
r
 
 Lux mutants of Y. enterocolitica 
were generated by transposon 
mutagenesis using a 
promoterless, complete lux 
operon (luxCDABE) derived from 
P. luminescens. Tn5 lux 
transposon integrates randomly 
into the Yersinia chromosome. 
The lux genes are under the 
control of a promoter active in 
foodstuff at low temperatures. 
(Maoz et al., 2002) 
Listeria monocytogenes pAUL- A Tn4001 
LuxABCDE 
 
The Lux genes (ABCDE) were 
derived from P.luminescens and 
were modified, by introduction of 
Gram-positive ribosome binding 
site, to be functional in Gram 
positive and Gram negative.  
(Francis et al., 2000) 
Clavibacter 
michiganensis 
 
Tn1409::Lux 
 
Contains promoterless LuxCDABE 
operon and Tn1409 transposon. 
Inserts into chromosome. Lux 
genes were derived from P. 
luminescens. No exogenous 
substrate added. The strain was 
constitutively bioluminescent. 
(Xu et al., 2010) 
Escherichia coli Mini-MuLux Combines the mini-mu 
transposon with luxCDABE genes 
from V. fischeri. Mini-mulux 
transposon lacks the lux operon 
promoter so expression of the lux 
genes was regulated by 
promoters located outside of the 
Mu right end. The lux-transposon 
was capable of inserting at 
random or in either orientation 
into chromosomal or plasmids 
DNA. 
(Engebrecht et al., 
1985) 
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Early efforts at lux-tagging microorganisms involved cloning the luxAB genes which 
encode the catalytic luciferase enzyme and the substrate for the reaction was added 
exogenously. It is now more common and more efficient to clone the entire lux gene 
cluster, luxA-E, so that in addition to producing the luciferase enzyme the 
recombinant strain also produces the substrate. The lux genes can be placed under the 
control of a variety of promoters depending on the particular application. For 
constant expression, the lux genes can be placed under the control of a constitutive 
promoter which can be optimized for the host strain. For example Riedel and co-
workers altered the constitutive Lactococcus consensus promoter PCP25 by 
introducing the 5’ untranslated region of the Listeria monocytogenes hlyA gene. This 
new promoter Phelp (help; highly expressed Listeria promoter) gives a strong signal in 
Listeria and other genera (Riedel et al., 2007a; Riedel et al., 2007b). The lux system 
can also be used as a reporter of gene expression. The promoter of any gene of 
interest can be fused to the lux genes on a plasmid vector. When environmental 
conditions induce expression of the promoter the lux genes are expressed and light is 
emitted. For example a hly promoter fusion study confirmed that this L. 
monocytogenes promoter was induced by heat shock (Park et al., 1992) and similarly 
a ces promoter fusion study was used to examine expression of the Bacillus cereus 
cereulide toxin gene in various foods (Dommel et al., 2010). 
In certain cases, the stability of plasmids used to lux-tag strains may be an issue and 
antibiotic addition may be required to maintain the plasmid. This problem may be 
addressed by using plasmids which integrate into specific sites on the bacterial 
chromosome. Examples include plasmid p16Slux which integrates into the 16S 
rRNA gene of Gram negative bacteria, including Escherichia coli, Cronobacter 
sakazakii, Citrobacter rodentium, Salmonella Typhimurium and Pseudomonas 
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aeruginosa (Riedel et al., 2007a) or plasmid pPL2lux which integrates into the 
tRNA
Arg
 locus in the L. monocytogenes chromosome (Bron et al., 2006). Single copy 
integration systems may be preferred over multi-copy plasmid systems when 
expression levels of promoters are assayed. Howe et al. (2010) generated a plasmid 
where luxA-E genes under the control of the constitutive E. coli frr promoter are 
flanked by Tn7 transposon arms. The plasmid also contains tnsABCD genes required 
for transposition and the plasmid inserts at the attTn7 site in the genome. This system 
was used to successfully and stably confer bioluminescence to eleven Salmonella 
enterica strains (Howe et al., 2010). 
 
3.1 Transposons 
Bioluminescent strains can also be generated by transposon mutagenesis where lux 
genes are transferred on transposons which usually integrate randomly into the 
bacterial chromosome. The lux genes can be placed under the control of a 
constitutive promoter e.g. EM7 promoter for Tn5 (Burns-Guydish et al., 2005). 
Alternatively, promoterless lux genes can be used and the lux genes are then 
expressed via a promoter it acquires upon transposition. In this case the bank of 
transposants must first be screened for mutants with strong light emission (e.g. Maoz 
et al., 2002). It has been noted that creation of lux-tagged strains using transposons 
may not be suitable for all studies as integration of a transposon may potentially 
influence bacterial pathogenesis. For example in a study by Hardy and coworkers 
(2004) the lux-tagged L. monocytogenes transposon mutant used was significantly 
attenuated when compared to the parent strain; the LD50 was 4-fold higher than that 
of the parent strain (Hardy et al., 2004). 
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3.2 Benefits and limits of lux-based assays 
One of the major advantages of luminescent reporters over other classical reporters 
such as green fluorescent protein (GFP) is the shorter half-life of luciferases, which 
allows for repeated measurement in quick succession (Waidmann et al., 2011). In 
addition, fluorescent reporters have to be excited prior to measurements, which can 
result in a high background of autofluorescence (Shaner et al., 2005). This problem 
was not encountered with luciferase reporters and background luminescence is low. 
Bioluminescent imaging is a faster and less labour intensive method of tracking 
bacterial growth when compared to conventional methods such as performing viable 
plate counts. While the latter requires preparation of media, overnight incubation of 
plates and enumeration the following day, bioluminescence readings can be 
measured in real-time and the output is instantaneous. The use of automated 
microtitre plate readers allows large numbers of samples to be assayed at a time and 
experiments can easily be performed over long time frames without the need for 
researcher input, thereby increasing laboratory efficiency. Bioluminescence methods 
are non-destructive as measurements can be made in situ in food products with 
minimal or no matrix disruption. Information can be obtained with regard to the 
precise location of bacteria in food and can determine hotspots of contamination. 
Other methods used to assess food samples require complete disruption of the food 
matrix before bacterial enumeration, resulting in a loss of spatial information. 
Bioluminescence-based methods may be of use in monitoring growth of bacteria in 
opaque liquids such as milk which are not conducive to optical density 
measurements. Growth in opaque liquids is generally examined by performing plate 
counts or indirect methods such as measuring pH. Monitoring growth by measuring 
13 
 
bioluminescence is now being considered as a more attractive alternative (Morrissey 
et al., 2011). 
The production of reduced flavin mononucleotide is limited by a functional electron 
transport chain, meaning only metabolically active cells can emit light (Alloush et 
al., 2006, Howe et al., 2010). However, this may also be considered beneficial as the 
monitoring of light output over time may tell if a microorganism is growing (increase 
in light emission), dead (decrease in light emission) or injured (light output remains 
constant) (Griffiths, 2000). A shortcoming of using the luciferase system is that 
oxygen is required for light emission meaning that light output cannot be measured 
under anaerobic conditions. Another potential drawback of lux-tagging is that the 
strain of interest must be engineered to contain the lux genes and this is not always 
possible for all strains. It is also possible that the expression of the luciferase and 
accessory proteins and the process of light emission may place a burden on bacterial 
metabolism and may impair growth of some strains. It should also be noted that 
certain compounds may quench or enhance the luciferase reaction (e.g. strong 
disinfectants and detergents) so it is imperative that appropriate controls are included 
in experiments. 
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4. Applications of lux-tagged microorganisms in the food industry 
Bioluminescence can be employed to track bacteria in real-time in a fast, reliable, 
non-destructive manner. The following sections describe studies which highlight the 
potential applications of lux-tagged microorganisms in the food industry and their 
advantages over conventional approaches. 
 
4.1 Reporter of the microbial ecology of foods 
Bioluminescence-based systems can be employed to study the microbial ecology of 
foods and offer a rapid and simple method of establishing whether food products can 
support the growth of a particular microorganism. Experiments can be performed in 
situ in the food product and bioluminescence can be measured in opaque matrices 
and in the presence of background microflora (See Fig. 2 for examples). 
Bioluminescent reporter organisms can be used to monitor survival of bacteria during 
simulated manufacturing processes and show potential as tools for developing 
quantitative risk assessment models, where the data obtained could be applied to 
determine appropriate preservation regimes and storage conditions. 
Bioluminescence-based systems can also provide information on the spatial 
distribution of bacteria in food and identify hot-spots for contamination. Specific 
studies from the literature have been selected to highlight the aforementioned 
applications of bioluminescence-based assays. 
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Fig 2. Bioluminescent images of (A) lux-tagged C. sakazakii in infant formula, (B) 
lux-tagged S. enterica serovar Typhimurium in egg yolk emulsion and (C) lux-tagged 
L. monocytogenes on minced meat. All images were taken with an Xenogen IVIS 
100 Imager.  
 
 
 
(A) 
 
(B) 
 
(C) 
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Bioluminescent E. coli and Listeria have been used to determine post-processing 
survival of these bacteria in yoghurt and cheese, lux-tagged Campylobacter jejuni 
were used to assess egg shell colonization and penetration in eggs and the survival of 
bioluminescent E. coli in fermented sausage has also been examined (Chen and 
Griffiths, 1996a, Hudson et al., 1997, Fratamico et al., 1997, Tomicka et al., 1997, 
Ramsaran et al., 1998, Allen and Griffiths, 2001). Riedel et al. (2007b) investigated 
growth of a lux-tagged L. monocytogenes strain in hot dogs and Camembert cheese, 
two food products commonly associated with Listeria contamination, by measuring 
bioluminescence and performing viable plate counts. Results showed that Listeria 
grew well in hot dog homogenate and that during exponential growth 
bioluminescence readings closely correlated with plate counts. High standard errors 
were recorded for plate counts performed on cheese homogenates and no significant 
growth of Listeria was observed (Riedel et al., 2007b). In comparison, luminescence 
readings were more reproducible and they indicated a two-fold increase in bacterial 
numbers (Riedel et al., 2007b). Low standard errors were recorded for luminescent 
results and therefore these results were deemed to be more accurate than manual 
plate counts recorded. Chen & Griffith (1996a) used lux-tagged Salmonella 
enteritidis to determine whether the strain could penetrate the membrane of an egg 
and grow in the egg under varying storage conditions. Results revealed that the strain 
could not penetrate the egg membrane but could grow in the space between the shell 
and the membrane. It was also shown that the lux-tagged strain remained 
metabolically active in the egg for up to four weeks at 4°C (Chen and Griffiths, 
1996a). A study by Maoz et al. (2002) used a bioluminescent mutant of Yersinia 
enterocolitica to monitor growth of the strain on Camembert cheese. Bioluminescent 
readings determined that although the entire surface of the cheese samples were 
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initially contaminated with Y. enterocolitica, over time certain areas on the cheese 
became more highly contaminated than others (Maoz et al., 2002). This implies that 
the local micro-heterogeneity of food plays an important role in pathogen distribution 
on the surface of the food and that this can be tracked using bioluminescence. A 
similar study used bioluminescent readings to show that light emitting L. 
monocytogenes only grew in Camembert cheese on sites close to the surface of the 
cheese. This confirmed that the altered pH in this region, due to growth of 
Penicillium camembertii, promoted growth of the pathogen (Ramsaran et al., 1998). 
Howe et al. (2010) developed a reporter system for lux-tagging Salmonella strains 
and evaluated the performance of the strains on chicken skin sections at two 
temperatures in an aqueous environment. The authors suggest that their model may 
be employed to evaluate the in vitro efficacy of pathogen mitigation strategies such 
as antimicrobial compounds, and examine processing parameters that may be used in 
the poultry processing industry to control Salmonella (Howe et al., 2010). 
Chapter II of this thesis demonstrates the benefits of lux-technology in monitoring 
growth of bacteria in opaque liquids. This study showed that growth of the pathogen 
C. sakazakii could easily be measured in real-time in reconstituted infant formulae by 
monitoring bioluminescence even when low initial inocula were used. It was also 
noted that light could be detected in the presence of competing bacteria (Morrissey et 
al., 2011). This is important as infant formula is not produced in a sterile 
environment and contains a resident microflora. Overall, results of this study suggest 
that lux-technology could potentially be employed to examine the influence of 
various ingredients and inhibitors on the growth of C. sakazakii and assist in the 
development of novel infant formula. 
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Lux-tagged strains can be employed to understand the effects of storage time on the 
microbial food safety of products. This is important as when products approach the 
end of their shelf life the concentration of preservatives may be rapidly decreasing 
due to their instability or interaction with the food matrix. Bioluminescence-based 
biosensors have been used to determine the levels of bacteriocins such as Nisin in 
food samples (Immonen and Karp, 2007). The assay was very sensitive; having the 
ability to detect 0.1 pg/ml in pure solution and 3 pg/ml in opaque solution (Immonen 
and Karp, 2007). This technique therefore allows for extensive dilutions of food 
samples prior to nisin quantification; this subsequently minimizes the impact of 
possible interfering factors in food matrices such as milk (Immonen and Karp, 2007).  
Bioluminescence also has applications in the study of pathogen colonization 
dynamics in plants. Clavibacter michiganensis subsp. michiganensisis is a Gram 
positive bacterium that causes wilting and bacterial canker in tomatoes, resulting in 
economic loss for growers. The method of infection in tomatoes is known; however, 
the mechanism of seed-to-seedling transmission is not well understood. Xu et al. 
(2010) constructed a lux-tagged C. michiganensis strain that allowed bioluminescent 
tracking of the colonization dynamic in tomato plants. When healthy tomato 
seedlings were inoculated with the bioluminescent strain by soaking, and careful 
dissection, it was revealed that the lux-tagged strain aggregated at highest levels on 
the hypocotyles and cotyledons (found in plant seedlings), during the early stages of 
germination (Xu et al., 2010). It was also shown that the colonization dynamics of C. 
michiganensis infection of on seedlings promoted future infection when real-time 
imaging showed that BL-cmm17 aggregated on the hypocotyls and cotyledons (Xu et 
al., 2010). With this information, attempts can be made to prevent or control C. 
19 
 
michiganensis aggregation, during the germination stage, which in turn could 
contribute to the improved shelf-life of tomato plants.  
 
4.2 Studying injury and survival of pathogenic and spoilage microorganisms 
Bioluminescence-based assays can be used to understand the factors affecting the 
growth and survival of pathogens in foods or food-related environmental conditions 
(e.g. low temperature), and may aid in determining appropriate storage conditions or 
the development of novel bioprocessing technologies. 
Ellison and co-workers (1991) used bioluminescent imaging (BLI) as a real-time 
monitor of cell injury and recovery of S. Typhimurium following freezing at -20°C. 
Frozen cells were thawed and subsequently compared to the non-frozen cells. 
Bioluminescence was measured and manual plate counts were performed. Though 
both methods yielded the same results, the bioluminescent measurements were 
produced in real-time and showed that immediately after thawing there was a five-
fold decrease in the number of viable cells recovered (Ellison et al., 1991). Chen and 
Griffiths used bioluminescence as a real-time reporter of the effects of heat 
treatments (50°C, 55°C and 65°C) and pH (from 1 to 7) on the survival, growth and 
recovery of Salmonella cells (Chen and Griffiths, 1996a, Chen and Griffiths, 1996b). 
The lux-tagged strains were also used to monitor growth and survival of the pathogen 
in food samples including homogenized chicken meat, whole liquid egg and fluid 
milk. Duffy & co-workers (1995) used bioluminescence to model the thermal 
inactivation of Salmonella Typhimurium. This revealed that, while severely heat-
treated cells could not be detected by viable plate counts, bioluminescence recovery 
curves could be extrapolated to study lower survival levels (Duffy et al., 1995). The 
authors conclude that for their thermal inactivation experiments the bioluminescence 
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and plate count data showed complete equivalence and suggest that bioluminescence 
could be used for future experiments without parallel plate counts. It was also noted 
that production of bioluminescence was unaffected by the presence of competing 
microorganisms which included E. coli, Citrobacter freundii and Pseudomonas 
fluorescens. 
Duncan and colleagues (1994) used bioluminescence to detect the activity of starved 
and viable but nonculturable bacteria (Vibrio harveyi, E. coli and P. fluorescens). 
Measurement of luminescence was found to be significantly more sensitive, rapid 
and convenient in quantifying metabolic activity following nutrient amendment 
(addition of yeast extract and nalidixic acid) than measurement of changes in cell 
length (Duncan et al., 1994). This technique could potentially be applied to the food 
industry to assess nutrient limitations in a number of food systems. Liu and co-
workers (2008) used a lux-tagged L. monocytogenes strain to demonstrate that 
heterologous production of the bacteriocin enterocin A by a Lactococcus starter 
strain could decrease numbers of the pathogen in cottage cheese (Liu et al., 2008). 
Lux technology has also been used to demonstrate the enhanced activity of a variant 
of the bacteriocin Nisin against L. monocytogenes in frankfurters (Field et al., 
2010c). 
Bacterial spores are generally not considered a hazard in foods as they are 
metabolically dormant. However, spores can germinate under favourable conditions 
and the subsequent growth, proliferation and/or toxin production can result in food 
spoilage or food poisoning. Food manufacturers commonly use heat treatments to 
reduce spores in foods; however, these treatments may negatively affect the taste and 
organoleptic quality. Furthermore, the effects of preservation treatments used to 
target spores are not fully understood; for example, it is not always known if 
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treatments kill or injure spores or affect spore germination and vegetative outgrowth 
(Ciarciaglini et al., 2000). Bioluminescence-based experiments may be of use in 
addressing this lack of information. Ciarciaglini et al. (2000) used a strain of Bacillus 
subtilis in which the lux genes were placed under the control of the promoter for sspB 
(encoding the spore coat associated small acid soluble protein). This system resulted 
in light emission only from germinating spores and was used to monitor the effects 
of preservative treatments on germination. It was demonstrated that the combination 
of mild acidity, lactic acid and a pasteurization step resulted in enhanced inhibition 
of spore germination compared with the effects of the individual treatments alone 
(Ciarciaglini et al., 2000). The authors highlight the advantages of the 
bioluminescence-based system over traditional methods of monitoring germination 
including rapidity, automated data capture and the ability of performing high 
throughput assays. Experiments can be performed in microtiter plates meaning that 
only small quantities of spores are required but more importantly it easily allows the 
study of potentially hundreds of treatment conditions. Germination-induced 
bioluminescence reporter systems can be employed to optimize existing preservation 
treatments and study the effects of new treatments or combination of treatments in 
order to develop milder preservation systems. 
 
4.3 Reporters of virulence gene expression and pathogenesis 
Lux-based gene expression experiments may provide information on how food 
ingredients, food compositions and environmental storage conditions affect 
expression of virulence genes. For example, lux-based approaches can be used to 
examine the expression of bacterial toxins in foods. This could identify potential 
sources of risk to the consumer as it could be used to assign foods and food 
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ingredients into different risk categories according to their ability to support toxin 
production. This application of lux-technology has been elegantly demonstrated in B. 
cereus by Dommel et al. (2010). The promoter of the cereulide toxin gene ces was 
fused to lux genes and the activity of the promoter in different foods was monitored 
by measuring bioluminescence. High promoter activity was observed in cooked rice 
while only intermediate promoter activity was observed in Camembert cheese 
(Dommel et al., 2010). This finding is interesting as reports of emetic food poisoning 
implicate starchy foods rather than proteinaceous foods. A selection of retail food 
products (crème fraiche, pastry snack, Quark dessert, Camembert cheese, sauce 
Bernaise and cooked pasta) were inoculated with the bioluminescent B. cereus 
reporter strain and examination of bioluminescence allowed division of foods into 
categories by their potential to support toxin synthesis (low risk, risk and high risk). 
The amount of cereulide toxin extracted from spiked foods correlated well with the 
bioluminescence data. The authors conclude that as methods required for cereulide 
quantification are time consuming, laborious and error prone (especially from fat-
rich foods), the bioluminescence-based approach developed may be an attractive 
alternative (Dommel et al., 2010). Sheehan and co-workers (1992) fused the 
promoter of the S. aureus eta gene (encoding epidermolytic toxin A) to lux genes and 
examined the effects of environmental conditions on promoter expression by 
measuring bioluminescence (Sheehan et al., 1992). A study by Cotter et al. (2008) 
investigating Listeriolysin S (LLS), a peptide haemolysin associated with L. 
monocyogenes strains responsible for the majority of listeriosis outbreaks, used a lux 
reporter system to demonstrate that lls is induced by oxidative stress (Cotter et al., 
2008).  
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Lux-tagged pathogens can be employed in in vitro and in vivo models of infection. 
For example, bioluminescent high-throughput assays can be employed to examine 
the interaction of bacteria with mammalian intestinal cells in vitro (Brovko et al., 
2011). Shimizu and co-workers (2011) constructed a bioluminescent reporter system 
to examine expression of Shiga toxin genes stx1 and stx2 in enterohemorrhagic E. 
coli 0157. This revealed that expression of stx1 and stx2 was enhanced upon contact 
with intestinal epithelial cells and within macrophages (Shimizu et al., 2011). 
Bioluminescence can also be used to examine pathogen infection in animal models 
such as mice and permits monitoring of the spatiotemporal distribution in various 
organs as demonstrated by Bron et al. (2006) and Hardy et al. (2004) for L. 
monocytogenes. Live animals can be imaged several times over the course of an 
experiment allowing a reduction in the number of animals required for a given 
experiment (See Fig. 3). Experiments performed with lux-tagged L. monocytogenes 
strains have revealed that the ability to grow in the gall bladder may be an important 
facet of listerial pathogenicity. Hardy et al. (2004) demonstrated that the bacterium 
could grow extracellularly in the lumen of murine gall bladders. Further 
bioluminescence-based investigations by this group demonstrated that Listeria could 
be released from the gall bladder into the intestine via bile providing a means of re-
infecting the same animal or allowing excretion in feces (Hardy et al., 2006). Dowd 
and co-workers (2011) demonstrated growth of lux-tagged L. monocytogenes in ex 
vivo porcine gall bladders (Dowd et al., 2011). 
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Fig 3. Visualisation of a L. monocytogenes-infected mouse over a three day period. 
The mouse was orally infected with lux-tagged L. monocytogenes and images were 
taken daily with a Xenogen IVIS 100 Imager.  (Hill, unpublished image). 
 
4.4 Detection of pathogens 
The detection of food pathogens is critical for food safety. Traditional detection and 
identification methods are primarily phenotype-based and measure biochemical and 
antigenic properties. These approaches are usually laborious, time consuming and 
costly so alternative approaches are desirable. Bioluminescence-based methods for 
detection of bacteria have been investigated. This involves cloning the lux genes into 
a host specific bacteriophage and upon infection the lux genes are transferred to the 
host bacterium, transcribed and produce light (Griffiths, 2000). Luminescence cannot 
be expressed and emitted until the lux genes have been transferred to the bacterial 
host, as the bacteriophage do not contain the intracellular biochemistry to transcribe 
the genes themselves (Griffiths, 2000). This approach has successfully been applied 
 
Day 1 Day 2 Day 3 
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to several foodborne pathogens including E. coli, L. monocytogenes, S. aureus, 
Mycobacterium tuberculosis and S. Typhimurium (Ulitzur and Kuhn, 1987, Chen 
and Griffiths, 1996b, Loessner et al., 1997). 
Ulitzur & Kuhn (1987) added lux-modified L4 bacteriophage to E. coli W3110 and 
observed that the amount of light produced was directly related to the initial 
inoculum of the E. coli present in the medium and that as few as 10 cells could be 
detected within 100 minutes (Ulitzur and Kuhn, 1987). The lux L4 phage was also 
capable of detecting E. coli W3110 in sterile milk and could detect 10 E. coli cells/ml 
of milk within 30 minutes (Ulitzer and Kuhn 1987). Turpin & co-workers (1993) 
developed a lux-tagged phage to detect Salmonella. The method was found to be 
selective, it could detect Salmonella cells present in mixed cultures and in 
environmental samples, and there was an excellent correlation between luminescence 
and standard plate counts. It was also noted that no false positives or negatives were 
obtained (Turpin et al., 1993). Chen & Griffiths (1996b) used lux-tagged phages to 
detect Salmonella in eggs. Eggs contaminated with 10
3
 CFU of Salmonella became 
luminescent after 16 h of incubation, however, the limit of detection could be 
decreased to a little as 63 Salmonella cells when the incubation period was extended 
to 24 hours. Loessner & co-workers (1996) constructed a lux-tagged bacteriophage 
for detection of L. monocytogenes and established that following infection and a 2 h 
incubation period between 10
2
 and 10
3 
L. monocytogenes cells per ml of media could 
be detected. The authors subsequently demonstrated that with a short enrichment step 
(20 h) the phage was capable of detecting very low (less than 1 cell per gram of 
contaminated food) initial bacterial numbers in foods artificially contaminated with 
L. monocytogenes (Loessner et al., 1996). These foods included ricotta cheese, 
chocolate pudding and cabbage, and foods with large background flora such as 
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minced meat and soft cheese (Loessner et al., 1997). When this lux-tagged phage 
method was used for detection of L. monocytogenes in natural food and 
environmental samples from within the dairy plant, it was found to be as sensitive as 
standard plating procedures. It was noted, however, that the time required for 
detection of Listeria with the luciferase phage assay was 24 h compared to the four 
days needed for the plating method. 
These examples illustrate that bioluminescence-based pathogen detection methods 
are sensitive, reliable and capable of detecting pathogens in the presence of 
background bacteria. The sensitivity of assays can be improved further by including 
an enrichment step. The construction of “locked” lux-tagged phages has been 
reported. These phages carry lux genes but because they lack an essential gene they 
cannot grow until it infects a host that synthesizes the missing protein. These 
“locked” phages may prevent accidental release of the genetically modified phage 
into the environment (Kuhn et al., 2002). 
 
4.5 Biofilm formation and biocide efficiency  
Biofilms are sessile communities of cells which attach to surfaces and are known to 
enhance resistance of cells to environmental stresses (Kumar and Anand, 1998, 
Marshall, 1992) and provide protection against routine disinfectants and sanitizers 
(Kim et al., 2006, Kim et al., 2007a). Biofilms have been shown to occur in food 
preparation areas, on utensils, and conveyer belts, as well as on a number of other 
surfaces in food preparation facilities (Kumar and Anand, 1998). They are of major 
concern to the food industry as they cannot be removed by normal cleaning regimes 
and increase the risk of food-borne illness through cross contamination with raw 
ingredients. Biofilm formation and attachment has been demonstrated in a variety of 
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bacteria including E. coli, L. monocytogenes, C. sakazakii and Pseudomonas putida 
(Siragusa et al., 1999, Hibma et al., 1996, Hurrell et al., 2009, Chumkhunthod et al., 
1998). 
Bioluminescence provides a fast and easy way of monitoring biofilms and enables 
one to determine how various environmental factors influence their formation and 
growth. Hibma et al. (1996) employed a lux-tagged L. monocytogenes strain to study 
the attachment of biofilms to stainless steel surfaces and intravenous rubber tubing. 
Results showed that the luminescent signals recorded were similar to that of the 
manual plate counts and in some instances, the bioluminescent bacteria proved more 
efficient, as it gave results in real time whereas manual counts required longer 
periods of time for colony formation (Hibma et al., 1996). Siragusa et al. (1999) used 
a lux-tagged E. coli strain to examine the ability of the organism to adhere to beef 
carcass tissue. Analysis of the bioluminescent output was higher on the lean fascia 
covered tissue than on adipose fascia covered tissue. This suggests that the physical 
topography and structure of a surface influences the bacterial association of biofilms 
to that surface (Siragusa et al., 1999). It was noted that luminescence strongly 
correlated with bacterial counts. 
Bioluminescence can be used to rapidly test the efficacy of sanitizers and 
disinfectants. Fabricant & co-workers (1995) investigated the effects of five biocides 
on four strains of bioluminescent E. coli. Results demonstrated that bioluminescent 
E. coli responds rapidly to varying concentrations of biocides (Fabricant et al., 
1995). Robinson & co-workers (2011) investigated the use of a lux-tagged E. coli as 
a whole-cell bioreporter of the very early stage of kill of fast-acting biocides under 
clean conditions and in the presence of organic soil. Their findings showed that even 
among biocides with similar mechanisms of action or with common active agents 
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there are differences in their activity during the very early phase of kill. The authors 
note that these differences would not be measurable using traditional recovery count 
methods due to the time required to transfer samples to neutralising diluents 
(Robinson et al., 2011). This study highlights how bioluminescent-based 
experiments can provide a greater understanding of the mechanism and kinetics of 
microbial kill by biocides. 
Bioluminescent strains have been employed to rapidly monitor the efficacy of 
santizers against biofilms.  For example Chumkhunthod et al. (1998) used 
luminescent P. putida to examine the effect that two sanitizers employed in dairy 
plants for cleaning in place (a non-foaming acid sanitizer and a liquid hypochlorite 
sanitizer) had on this organism. Results demonstrated that neither sanitizer could 
completely eliminate biofilm-associated P. putida. The authors concluded that 
microbial bioluminescence was better for assessing the effectiveness of sanitizers 
against microbial biofilms as compared to manual plate counts as bioluminescence 
produced results in real-time (Chumkhunthod et al., 1998).  
Bioluminescence-based approaches may be of use in evaluating the efficacy of 
biocides, but it is important to note that some stronger disinfectants and detergents 
may either enhance or quench the luminescent reaction. For example ethanol at 1% 
v/v inhibited the luminescent reaction by 15% while ethanol at 4% v/v enhanced the 
luminescent reaction (Calvert et al., 2000).   
Bioluminescence can be used to examine the expression of specific genes associated 
with biofilm formation (Rice et al., 1995, Wallace et al., 1994). For example, 
Wallace et al. (1994) investigated the role of the exopolysaccharide alginate in 
adherence and biofilm formation by P. aeruginosa by creating a  algG-lux reporter 
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fusion plasmid and were easily able to demonstrate the effect of environmental 
stimuli and carbon sources on algG expression (Wallace et al., 1994).    
 
4.6 Probiotics 
In recent years there has been growing interest in the addition of probiotic bacteria to 
functional food products for the maintenance of general gastrointestinal health and 
the prevention of intestinal infections (FAO/WHO, 2001, Ross et al., 2005). In order 
for probiotic bacteria to elicit their positive effects on the host they must be 
successfully delivered to and survive in the gastrointestinal tract. Bioluminescence-
based methods are currently used in research to elucidate the behaviour of probiotic 
strains both in vitro and in vivo. Non-invasive, lux-based reporters could be used to 
monitor probiotic bacteria capable of reaching the gut in high numbers and 
subsequently interacting in a positive way with the gastrointestinal tract. Using this 
knowledge, robust probiotic strains could be identified and used to develop novel 
functional foods. This technology could help the food industry to identify the most 
effective mode of probiotic delivery to the gastrointestinal tract (Jiang et al., 2006). 
Advances in genetic tools for manipulation of probiotic strains means that it should 
be possible to transform them with lux genes. Indeed, Jiang et al. (2006) transformed 
lactic acid bacteria with lux genes and Loessner and colleagues (2009) lux-tagged E. 
coli Nissle (Loessner et al., 2009). Cronin and colleagues (2008) developed a lux-
based reporter system for tracking of Bifidobacterium breve in mice and the authors 
were able to track the colonisation potential and persistence of this probiotic species 
in real-time (Cronin et al., 2008). 
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4.7 Monitoring starter culture activity 
Starter culture strains used in the production of fermented foods can be inhibited by 
phage or antibiotics. In order to limit any potential negative effects of phage or 
antibiotics, starter strain rotation strategies (SSR), which involve rotating the number 
and type of starter strains used in the batch fermenter, are employed. However, SSR 
requires detailed information on each starter used and results in inconsistent flavours 
and textures. Currently the most popular method of assessing starter culture activity 
is direct measurement of lactic acid levels using the Heap-Lawrence starter culture 
activity test (Durmaz and Klaenhammer, 1995, Sing and Klaenhammer, 1993). This 
test requires several hours to yield a result and can only be carried out once the 
starters are added to the fermentation tanks.  
Lux genes have been introduced into strains of lactic acid bacteria including 
Lactococcus lactis, Lactobacillus casei and Lactobacillus plantarum and 
bioluminescent-based assays have been successfully used to detect antibiotics and 
bacteriophage in whole milk. Ahmad & Stewart used a bioluminescent strain of 
Lactococcus lactis subsp. diacetylactis and were able to detect bacteriophage active 
against that organism at concentrations as low as 10
5
/ ml in 100 minutes (Ahmad and 
Stewert, 1988, Ahmad and Stewart, 1991, Stewart, 1990). Using a luminescent 
derivative of Lactobacillus casei, low levels of antibiotics could be detected in milk; 
for example 0.3 µg/ml of penicillin G could be detected in milk in less than 30 
minutes (Dostalek and Branyik, 2005, Ulitzur, 1986). These experiments highlight 
the potential of using lux-tagged starter strains to develop rapid and robust methods 
to assess the presence of bacteriophage or antibiotics in milk. Non-lux-tagged 
counterparts can subsequently be used in the cheese making process. 
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5. Conclusion and future directions 
It is evident that bioluminescence-based assays have numerous potential food 
industry-related applications and offer many advantages over traditional methods, 
which are usually microbiologically based. Bioluminescence-based assays may be of 
particular benefit to the field of food safety. Ensuring a safe food supply is a major 
challenge to the food industry especially since there is increased consumer demand 
for minimally processed, ready-to-eat foods. Bioluminescence-based assays can be 
used to examine the growth and survival of pathogens in various foods and under a 
variety of storage conditions. The availability of the entire genome sequences of 
food-borne pathogens will facilitate lux-based promoter probe assays, which may aid 
in elucidating the mechanisms employed by pathogens to adapt to the conditions 
encountered in food processing surroundings. It is becoming increasingly obvious 
that the environment to which a food-borne pathogen is exposed prior to ingestion 
can affect the outcome of infection. Lux-tagged strains can be used to easily examine 
the effects of various food compositions or storage conditions on the ability of 
pathogens to cause disease in animal models. Taken together, the results of these 
assays may aid in the design of optimal processing regimes or the development of 
novel preventative and control strategies which in turn may ultimately lead to a safer 
food supply. Bioluminescence-based assays may also have many potential uses in the 
area of beneficial food microbiology including the development of functional foods 
containing probiotics or monitoring starter culture activity. Lux-technology may also 
be of benefit to the improvement of hygiene in food processing environments by 
providing important insights into bacterial biofilm formation and biocide resistance. 
In conclusion, lux-based technologies offer a sensitive, real-time, spatial and 
temporal methodology for monitoring the presence, quantity and behaviour of 
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bacteria in situ in complex food systems, something which has been a goal of food 
microbiologists since the first recognition of the importance of bacteria in food 
systems. 
 
 
Aims of this thesis 
The objectives of this thesis were to examine the potential applications of 
luciferase-tagged microorganisms to the food industry. The first aim was to monitor 
a lux-tagged Cronobacter sakazakii in reconstituted infant milk formula, in real-
time. The second aim was to investigate a bioluminescent-based early warning 
system for starter culture disruption by bacteriophages and antibiotic residues. The 
third of this thesis was to examine the use of a bioluminescent-based assay to test 
the activity of bioengineered Nisin derivatives M21V and S29A against foodborne 
pathogens in laboratory media and selected foods.    
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Chapter II 
 
Real-Time Monitoring of Luciferase-Tagged 
Cronobacter sakazakii in Reconstituted Infant Milk 
Formula 
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Abstract 
The aim of this study was to examine the potential of using a lux-tagged Cronobacter 
sakazakii strain to monitor growth of the bacterium in various liquids. C. sakazakii 
was transformed with plasmid p16Slux and integration of the plasmid at the desired 
site on the chromosome was confirmed by PCR. The growth of the lux-tagged strain 
was similar to that of the non–lux-tagged strain and the integrated plasmid was stable 
when cells were cultured in the absence of antibiotic. Growth of the lux-tagged strain 
was monitored in real-time in Luria-Bertani broth, skim milk and infant milk formula 
by using both the Luminoskan luminometer and the Xenogen IVIS imager. 
Bioluminescence could be detected when the lux-tagged strain was co-cultured with 
other bacteria. The effect of monocaprylin and nisin on the growth of C. sakazakii in 
milk was monitored by measuring bioluminescence. In conclusion, growth of a lux-
tagged C. sakazakii can be monitored in real time in both clear and opaque liquids by 
measuring bioluminescence. Lux-tagged C. sakazakii strains could be potentially 
employed in high-throughput assays to monitor the effects of various infant milk 
formula compositions on growth of the bacterium. 
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Introduction 
Enterobacter sakazakii was described as a new species in 1980 (Farmer et al., 1980, 
Kucerova et al., 2010). Members of this species were shown to be relatively 
heterogenous, and extensive geno- and phenotypic evaluations led to the definition of 
six new species that were moved to a new genus, named Cronobacter (Iversen et al., 
2007). Although Cronobacter infections in adults have been reported, infants and 
children are considered to be most at risk. Infections can result in necrotizing 
enterocolitis, sepsis and meningitis and mortality rates can be as high as 40 to 80% 
(Back et al., 2009, Breeuwer et al., 2003, Cawthorn et al., 2008, Iversen and 
Forsythe, 2003, Liu et al., 2006, Willis and Robinson, 1988). While Cronobacter 
sakazakii has been isolated from a wide variety of environments and foods (e.g., 
fresh water, plants, spices and vegetables), Powered infant formula (PIF) is thought 
to be the primary transmission vehicle (Al-Holy et al., 2010, Bowen and Braden, 
2006, Drudy et al., 2006, Kandhai et al., 2004, Kandhai et al., 2006, Molloy et al., 
2009, Mullane et al., 2008a, Mullane et al., 2008b, Nazarowec-White and Farber, 
1997). PIF is manufactured in a non-sterile environment and so, given the ubiquitous 
nature of C. sakazakii, contamination with this pathogen is difficult to prevent. 
Microbiological analyses of commercially available PIF’s using the method devised 
by the U.S. Food and Drug Administration have isolated the pathogen from 2.5 to 
14% of samples tested (Iversen et al., 2004, Muytjens et al., 1988). As it is now 
evident that this isolation method has a number of limitations (Lampel and Chen, 
2009), these figures may not reflect the true occurrence of C. sakazakii in PIF.  
Research is currently focusing on updating detection methods by using a 
combination of microbiological and molecular methods (Lampel and Chen, 2009). 
Given the serious consequences of C. sakazakii infections and the economic costs of 
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product recalls, PIF manufacturers are devoting considerable efforts to preventing 
product contamination by the bacterium. Research is also focusing on identifying 
anti-Cronobacter agents, such as antimicrobial peptides, monoglycerides, etc., that 
can inhibit or kill the pathogen if present in the product (Hayes et al., 2009, Nair et 
al., 2008). Furthermore, as PIF manufacturers are continuously developing food 
ingredients destined for consumption by infants, to ameliorate milk allergies and 
influence the composition of gut microbiota, it will be vital to examine the effect of 
varying PIF compositions on the growth and survival of C. sakazakii. As 
reconstituted PIF is opaque and does not lend itself to optical density measurements, 
growth of the bacterium is generally examined by performing direct plate counts 
(Nair et al., 2008) or, indirectly, by measuring pH changes (Chang et al., 2010) or 
alterations in electrical impedance. These methods can be time-consuming; thus, a 
faster method of monitoring C. sakazakii growth would be beneficial.  
A method for lux-tagging Gram-negative bacterial strains by using p16Slux has 
recently been developed in our laboratory (Riedel et al., 2007a). This plasmid 
contains the lux operon derived from Photorhabdus luminescens, under the control of 
the constitutive promoter Phelp (the subscript ‘‘help’’ is an acronym for ‘‘highly 
expressed Listeria promoter’’) (Riedel et al., 2007b) and facilitates homologous 
recombination–based integration into the 16S rRNA gene of Gram-negative bacteria. 
The aim of the present study was to examine the growth characteristics of a lux-
tagged C. sakazakii strain and explore its potential use in monitoring real-time 
growth of the bacterium in liquids including reconstituted infant formula (RIF). 
 
 
 
37 
 
Materials and Methods 
Bacterial strains, media, and chemicals 
C. sakazakii NCTC 8155 was transformed with plasmid p16Slux as previously 
described (Riedel et al., 2007a). Escherichia coli, Salmonella Typhimurium, Listeria 
monocytogenes, Bacillus licheniformis, and Bacillus cereus strains were obtained 
from the University College Cork culture collection. The bacilli were isolated from 
commercial PIF (Begley, Unpublished data). C. sakazakii, E. coli, Salmonella 
Typhimurium, and Bacillus strains were routinely grown in Luria-Bertani (LB) 
medium (Merck, Darmstadt, Germany). L. monocytogenes was grown in brain heart 
infusion broth (Oxoid, Basingstoke, UK) at 37° C with shaking. When required, the 
antibiotic erythromycin (Sigma-Aldrich, MO, USA) was added at a concentration of 
500 mg/ml. Stock solutions of nisin (10 mg/ml; 2.5% nisin from Lactococcus lactis 
N5764 (Sigma-Aldrich, MO, USA) were prepared in sterile water. Stock solutions (1 
M) of monocaprylin (1-octanoyl-rac-glycerol; Sigma-Aldrich, MO, USA) were 
prepared in ethanol. 
 
Plasmid stability 
The lux-tagged C. sakazakii strain was grown overnight (approximately 16 h) in 
triplicate in LB broth containing 500 mg of erythromycin per ml. One millilitre of 
each culture was centrifuged at 9000 x g for 8 min, washed, and resuspended in an 
equal volume of ¼ -strength Ringer’s solution (Merck, Darmstadt, Germany). Two 
hundred microliters was transferred into 10 ml of fresh LB broth without antibiotic. 
Tubes were incubated with shaking at 37 °C for approximately 8 h, after which time 
200 µl of culture was transferred into fresh broth and incubated at 37 °C with 
shaking overnight. This passaging was repeated for a further 3 days. At every 
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passage, 100 µl aliquots were serially diluted in ¼ -strength Ringer’s solution and 
spread plated onto LB agar. Plates were incubated at 37 °C. Fifty random colonies 
from each passage were scored for antibiotic resistance by patching colonies onto LB 
agar and LB agar plus 500 mg/ml of erythromycin. 
 
Molecular biology experiments 
A PCR was performed using primers (Eurofins MWG, Ebersberg, Germany) 
16S_fwd_new (5’ ACACTGGAACTGAGACACGGTCCAGACTCC- 3’) and 
16S_int_rev 5’ TTGTAAAACGACGGCCAGTGAGCGCGCG- 3’) to confirm the 
integration of p16Slux. Reactions were carried out in 50-µl volumes consisting of 
primers, Taq polymerase (Biotaq, Bioline, Luckenwalde, Germany), and 
deoxynucleotide triphosphates (dATP, dTTP, dGTP, and dATP) (Roche Diagnostics 
GmbH, Mannheim, Germany), which were used according to manufacturers’ 
recommendations. Colonies were lysed prior to PCR by suspending a colony in 5 µl 
of water and microwaving at 800 W for 5 min. Amplification of the target region was 
achieved with 30 cycles of 95 °C for 2 min, 53.5 °C for 1 min, and 72 °C for 1 min. 
The PCR was carried out in a T3000 Thermocycler (Biometra, Gottingen, Germany). 
Four microlitres (µl) of the PCR mixture was run on a 1% agarose gel (Invitrogen, 
Carlsbad, CA) at 90 V and 2 A for 60 min with a Power pack 200 (Bio-Rad, 
Hercules, CA). The gel was imaged under UV light in an Innovate gel doc system 
(Alpha Innotech, San Leandro, CA).  
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Monitoring of growth in LB broth by performing viable plate counts and 
measuring bioluminescence 
One millilitre of overnight cultures was centrifuged at 9000 x g for 8 min, washed, 
and resuspended in an equal volume of ¼ -strength Ringer’s solution. A 2% 
inoculum was added to fresh LB broth. Viable plate counts were performed at 
intervals by diluting 100 µl aliquots in ¼ -strength Ringer’s solution and plating onto 
LB agar. Two hundred microliters of the freshly inoculated LB broth was added to a 
96-well white plate (Nunc, Thermo Fisher Scientific, Roskilde, Denmark), and 
bioluminescence measurements were recorded every h in relative light units (RLU) 
by a Luminoskan luminometer automatic plate reader (Thermo Fisher Scientific, 
Roskilde, Denmark). Two hundred microliters was also added to 96-well clear plates 
(Starsted Ltd., Numbrecht, Germany), and bioluminescence was measured in photons 
per second per square centimeter with the IVIS Xenogen Imaging 100 system 
(Xenogen, Alameda, CA) with a binning of 16 and an exposure time of 1 min.  
 
Monitoring bioluminescence in the presence of other bacteria 
C. sakazakii, B. licheniformis, B. cereus (two strains), L. monocytogenes, Salmonella 
Typhimurium, and E. coli overnight cultures (approximately 16 h) were washed in 
Ringer’s solution as previously described. Approximately 4 CFU/ml of C. sakazakii 
per ml was transferred into a fresh tube of LB broth, and an equal level of B. 
licheniformis was added. The tube was vortexed and 200 µl was transferred to a well 
of a 96-well white plate; bioluminescence was measured every h with a Luminoskan 
luminometer. This was repeated for the other bacteria. In each case equal levels of C. 
sakazakii and the competing bacterium were used.  
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Monitoring bioluminescence in milk 
Six popular brands of PIF and two brands of skim milk powder were purchased from 
a local supermarket. RIF was prepared by adding 10 g of powder to 100 ml of boiled 
water cooled to 70 °C, in bottles that were sterilized in a Smartec electronic steam 
sterilizer (Mothercare, Watford, UK). Reconstituted skim milk (RSM) was prepared 
by adding 10 g of skim milk powder to 100 ml of deionized water and autoclaving at 
110 °C for 10 min. Ten-millilitre aliquots of room temperature RSM and RIF were 
transferred into universal containers (Sterilin, Caerphilly, UK) and inoculated with 
200 µl of washed C. sakazakii overnight cultures (1 x 10
9
 CFU). Aliquots of 200 µl 
were added to 96-well plates and bioluminescence was measured every h by both a 
Luminoskan luminometer and a Xenogen IVIS imager as previously described. For 
experiments involving nisin and monocaprylin, the required levels of freshly 
prepared stocks were added to RSM prior to addition of bacteria. As monocaprylin is 
prepared in ethanol, equivalent levels of ethanol alone (i.e., minus monocaprylin) 
were added to RSM to serve as an appropriate control. Aerobic plate counts were 
performed for infant formula by performing serial dilutions in maximum recovery 
diluent (Oxoid, Basingstoke, UK) and plating onto standard plate count agar (Oxoid, 
Basingstoke, UK). Plates were incubated at 37 °C for 48 h.  
 
Reproducibility and statistical analysis 
All experiments were performed in triplicate from three separate cultures (i.e., three 
biological repeats) and repeated twice on two other separate days. The data presented 
are for results obtained on one particular day, but similar results were obtained for 
repeat experiments. Analysis of the scientific data was carried out using the basic 
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statistical software Excel. Statistical significance was determined by Student’s t test 
(P< 0.05). 
 
 
Results 
Analysis of a lux-tagged C. sakazakii strain  
C. sakazakii NCTC 8155 was transformed with plasmid p16Slux by electroporation 
as previously described (Oh and Kang, 2005). This plasmid contains the lux operon 
derived from P. luminescens under the control of the constitutive promoter Phelp 
(Riedel et al., 2007b) and facilitates homologous recombination–based integration 
into the 16S rRNA gene of Gram-negative bacteria (Fig. 1A). Using primers based 
on the integration site, PCR amplification of a 1,163-bp product in the lux-tagged C. 
sakazakii strain confirmed that p16Slux had integrated at the desired location. As 
expected, a PCR product was not amplified from the non–lux-tagged strain (Fig. 1B). 
Examination of strains streaked onto LB agar revealed that, as expected, the lux-
tagged strain emitted light whereas the non-tagged strain did not (Fig. 1C). In order 
to investigate whether the presence of p16Slux or the generation of light interfered 
with bacterial growth under standard laboratory conditions, growth of the strains in 
LB broth was followed by performing viable plate counts at intervals. It was 
observed that the two strains had similar growth rates (Fig. 2A). It was also noted 
that colony shape, size, and morphology were identical for both strains on all media 
examined (LB, tryptic soya agar [TSA] and Druggan Forsythe Iversen (DFI) 
selective agar) and that both strains produced yellow-pigmented colonies on TSA 
incubated at 25 °C (data not shown). Because the entire plasmid is present in the 
strain, albeit integrated into the chromosome, it is possible that it will excise and be 
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lost in the absence of selective pressure. Bearing that in mind, the stability of the 
integrated p16Slux plasmid was examined by continuously passaging the strain in LB 
broth in the absence of erythromycin. It was determined that the integrated plasmid 
was 100% stable over two transfers and 98% stable over four transfers but was 
slightly unstable over longer time periods (Fig. 2B). Therefore, the p16Slux-tagged 
C. sakazakii can be used in short-term assays, lasting no longer than 2 days, in the 
absence of selective pressure. 
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Fig. 1. (A) Map of p16Slux showing Phelp promoter, E. coli DH10B 16S gene and lux 
operon (luxABCDE). (B) Gel picture of PCRs performed to check the integration of 
p16Slux into the chromosome. M, molecular marker (1 kb; Promega); lane 1, 
nontagged C. sakazakii used as template DNA; lane 2, lux-tagged C. sakazakii used 
as template DNA; lane 3, negative control (water). (C) C. sakazakii lux-tagged and 
non-tagged strains streaked onto LB and viewed with a Xenogen IVIS 100 imager. 
The colour bar represents the bioluminescent signal measured in photons per second 
per square centimetre. 
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Fig 2. (A) Growth of lux-tagged (■) and non-tagged (o) C. sakazakii strains in LB 
broth at 37 °C. Data are presented as average Log CFU per milliliter +/- standard 
deviations for three biological repeats. (B) Stability of p16Slux. Shown are 
percentages of erythromycin-resistant colonies following passaging of the lux-tagged 
C. sakazakii every 8 hours in the absence of antibiotic selection. P, passage number; 
O/N, overnight; ery, erythromycin. 
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Monitoring of bioluminescence in LB broth 
Growth of the lux-tagged strain was monitored in LB broth by measuring 
bioluminescence with both a luminometer and a Xenogen IVIS imager (Fig. 3A and 
3B, respectively; OD data presented in appendix). The amount of bioluminescence 
increased over time as cell numbers increased. Bioluminescence was not detected for 
the non–lux-tagged strain or LB broth alone, confirming that there was no 
background interference. Results were reproducible; biological repeats within one 
experiment and repeat experiments performed on different days all gave similar 
results. It was noted that RLU readings can be correlated with viable plate counts (R
2
 
~ 0.84; correlation scatter shown in Fig. 1 appendix). 
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Fig 3. (A) Growth of lux-tagged (■) and non-tagged (o) C. sakazakii strains in LB 
broth at 37 °C. ioluminescence was m asured by a Luminoskan luminometer. Error 
bars represent the standard deviations of triplicate experiments. (B) Growth of lux-
tagged C. sakazakii in LB broth at 37 °C. Biolu inescence was measured with a 
Xenogen IVIS 100 imager. 
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Monitoring of bioluminescence in the presence of other bacteria 
In order to examine whether growth of the lux-tagged strain could be monitored in 
the presence of other bacteria by measuring bioluminescence, the lux-tagged strain 
was co-cultured with other foodborne pathogens from our laboratory culture 
collection and also Bacillus strains previously isolated from PIF. Figure 4A shows 
the results obtained for the experiments performed with B. licheniformis. It was 
observed that bioluminescence readings in the presence of B. licheniformis were 
similar to those obtained when C. sakazakii alone was grown in LB. Similar results 
were obtained when C. sakazakii was co-cultured with equal concentrations of B. 
cereus, L. monocytogenes, E. coli, and Salmonella Typhimurium (Fig. 4 appendix). 
These experiments show that the ability of the lux-tagged C. sakazakii strain to emit 
light is unaffected and growth can be monitored in the presence of competing 
bacteria by measuring bioluminescence.  
 
Monitoring bioluminescence in milk  
Growth of the lux-tagged strain was examined in two different brands of RSM and 
six different brands of commercially available PIF. Similar to the results obtained for 
LB broth, it was observed that bioluminescence readings increased over time as cell 
numbers increased (luminometer data are presented in Fig. 4B; Fig. 1 appendix). As 
PIF is not produced in a sterile environment, it usually contains an inherent microbial 
flora, which we also expected to increase in numbers over the time course of our 
assay. Indeed, aerobic plate counts performed with PIF after the 24-h incubation 
revealed average counts of 10
8
 CFU/ml, again demonstrating that the lux-tagged C. 
sakazakii can be detected in the presence of competing microflora. Bioluminescence 
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results obtained for RSM and PIF experiments were reproducible; biological repeats 
within one experiment and repeat experiments performed on different days all gave 
similar results (Fig. 4 appendix).  
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Fig 4. (A) Growth of lux-tagged C. sakazakii alone in LB (●) or in the presence of B. 
licheniformis (□). Error bars represent the standard deviations of triplicate 
experiments. (B) Growth of lux-tagged C. sakazakii in six different brands of RIF (●, 
o, Δ, ■, +, X) and two different brands of reconstituted skim milk (▲, □). 
Bioluminescence was measured with a Luminoskan luminometer. Error bars 
represent the standard deviations of triplicate experiments. 
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Examination of the effects of monocaprylin and nisin on the growth of C. 
sakazakii in milk 
Monocaprylin and nisin have previously been investigated for their potential to 
inhibit C. sakazakii. In these studies, bacterial numbers were monitored by 
performing viable plate counts (Lee and Jin, 2008, Nair et al., 2004). We decided to 
carry out similar experiments to investigate whether growth of C. sakazakii in the 
presence of these compounds could be monitored by measuring bioluminescence 
rather than performing plate counts. Nair et al. demonstrated that monocaprylin 
rapidly inactivates C. sakazakii; the bacterium was reduced by 5 log units after a 60-
min exposure to 50 mM monocaprylin (Nair et al., 2004). The results of our 
bioluminescence-based experiments agree with these findings (Fig. 5A). 
Monocaprylin stocks were prepared in ethanol as this fatty acid does not dissolve in 
water. Ethanol alone (2.5%, vol/vol) was added to RSM to serve as an appropriate 
control. It was observed that ethanol affected growth of C. sakazakii (as determined 
by plate counts), hence explaining why RLU readings are lower than those normally 
obtained for C. sakazakii in RSM alone (Fig. 5B). In agreement with a previous 
study (Lee and Jin, 2008), addition of various concentrations of nisin (100 to 500 mg 
of nisin powder/ml) did not have any effect on the growth of C. sakazakii. Results 
obtained for 100 mg/ml nisin are shown in Figure 5B. 
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Fig 5. (A) Growth of lux-tagged C. sakazakii in RSM containing 2.5% (vol/vol) 
ethanol (▲) and in RSM supplemented with 25 mM monocaprylin (Δ). (B) Growth 
of lux-tagged C. sakazakii in RSM (▲) and in RSM supplemented with 100 mg/ml 
nisin (Δ). Data are presented as average relative light units +/- standard deviations 
for three biological repeats. 
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Sensitivity of bioluminescence measurements 
C. sakazakii is usually only present in low numbers in natural environments such as 
contaminated PIF (Muytjens et al., 1988); therefore, it is likely that future 
experiments aimed at examining the growth potential of the bacterium in various 
surroundings will use low starting cell numbers. Hence, we decided to investigate the 
sensitivity of measuring bioluminescence as an indicator of C. sakazakii growth. 
Media (LB, RSM, and RIF) were inoculated with various initial inocula and 
bioluminescence was measured over 25 h periods. It was observed that even with the 
lowest initial inoculum (100 CFU/ml); growth of the bacterium could be easily 
detected within the time course of the assay (Fig. 6 shows data obtained for RSM; 
Fig. 2 appendix (PIF data)). 
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Fig 6. Growth of lux-tagged C. sakazakii in RSM. Varying initial inocula were used: 
2 Log CFU/ml (■), 3 Log CFU/ml (□), 4 Log CFU/ml (▲), 5 Log CFU/ml (Δ), 6 
Log CFU/ml (●), and 7 Log CFU/ml (o). Bioluminescence was measured with a 
Luminoskan luminometer. Data are presented as average relative light units +/- 
standard deviations for three biological repeats. 
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Discussion 
C. sakazakii infections can cause a number of severe and life-threatening conditions 
including meningitis, bacteremia, and necrotizing enterocolitis in neonates and 
infants. PIF has been implicated as the primary vehicle of transmission of the 
bacterium (Bowen and Braden, 2006, Codex Alimentarius Commission, 2008). PIF 
manufacturers are therefore interested in identifying ingredients that may inhibit the 
growth of C. sakazakii. Casein-derived antimicrobial peptides, bacteriophages, 
monoglycerides, etc., have been investigated in this regard (Hayes et al., 2009, Kim 
et al., 2007b, Nair et al., 2008). Furthermore, as manufacturers are continuously 
aiming to improve PIF formulations by the addition of constituents that will enhance 
infant nutrition and health, they will be interested in examining the ability of C. 
sakazakii to grow and survive in the resulting products. Real-time methods for 
monitoring growth of the bacterium in RIF would greatly assist these endeavours. As 
milk is opaque, growth of C. sakazakii in milk cannot be assessed by direct 
measurement of optical density. At present, growth of the bacterium in milk is 
primarily monitored by performing viable plate counts and plating onto chromogenic 
differential agar such as Druggan Forsythe Iversen agar (Back et al., 2009, Breeuwer 
et al., 2003, Gurtler and Beuchat, 2007, Lampel and Chen, 2009, Nair et al., 2008). 
Indirect methods include monitoring pH changes by the addition of pH indicators 
such as bromocresol blue and measurement of alterations in electrical conductance; 
for example, the Don Whitley RABIT (Rapid Automated Bacterial Impedance 
Technique) technology (Forsythe, 2009, Iversen et al., 2008). Oh and Kang have also 
described a method for the fluorogenic detection of C. sakazakii by the addition of 4 
-methylumbelliferyl-α-D-glucoside to broth, which is hydrolysed as the bacterium 
produces α-glucosidase (Oh and Kang, 2005). The aim of the present study was to 
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examine the potential of using lux-tagged C. sakazakii as a faster method of 
following growth of the bacterium in liquids, including standard laboratory media, 
skim milk and RIF. While attempts by other researchers to lux-tag C. sakazakii failed 
(Forsythe, 2009), we succeeded by using the integrative plasmid p16Slux. Initial 
experiments focused on examining the effect of introducing the plasmid on the 
general growth characteristics of C. sakazakii. It was found that the plasmid did not 
negatively impact growth and the lux-tagged strain behaved in a manner similar to 
that of the non-tagged counterpart under standard laboratory conditions. Continuous 
passaging of the strain in the absence of antibiotic confirmed that the plasmid was 
sufficiently stable for monitoring growth over relatively short time frames. 
Subsequent experiments showed that growth of the lux-tagged strain could be 
monitored in real time in LB broth, milk and RIF by using both a luminometer and a 
Xenogen IVIS imager. Tracking of a lux strain by measuring bioluminescence 
proved to be very reproducible and bioluminescence was shown to be unaffected by 
the presence of other competing bacteria including Bacillus spp., which are the major 
competitors in infant formula. Bioluminescent tracking of C. sakazakii in milk is a 
faster and less labour-intensive method of monitoring growth than other, 
conventional methods, such as performing viable plate counts. The latter can require 
preparation of large amounts of media and a limited number of samples can be 
analysed at a specific time as samples must be serially diluted and plated. 
Furthermore, plates require overnight incubation, after which colonies must be 
counted. Bioluminescence- based experiments offer many advantages. Readouts 
from the luminometer are instantaneous, so growth can be monitored in real time. 
The use of automatic microplate readers allows larger numbers of samples to be 
analysed, experiments can easily be performed over longer time frames (e.g., 
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overnight) and as the system is automated, researchers are free to conduct other work 
simultaneously. Bioluminescence-based tracking could be of benefit to high-
throughput assays. A potential drawback is that the C. sakazakii strains of interest 
must be engineered to contain the lux plasmid and while we did not encounter 
problems with the C. sakazakii strain that we used, not all C. sakazakii strains may 
be as readily genetically manipulated. Future efforts should also investigate the 
potential of lux-tagging the other six Cronobacter species (C. malonaticus, C. 
turicensis, C. muytjensii, C. condimentii, C. universalis and C. dublinensis). While it 
has been reported that certain factors (such as alcohol) can affect luciferase and 
hence the generation of light by causing either enhancement or quenching effects, 
these factors will not likely be encountered when performing experiments mimicking 
‘‘real-life’’ PIF conditions. In summary, our study demonstrates that bioluminescent 
imaging facilitates real-time tracking of C. sakazakii in a culture-independent 
manner, in opaque food matrices such as infant formula, which are not conducive to 
optical density measurements. This method could be employed to examine the 
influence of various ingredients and inhibitors on the growth of C. sakazakii in infant 
milk formula. 
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Conclusion 
In conclusion we have examined the potential of using a lux-tagged C. sakazakii 
strain to monitor growth of the bacterium in various liquids. The tagged strain was 
shown to integrate at the desired site on the chromosome and growth of the lux-
tagged strain was similar to that of the non–lux-tagged strain. The integrated plasmid 
was stable when cells were cultured in the absence of antibiotic. Growth of the lux-
tagged strain was monitored in real-time in Luria-Bertani broth, skim milk and infant 
milk formula by monitoring bioluminescence. Bioluminescence could be detected 
when the lux-tagged strain was co-cultured with other bacteria. The effect of 
antimicrobial agents on the growth of C. sakazakii in milk was monitored by 
measuring bioluminescence. Growth of the lux-tagged C. sakazakii could be 
monitored in real time in both clear and opaque liquids by measuring 
bioluminescence.  
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Chapter III 
 
Investigation of a Bioluminescence Based ‘Early-
Warning’ System for Starter Disruption by 
Antibiotic residues and Bacteriophages  
 
 
 
 
 
 
 
 
 
A manuscript based on this chapter is in preparation  
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Abstract 
The presence of antimicrobial agents in bulk milk can inhibit or slow Lactococcus 
proliferation during cheese fermentation having a negative impact on cheese quality 
or result in complete failure of cheese batches. A rapid method of tracking starter 
culture activity would therefore be useful to the cheese industry. As starter culture 
strains are not always easily manipulated by means of electroporation, the aim of this 
study was to construct a bioluminescent panel of Lactococcus strains using a 
conjugative lux-vector. These tagged strains would subsequently be used to monitor 
the action of antimicrobial agents in opaque environments such as milk.  
The newly constructed plasmid pRH001lux consisting of an Escherichia coli-
Lactococcus shuttle vector ligated to luxABCDE genes isolated from p16Slux was a 
suitable vector for expressing the lux genes and in the presence of pMRC01 
facilitated conjugative transfer of the lux plasmid between Lactococcus strains. As 
current methods of phage/antibiotic detection are slow, the newly developed plasmid 
could help identify those strains suitable for starter strain rotation strategies and 
provide techniques for identifying antibiotic residues in whey. In conclusion, we 
have constructed a stable conjugative lux vector which can be monitored in clear and 
opaque environments by measuring bioluminescence. The lux-tagged starter strains 
are capable of monitoring the effects of various antibiotics on the growth of a variety 
of tagged starter culture strains. 
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Introduction 
Lactococcus lactis cultures are extensively used in the dairy industry where they are 
employed as starter culture strains for the production of a variety of cheeses. During 
cheese production these Lactic Acid Bacteria (LAB) utilise lactose and citrate and 
excrete lactic acid, which in turn coagulates the milk; an essential step for successful 
cheese production. However, the bulk milk can become contaminated with 
antimicrobial agents through the presence of phage or antibiotics and this may lead to 
subsequent starter culture failure, resulting in huge economic and time loss for 
cheese manufactures (Ahmad and Stewart, 1991, Guinee and O’Brien, 2010). At the 
moment a range of antibiotics are used as veterinary treatments for bovine infections 
such as mastitis. If sufficient levels of antibiotic are present in milk obtained from 
antibiotic treated animals, the starter culture inoculum can be slow to ferment and in 
severe cases may fail to develop altogether (Ahmad and Stewart, 1991). Other 
antimicrobial agents which negatively influence cheese production include L. lactis 
bacteriophage. L. lactis phages have been assigned to 10 species (Marvig et al., 
2011, Deveau et al., 2006). The most common Lactococcus phages that are 
problematic in the dairy industry include; 936, c2 types and P335 types, with c2 and 
936 being isolated most frequently (Mahony et al., 2008, Moineau et al., 1996). 
Thermal inactivation is most commonly used for phage inactivation but many c2 
phages survive pasteurisation temperatures as well as traditional cheese milk 
temperatures if present in high enough numbers (10
4
 PFU/ml) (Marvig et al., 2011, 
Atamer et al., 2010, Garneau and Moineau, 2011). 
A number of phage defence mechanisms have evolved to counter-act the action of 
phage with much success. Three of these mechanisms are prevention of phage 
adsorption, restriction and modification, and abortive infection (Murray, 2000, Sing 
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and Klaenhammer, 1993, Tükel et al., 2006, Chopin et al., 2005, Madera et al., 2003, 
Pingoud et al., 2005, Garneau and Moineau, 2011). These mechanisms are often 
encoded on plasmids and in some cases multiple genes can be present on the same 
plasmid providing elevated levels of phage resistance (Sing and Klaenhammer, 
1993). In addition, advances in our understanding of novel phage resistance 
mechanisms have led to the use of natural mutations or genetically modified defence 
strategies such as Bacteriophage Insensitive Mutants (BIM’s), phage-encoded 
resistance (Per), antisense RNA and superinfection exclusion (Sie) (Mahony et al., 
2008, McGrath et al., 1999). However phage can overcome these resistance 
mechanisms. 
Due to the ubiquitous nature of bacteriophage and the on-going use of antibiotics for 
the treatment of bovine infections, complete elimination of antimicrobial substances 
from the cheese production environment is not possible. Methods designed to protect 
and monitor starter culture strains used in the dairy industry have been developed and 
include starter strain rotation (SSR) strategies (protects against phage attack) and 
measurement of lactic acid levels (indicating presence of phage and/or antibiotics) 
using the Heap-Lawrence Starter Activity Test (SAT) (Sing and Klaenhammer, 
1993, Heap and Lawrence, 1976). However, SSR can lead to cheese products of 
variable properties while SAT’s requires continuous passaging of test milk samples 
and can require up to 24 h or more to yield a result. For these reasons a rapid assay 
for screening starter culture strains against antimicrobial agents would be very useful 
to the dairy industry.  
One such solution to this problem could involve bioluminescence and use of the 
bacterial lux system. Bioluminescence is the production of light by living organisms 
as a result of a number of enzyme catalysed reactions. These enzymes are known as 
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luciferases and in the presence of oxygen the enzyme catalyses the oxidation of 
reduced flavin mononucleotide and a long chain aliphatic aldehyde to yield flavin 
mononucleotide (FMN) and a long chain fatty acid and light. The luciferase enzyme 
is encoded by the luxAB genes and the fatty acid reductase complex responsible for 
regeneration of the aldehyde is coded for by the luxCDE genes. Previously, lux-
tagging microorganisms involved cloning the luxAB genes, encoding the catalytic 
luciferase enzymes, from a naturally luminescent host to the target microorganism 
with the substrate for the reaction being provided exogenously (Baker et al., 1992, 
Ahmad and Stewart, 1991). However, now an entire lux cassette can be transferred 
from its original host and expressed in other bacteria with the resulting lux-tagged 
bacteria emitting light independently of exogenously provided substrates (Morrissey 
et al., 2013). Previously, Ahmad & Stewart (1991) constructed a promoter-
lux plasmid which was transferred into Lactobacillus casei, Lactococcus lactis 
and Lactococcus lactis subsp. diacetylactis by electroporation (Ahmad and Stewart, 
1991). When examined all transformants expressed the bioluminescent phenotype in 
the presence of exogenous aldehyde. These could be used to successfully monitor 
antimicrobial substances in milk active against starter culture strains for example; 
antibiotics (Ahmad and Stewart, 1991). Stewart & Ahmad also showed that a 
bioluminescent strain of L. lactis subsp. diacetylactis was able to detect 
bacteriophage active against that organism at concentrations as low as 10
5
 PFU/ml in 
100 mins (Ahmad and Stewart, 1991, Stewart, 1990, Ahmad and Stewert, 1988). 
However, this method of monitoring bacteriophage was not a highly automated 
method with one ml samples being withdrawn and tested every hour in order to 
obtain bioluminescent measurements. Secondly, the assay involves cloning the luxAB 
genes from Vibrio fischeri which encode the catalytic luciferase enzyme and the 
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subsequent addition of exogenous aldehyde for light production. Nowadays, it is 
considered more efficient and less labour intensive to clone the entire lux operon, 
luxABCDE, so as well as producing the luciferase enzyme the recombinant strain 
also produces the substrate necessary for the reaction (Morrissey et al., 2013). 
Finally, the plasmid was only shown to be transferrable by electroporation which is 
not always possible with industrially important starter strains.   
Other applications of bioluminescent bacteria have been explored through the years; 
however, studies involving bioluminescent Lactococcus reporters have been few and 
far between with a few exceptions (Jiang et al., 2006, Immonen and Karp, 2007, 
Geoffroy et al., 2000, Eaton et al., 1993).  
With this in mind, we set out to construct a new Lactococcus lux plasmid capable of 
mobilisation between strains by conjugation. Using this new plasmid we will 
construct, insofar as we can determine, the first bank of highly bioluminescent 
cheese starter culture strains and subsequently develop an assay capable of rapidly 
monitoring antimicrobial substance active against starter cultures strains in milk. As 
not all Lactococcus plasmids are readily genetically manipulated and electroporation 
as a means of plasmid transfer is not always possible, a plasmid capable of DNA 
transfer by conjugation and electroporation must first be generated.  
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Materials and methods 
Bacterial strains, media and chemicals 
A summary of strains and plasmids used in this study are listed in Table 1. Luria-
Bertani (LB) broth (Merck, Darmstadt, Germany) was used routinely for growing 
Escherichia coli cultures and Lactococcus cultures were grown in GM17 broth (M17 
broth supplemented with 0.5% glucose (Oxoid, Basingstoke, UK). Microbiological 
agar (Merck, Darmstadt, Germany) was added to LB and GM17 broth when solid 
agar was required. E. coli cultures were grown at 37°C, while Lactococcus cultures 
were grown at 30°C. When required, the antibiotic erythromycin (Sigma-Aldrich, 
MO, USA) was added at a concentration of 500 µg/ml for E. coli and 5 µg/ml for 
Lactococcus strains. Chloramphenicol (Cm) (Sigma-Aldrich, MO, USA) was used at 
a concentration of 10 µg/ml for E. coli, 5 µg/ml
 
for Lactococcus for electroporation 
experiments and 15 µg/ml for conjugation experiments.  
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Table 1. List of lactococcal strains/plasmids used in study, including source. UCC = University 
College Cork 
Strains/Plasmids                              Strain/Plasmid details Reference                                         
MG1363    
MG1614                                            
Il1403                                                
158                                                     
WM1                                                                                            
275                                                    
DPC 5101                                                    
DPC 4272 
DPC 743 
DPC 745 
DPC 4935 
DPC 5250                                             
pCI372        
p16Slux          
pRH001  
pRH001lux 
MG1363 + pMRC01                                         
158lux                                                     
WM1lux                                                                                            
275lux                                                    
5101lux                                                    
4272lux 
743lux 
745lux 
4935lux 
5250lux   
L. lactis subsp. cremoris  
L. lactis subsp. lactis Strep
r
 
L. lactis subsp. lactis  
L. lactis subsp. cremoris 
L. lactis subsp. lactis  
L. lactis subsp. lactis  
Industrial chedder cheese starters  
Industrial chedder cheese starters  
Industrial chedder cheese starters  
Industrial chedder cheese starters  
Industrial chedder cheese starters  
Industrial chedder cheese starters  
E.coli-Lactococcus shuttle vector, Cm
r
 
Integrates into 16S locus chromosome, Ery
r
 
pCI372 containing oriT region, Cm
r
          
pRH001 + luxABCDE operon +Phelp promoter, Cm
r
,                                                                                  
L. lactis subsp. cremoris containing pMRC01 
158:: pRH001lux, Cm
r  
                                                                               
WM1:: pRH001lux, Cm
r  
                                                           
275::pRH001lux, Cm
r  
                                                                               
5101:: pRH001lux, Cm
r  
                                                                                  
4272:: pRH001lux, Cm
r
 + Rif 
r
                                                                                  
743:: pRH001lux, Cm
r
 + Rif 
r
                                                                                                                                                                   
745:: pRH001lux, Cm
r
 + Rif 
r
                                                                                                                                                                  
4935:: pRH001lux, Cm
r
 + Rif 
r
                                                                                                                                                                 
5250:: pRH001lux, Cm
r
 + Rif 
r
                                                                                                                                                                    
UCC collection 
UCC collection 
UCC collection 
UCC collection 
UCC collection 
UCC collection 
Hickey et al., 2001 
Hickey et al., 2001 
Hickey et al., 2001 
Hickey et al., 2001 
Hickey et al., 2001 
Hickey et al., 2001 
UCC collection 
Riedel et al., 2007a 
Hickey et al., 2001 
This study       
Hickey et al., 2001 
This study          
This study      
This study                  
This study       
This study                  
This study                  
This study        
This study
This study                
a
Cm
r
, Chloroamphenicol resistant. Ery
r
, Erythromycin resistant. Strep
r
, Streptomycin resistant. 
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Transformation of p16Slux into Lactococcus 
To determine whether the lux genes could be expressed in Lactococcus, plasmid 
p16Slux (Riedel et al., 2007a) was transformed into two commonly used 
Lactococcus strains (L. lactis subsp. cremoris MG1363 and L. lactis subsp. lactis 
IL1403). p16Slux plasmid was extracted from its E. coli host strain using the 
Invitrogen Quick plasmid miniprep kit (Invitrogen, Löhne, Germany) and 
transformed by electroporation as described by Holo and Nes, but with minor 
modifications (Holo and Nes, 1989). Lactococcus cultures were grown in GM17 
broth to an OD600 nm of 0.5–0.8, and then diluted 100-fold in SGM17 (GM17 
supplemented with 0.5 M sucrose and 0.5 M glucose). Incubation at 30°C was 
continued until an OD600 nm of 0.4–0.6 was reached. Cells were harvested at 4 °C 
by centrifugation at 2500 x g for 10 mins. After two washings with ice-cold washing 
buffer (0.5 M sucrose containing 10% glycerol) the cells were suspended in 4 mls of 
washing buffer. For electroporation assays 50 µl of these competent cells were 
transformed with ~ 2 µg of purified plasmid in a 2-mm cuvette (Bio-Rad, 
Mississauga, ON, Canada). The pulse was delivered by a Gene Pulser Xcell (Bio-
Rad, Mississauga, ON, Canada), set at 25 µF, 2 kV, and 200 ohms. The cells were 
resuspended in 945 µl of GM17MC (GM17 containing 20 mM MgCl2 and 2 mM 
CaCl2) and the cell suspension was incubated at 30 °C for 2 h. Transformants were 
selected by plating on GM17 agar containing erythromycin (5 ug/ml). Plates were 
incubated for 24 h at 30 °C. Bioluminescence was measured (photons per second per 
square centimetre) using the IVIS Xenogen Imaging 100 system (Xenogen, 
Alameda, CA) with a binning of 16 and an exposure time of 1 min. 
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Construction of new recombinant plasmid – pRH001lux  
To construct the bioluminescent Lactococcus strain, the luxABCDE genes plus Phelp 
promoter were amplified from plasmid  p16Slux by PCR using 2X extensor long 
range PCR master mix (Thermo Scientific, Hempstead, UK) according to 
manufacturer’s  instructions and cloned into the multiple cloning site of pRH001 
(PCI372 containing 312-bp oriT). Amplification was carried out using luxABCDE 
primers for (5’-        CACCGCTACACCTGGAAT-3’) and rev (5’-
GAACTAGTGGATCCCCCG-3’) (Eurofins MWG, Ebersberg, Germany). 
Amplification of the target region was achieved with 30 cycles of 94°C for 2 min, 10 
cycles of 94°C for 10 sec, 57 °C for 30 sec, 68° C for 4 min, 20 cycles of 94°C for 10 
sec, 57 °C for 30 sec, 68° C for 4 min and 1 cycle of 68°C for 7 min. The PCR was 
carried out in a T3000 Thermocycler (Biometra, Gottingen, Germany).  
Following amplification the PCR product was purified with Purelink PCR 
Purification kit (Invitrogen, Männheim, Germany) according to manufacturer 
protocols and subsequently digested for 4 h at 37°C with Pst I restriction enzyme 
(Roche, UK). The plasmid pRH001 was digested with the same restriction enzyme 
under the same conditions and again purified using the PCR Purification kit. The 
ligation was performed in 1x buffer with T4 ligase, and incubated in ice-water for 16 
h overnight (Roche, UK). 
L. lactis chedder cheese starter culture strains (WM1, 158, 275 and 5101) were 
transformed with plasmid pRH001lux following electroporation protocols detailed 
above. Transformants were selected by plating on GM17 agar supplemented with 
chloramphenicol (5 µg/ml). Bioluminescence was measured with the IVIS Xenogen 
Imaging 100 system. PCR was performed to confirm the presence of the new lux 
plasmid based on PCI372 multiply cloning site primers PCI372 For      (5’-
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ACACTGGAACTGAGACACGGTCCAGACTCC-3’) PCI372 Rev       (5’ 
TTGTAAAACGACGGCCAGTGAGCGCGCG-3’) (Eurofins MWG,). L. lactis 
MG1363, L. Lactis MG1363 + pMRC01 and L. lactis IL1403 were also transformed 
with plasmid pRH001lux. All starter culture strains used in this study were isolated 
from whey samples obtained from the dairy industry and provided by University 
College Cork or the Agriculture and Food Development Authority, Teagasc, Fermoy, 
Cork (Table 1). 
 
Generation of spontaneous L. lactis rifampicin resistant recipients 
Ten millilitres of overnight culture starter strains cultures listed in table 1 were 
centrifuged at 2500 x g for 10 min. The supernatant was removed and the pellet was 
resuspended in 200 µl sterile ¼ strength Ringer’s solution (Merck, Darmstadt, 
Germany). One hundred microlitres of this suspension was plated onto GM17 agar 
containing 30 µg/ml rifampicin. Plates were incubated at 30 °C overnight. The 
following day a colony was picked and re-streaked onto GM17 agar containing 100 
µg/ml rifampicin (Smalla et al., 2000). 
 
Mobilization of pRH001lux into industrial starter strains by conjugation 
Filter matings were performed in triplicate using L. lactis MG1363 containing 
pMRC01 plus pRH001lux as the donor strain. The recipients used were rifampicin 
resistant variants of chedder cheese starter culture strains isolated from the dairy 
industry (Table 1). Ten millilitres of overnight culture of the recipient and 10 ml of 
overnight cultureof the donor were centrifuged at 2500 x g for 10 min, washed in 
Ringers’ solution, and resuspended in 10 ml GM17 broth (Smalla et al., 2000). Ten 
millilitres of washed culture of the recipient strain were passed through a 0.45 μm 
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nitrocellulose membrane filter (Millipore, Billerica, MA, USA) followed by 500 
µg/ml of proteinase-K and subsequently held for 5 min at room temperature. Ten 
millilitres of the donor strain was passed through the same nitrocellulose membrane. 
Filters were placed facedown onto GM17 agar and incubated overnight at 30°C. The 
following day, filters plus the underlying agar were placed in sterile tubes containing 
10 ml ¼ strength Ringers’ solution and gently agitated. One hundred microlitres of 
the ringers mix was spread plated onto GM17 agar (100 µg/ml rifampicin and 15 
µg/ml chloramphenicol) to identify recipient cells containing the lux plasmid. 
Positive transconjugants were confirmed by bioluminescence using the IVIS imager. 
To ensure only the lux plasmid (and not the lacticin 3147-encoding pMRC01 
plasmid) was being mobilised into the recipient, bacteriocin agar well diffusion 
assays were carried out on the transconjugants. These assays were performed by 
seeding GM17 agar with an appropriate indicator strain (L. lactis HP). Once the agar 
had set, wells were made in the agar (4.6 mm in diameter) and 50 µl of washed 
overnight cultures of the lux-tagged starter cultures (WM1, 158, 275, 5101, 4935, 
4272, 743, 745, 5250) was added to the wells. Fifty microliters of washed MG1363-
pMRC01 overnight culture was used as a positive control. Plates were incubated at 
30 °C overnight. The following day plates were observed for zones of clearing 
around wells indicating Lacticin 3147 production. 
 
Biological characteristics of the new lux plasmid- Plasmid stability 
The lux-tagged starter culture strains generated by transformation and conjugation 
were grown overnight (approximately 16 h) in triplicate in GM17 broth containing 
chloramphenicol (5 µg/ml). Three millilitres of culture was centrifuged, washed and 
resuspended in an equal volume of ¼ strength Ringer’s solution. Two hundred 
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microliters was transferred into 10 ml of fresh GM17 broth without antibiotic. Tubes 
were incubated (statically) at 30 °C for approximately 8 h, after which time 200 µl of 
culture was transferred into fresh broth and incubated at 30°C overnight. This 
passaging was repeated for an additional 2 days. At every passage, 100 µl aliquots 
were serially diluted in ¼ strength Ringer’s solution and spread plated onto GM17 
agar. Plates were incubated at 30°C. Fifty random colonies from each passage were 
scored for antibiotic resistance by patching on GM17 agar and GM17 plus 
chloramphenicol (5 µg/ml). Plates were incubated at 30°C overnight. These plasmid 
stability assays were repeated for each lux-tagged starter culture strain. 
 
Monitoring growth of the lux-tagged starter strains in GM17 broth and whole 
milk 
Growth patterns of the newly tagged transformant and transconjugant starter culture 
strains and the wild-type starter culture strains were monitored by measuring relative 
light units (RLU) and by viable plate counts (Log CFU/ml). Three millilitres of 
luminescent overnight culture was centrifuged (2500 x g, for 10 min), washed and 
resuspended in ¼ strength Ringers’ solution. A 2% inoculum of each strain was 
added to fresh GM17 broth. Two hundred microlitres of this freshly inoculated 
GM17 broth was added to a 96-well white plate (Nunc, Thermo Fisher Scientific, 
Roskilde, Denmark) and bioluminescent and optical density measurements were 
recorded hourly at 30 °C, in relative light units (RLU) using a Luminoskan 
luminometer (Thermo Fischer Scientific, Roskilde, Denmark) and OD595nm (Tecan, 
Männedorf, Germany). Viable plate counts were performed at hourly intervals by 
diluting 100 µl aliquots in Ringers’ solution and spread plating onto GM17 agar. 
This experiment was repeated in pasturised whole milk. Acid production was 
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determined by measuring pH values following 24 h incubation at 30 °C. pH was 
measured using a pH meter (Mettler Toledo, Gießen, Germany). Finally, growth 
curves of lux-tagged starter strains transformed by electroporation and conjugation 
were also completed to investigate whether various methods of plasmid transfer 
interfere with bacterial growth or stability under standard laboratory conditions.  
 
Susceptibility of L. Lactis starter strains to bacteriophage 
The susceptibility of each of the L. Lactis starter strains to a collection of 
bacteriophage was determined by the bacteriophage spot test (Parasion et al., 2012, 
Gutiérrez et al., 2010). Bacteriophage used in this study were propagated on their 
associated host strains as follows. The host strain was grown to an approximate 
optical density (OD595) of 0.15 in 10 ml GM17 broth. Calcium chloride was then 
added at a final concentration of 1 mM and the relevant phage was added. Following 
incubation at 30 °C, lysis of the broth occurred. The lysates were filtered through a 
0.45 µm pore filter to remove any residual bacterial contamination and stored at 4°C 
until required. 
To perform bacteriophage well assays, 10 ml of each starter culture strain was grown 
overnight in GM17 broth. Three hundred microliters of washed overnight culture 
was mixed with 4 ml of molten soft GM17 agar (0.7 %) and overlaid on the surface 
of solidiﬁed GM17 agar (1.5 %). Starter strain sensitivity to bacteriophage was 
established by spotting 30 µl of each phage onto the surface of the agar seeded with 
the starter culture strain. Lysis (indicated by a zone of clearing) occurs only at the 
spot where starter strains are sensitive to a particular phage.  
Once starter strains susceptible to phage atack was determined plaque, plaque assays 
were carried out to estimate phage titres necessary for starter strain inhibition. To do 
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this 350 µl of overnight culture, 100 µl of 1 M CaCl2 and 100 µl of phage dilutions 
(ranging between 10
-1
 and 10
-5
) were added to 3 ml of M17 overlay (0.7% agar). The 
contents were mixed, poured onto M17 agar, and incubated at 30 °C for 18 h. The 
following day plates were examined for plaques and the number of plaques and the 
phage dilution were recorded. Efficiency of plaquing (EOP) of a phage on a 
particular host was determined by dividing the phage titer on the test strain by the 
titer on the homologous phage-sensitive host (Terzaghi and Sandine, 1975, Coakley 
et al., 1997). 
Each of the bacteriophages used in this study (POO8, SK1, JJ50 340, 397, 531, 949 
WRP3, Tuc2009 c2 and Q54) were specifically selected as they were previously 
isolated from the dairy industry.   
 
Challenging L. Lactis 5250lux with bacteriophage 
Once starter strains sensitive to phage were identified and phage susceptibility ranges 
determined, assays challenging one of the lux-tagged starter strains (L. Lactis 5250-
lux) with phage were carried out. As all starter strains used in cheese fermentations 
are initially propagated in reconstituted skim milk (RSM), lux-tagged starter strain L. 
lactis 5250lux was cultured in commercially prepared RSM (10%) and incubated for 
16 h at 30°C. Following overnight incubation, RSM cultures was centrifuged and 
resuspended in Ringer’s solution and approximately 1 x 109 CFU/ml of Lactococcus 
culture was added to fresh whole milk. Freshly inoculated milk was subsequently 
spiked with of 1 x 10
9
 Plaque forming units (PFU) of c2 phage reaching a 
multiplicity of infection of 1.0. Assays were carried out in triplicate and the 
necessary controls to ensure adequacy of milk to support growth of the 
microorganism and sterility of broth were performed. Two hundred microliter 
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samples were transferred to a 96-well plate and bioluminescent measurements were 
recorded hourly in a luminoskan luminometer. The assays were carried out in 
triplicate and appropriate controls were included (Tuc2009 phage alone was used as 
the negative control) (Santos et al., 2010, Tükel et al., 2006). Assays were also 
carried out an MOI of 10. 
 
Challenging L. Lactis 5250lux with antibiotic 
Overnight cultures of L. Lactis 5250lux were centrifuged, and washed and 
resuspended in ¼ strength Ringer’s solution. A 2% inocula of this was added to fresh 
pasturised whole milk and the antibiotic kanamycin was added at a concentration of 
5 µg/ml. Two hundred microlitres of this was added to a 96-well white plate and 
bioluminescent measurements were recorded hourly in relative light units (RLU) 
using a Luminoskan luminometer. Similar experiments were performed using the 
antibiotics ampicillin and streptomycin (5 ug/ml). This assay were based on similar 
experiments preformed by ahmad and stewert, 1991.  
 
Interpretation of data and statistical analysis 
All experiments were performed in triplicate from three biological repeats and were 
repeated at least twice. The results shown represent the mean +/- standard deviations 
(error bars) for one particular experiment. Means and standard deviations were 
calculated using a basic Excel programme. Statistical significance was determined 
via Sigma plot t-test. In all cases, a P value less than 0.05 were considered to be 
statistically significant. 
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Results 
Construction of pRH001lux plasmid 
Initial experiments focused on determining whether the lux genes in the p16Slux 
plasmid could be expressed in L. lactis. Following electroporation, L. lactis MG1363 
and L. lactis IL1403 were successfully transformed with the p16Slux plasmid. 
Examination of re-streaked transformants revealed that lux-tagged strains emitted 
high levels of bioluminescence whereas, the non-tagged controls did not. The lux-
tagged strains could be maintained under antibiotic pressure when grown at 30 °C. 
Given that the lux genes under Phelp promoter (highly expressed Listeria promoter) 
control could be expressed in L. lactis, we constructed a new lux plasmid 
(pMRC01lux) which could be maintained under antibiotic pressure and could 
potentially be transferred between L. Lactis strains by conjugation and 
electroporation.  
This new conjugative vector (pRH001lux) consists of pRH001 and the luxABCDE 
genes plus Phelp promoter (Fig. 1 A, 1C), was sucessfully transformed into L. lactis 
MG1363, IL1403 and four L. Lactis starter culture strains (158, WM1, 275, 5101) by 
electroporation (Fig. 1B). To confirm the presence of the luxABCDE genes, a PCR 
was performed using primers based on the PCI372 multiple cloning site and analysed 
by 1% agarose gel electrophoresis (data not shown). Repeated attempts to transform 
pRH001lux into other starter culture strains (5250, 743, 745, 4935 and 4272) failed. 
Therefore only four starter cultures out of a possible nine were sucessfully 
transformed. We initally speculated that this was perhaps due to the large size of the 
plasmid. Attempts to transform a smaller plasmid (pCI372) into several starter strains 
(L. Lactis 743 and 745) were successful; however, starter strains L. Lactis 4935 and 
4272 could not even be transformed with pCI372. Attempts to transform other 
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plasmids (pNZ44 and pRH001) into competetent 4935 and 4272 starter strains were 
also unsuccessful. When electro-competent 4935 and 4272 cells alone were serially 
diluted and plated on GM17 agar, high cell numbers were recorded (~ 10
9
 CFU/ml). 
Despite these high cell numbers, electroporation was not always a suitable method of 
plasmid transfer to Lactococcus starter strains. 
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(A)                                                               (B) 
 
 
 
 
 
 
                                                                                                                                L. lactis containing pRH001        L. lactis containing pRH001lux 
 
(C)  
 
             
 
 
 
 
 
 
 
Fig 1. (A) Analysis of the recombinant plasmid pRH001lux by 0.7% agarose gel 
electrophoresis, run under 100 V for 60 min in 1X TAE buffer. The lux region was 
PCR amplified as described in the material and methods. M, molecular marker (1kb 
Bioline), lane 1, amplified luxABCDE + Phelp promoter region (isolated from 
p16Slux) Pst1 digested, lane 2, pRH001 (pCI372 plus oriT), Pst 1 digested. (B) L. 
lactis MG1363 containing pRH001 (empty plasmid) and pRH001lux, viewed with a 
Xenogen IVIS 100 imager. The colour bar represents the bioluminescent signal 
measured in photons per second per square centimeter. (C) Map of pRH001lux 
showing luxABCDE genes, Phelp promoter and origin of transfer region (oriT).  
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Mobilization of pRH001lux into industrial starter strains by conjugation 
In order to determine whether the new lux-plasmid could be transferred by 
conjugation as well as electroporation, attempts were made to mobilize pRH001lux 
into nine industrial L. Lactis starter strains (158, WM1, 275, 5101, 5250, 743, 745, 
4935 and 4272) by conjugation. All filter matings were successfully carried out but 
in all cases transfer efficiencies were low (~ 3.75 x 10
3
 transconjugates/µg); 
however, transconjugates were found to exhibit high levels of luminescence. To 
ensure pMRC01 (which contains the genes that encode lacticin 3147) was not co-
mobilized during the matings all nine starter strains were examined for the presence 
of pMRC01 using well diffusion assays testing for Lacticin 3147 production. All 
transconjugants tested negative for Lacticin 3147 production when tested against the 
sensitive indicator strain L. lactis HP with the exception of L. lactis MG1363 + 
pMRC01 which was used as positive control. 
 
Growth of transformants/transconjugants 
These experiments focused on examining the effect that the luxABCDE genes had on 
their Lactococcus host. A major concern of genetic manipulation of any strain is that 
the strain will be negatively affected in terms of general growth characteristics. 
However, introduction of the lux genes into starter strains either by transformation or 
conjugation had no negative effect on the general growth characteristics of the strains 
and the lux-tagged strains grew in a manner similar to that of the non-lux-tagged 
counterpart (Fig. 2). In fact, no statistical difference was observed between growth of 
the lux-tagged strains and wild-type strains when examined using plate counts (P 
<0.05; Fig. 1 appendix). 
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Fig 2. Growth curve of non-lux tagged L. Lactis 5250 (●) and the lux-tagged 5250 
transconjugants (o), in GM17 broth at 30 °C. Data are presented as mean OD595nm +/- 
standard deviations for three biological repeats. 
 
Growth of the lux-tagged strains could easily be monitored in GM17 broth when 
measuring optical density (OD) (Fig. 3A) or light emissions (RLU). Bioluminescent 
measurements increased over time as cell numbers increased (data not shown) and, 
as expected, bioluminescence was not detected for the non–lux-tagged strain or in 
uninoculated broth, confirming that there was no background interference. Results 
were reproducible, produced in real-time and RLU readings correlated with viable 
plate counts (R
2 
for L. lactis 5250lux ~ 0.8885; correlation scatter plot shown in Fig.1 
appendix). Growth of the lux-tagged strain was also examined in whole milk (Fig. 
3B). Similar to the results obtained for GM17 broth, it was observed that 
bioluminescence readings increased over time as cell numbers increased (data not 
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shown). When acidity of the lux-tagged strain was determined by measuring pH 
values after milk cultures were incubated at 30° C; it was determined that light could 
be emitted between pH’s of 4.1 and 6.6, confirming that luminescence can be emitted 
in mildly acidic environments.  
When strains transferred by conjugation were compared to those transformed by 
electroporation (by measuring growth patterns and plasmid stability) no significant 
differences were noted (P< 0.05) (Fig. 2 and Fig. 15 appendix). Starter culture strains 
created by electroporation and conjugation had similar growth and stability patterns 
and no significant difference were noted (P < 0.05; Fig. 4 – 18 appendix). 
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Fig 3. (A) Growth of each lux-tagged starter culture strain (transconjugants), 158 (●), 
4272 (o), WM1 (■), 4935 (□), 5250 (+), 5101 (X), 745 (▲), 743 (Δ), 275 (♦), in 
GM17 broth at 30 °C. Data are presented as mean OD595nm +/- standard deviations 
for three biological repeats. (B) Growth of lux-tagged starter culture strains 
(transconjugants), 158 (●), 4272 (o), WM1 (■), 4935 (□), 5250 (+), 5101 (X), 745 
(▲), 743 (Δ), 275 (♦), in whole milk at 30 °C. Data are presented as mean RLU’s 
(Relative Light Units) +/- standard deviations for three biological repeats. 
Bioluminescence was measured by a Luminoskan luminometer.  
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Stability of plasmid 
When lux-tagged strains were examined for stability by continuous passaging in the 
absence of antibiotic, strains were found to be stable. Results presented in figure 4 
represent assays carried out with lux-tagged L. lactis 5250lux. In this case the 
plasmid was found to be 96% stable over the first transfer, 92% stable over the next 
passage but approximately 70% stable after passage 5 (Fig. 4). Stability assays were 
repeated for each lux-tagged strain and in each instance similar results were observed 
(Fig. 4 - 13 appendix). This confirms that the plasmid was sufficiently stable for 
monitoring growth over relatively short time frames of approximately 24 h. 
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Fig 4. Stability of pRH001lux in L. lactis 5250lux represented as a percentage of 
chloramphenicol resistant colonies following passaging every 8 h in the absence of 
antibiotic. Data presented are the means of triple replicates +/- standard error. 
Stability assays were repeated for each lux-tagged starter strain (data not shown).       
 
Susceptibility of starter strains to bacteriophage 
Bacteriophage spot assays revealed that four lux-tagged starter strains (5101lux, 
743lux, 5250lux and WM1lux) were sensitive to phage c2 when starter culture 
overlays were spotted with a number of industrial relevant bacteriophage (Fig. 5A). 
Eight other phage tested had no inhibitory effect on the remaining five starter strains. 
Plaque assays confirmed this and determined the phage concentration necessary for 
starter strain inhibition (Fig. 20 appendix). However, when the bioluminescent 
phage- sensitive starter 5250lux was challenged with c2 phage, a significant increase 
o/n Culture           P1                     P2                    P3                   P4                    P5        
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(P> 0.05) in luminescence was observed when compared to the lux-tagged strain 
grown alone. This was unexpected and suggested that growth of the lux-tagged 
starter was increased in the presence of phage c2. However, plate counts confirmed 
c2 phage was in fact inhibiting bacterial numbers by approximately 1 Log after 2 h. 
In milk samples inoculated with L. lactis 5250lux together with the control 
bacteriophage Tuc2009, a significant increase in bioluminescence was again noted 
over a 24 h period (Fig. 5B). As expected, when plate counts were performed, 
Tuc2009 samples showed no reduction in cell numbers and grew similarly to the lux-
tagged strain grown in the absence of phage. Similar results were observed when 
assays were performed in GM17 broth. The strains used to propagate phage were 
grown in the absence of phage and filtered, and the filtrate was examined for 
luminescence. No luminescence was observed.  
 
 (A) 
 
 
 
                           
  
          5250lux                          5250lux + Tuc2009               5250lux + c2 
 
Fig. 5 (A) Spot assay demonstrating the effect of c2 phage and Tuc2009 phage 
(negative control) on growth of lux-tagged starter culture strain L. lactis 5250lux as 
determined using a conventional technique (Solid agar surface and soft agar). L. 
lactis 5250lux (left), L. lactis 5250lux+ Tuc2009 phage (centre) and L. lactis 5250lux 
plus c2 phage (right). 
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Fig. 5 (B) Mean effect of no phage (●), c2 bacteriophage (o) or Tuc2009 
bacteriophage (◊) on the level of luminescence produced by the lux-tagged starter 
culture strain L. lactis 5250lux in whole milk, as determined by the luminoskan 
luminometer. RLU = Relative Light Units.  
 
Susceptibility of starter strains to antibiotics 
Antibiotic susceptibility assays revealed that addition of kanamycin had a 
bacteriostatic effect on L. lactis 5250lux over the time course of the assay (Fig. 6A). 
This was particularly evident when Kanamycin was added at concentrations of 5 
µg/ml. Similar results were also observed when the antibiotic ampicillin (added at 
the same concentration as kanamycin) was tested against 5250lux (Fig. 19 appendix). 
The antibiotic streptomycin was also examined against the lux-tagged starter and was 
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found to have little inhibitory effect on growth of the strain (Fig. 6B). Viable plate 
counts supported this finding (data not shown). The influence of antibiotics on the 
growth of lux-tagged starter strains in milk can easily be tracked by measuring 
bioluminescence. 
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Fig. 6 (A) Bioluminescence as a measure of the antimicrobial activity of Kanamycin 
in whole milk as determined by the luminoskan luminometer over 20 h. (●) 
represents L. lactis 5250lux, (o) represents L. lactis 5250lux plus 5 µg/ml of 
Kanamycin. RLU = Relative Light Units. 
 
 
 
 
 
87 
 
(B) 
Time (h)
0 5 10 15 20
R
L
U
0
2
4
6
8
10
12
 
 
Fig. 6 (B) Bioluminescence as a measure of the antimicrobial activity of 
Streptomycin in whole milk as determined by the luminoskan luminometer over 20 
h. (●) represents L. lactis 5250lux, (o) represents L. lactis 5250lux plus 5 µg/ml of 
Streptomycin. RLU = Relative Light Units. 
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Discussion 
Fermentation of milk is an essential step in the production of cheese and despite 
extensive control measures, the presence of antimicrobial agents i.e. antibiotics and 
bacteriophage in the dairy industry is still a significant problem (McGrath et al., 
1999, Quiberoni et al., 2006, Marvig et al., 2011). If present in bulk milk, 
antimicrobial substances can either destroy the Lactococcus culture or, in complex 
starters, destroy the balance of inoculated strains with significant effects on product 
flavour and texture (Stewart, 1990). At present, Starter Activity Tests (SAT’s) are 
used to evaluate antimicrobial activity in milk; however, this requires several hours 
of incubation before an assessment can be made (Stewart, 1990). Methods to prevent 
starter strain contamination and subsequent economic loss have been established; for 
example; Starter Strain Rotation (SSR), improved hygiene and thermal treatment of 
milk. However, improved hygiene practices are not always successful and SSR 
strategies can lead to dairy products of inferior or variable quality (e.g poor/variable 
aroma, proteolysis etc) (Ledeboer et al., 2002). Techniques for improvement of 
phage resistance of starter cultures for example transfer of phage resistant plasmids 
to starter strains, as well as phage detection mechanisms have been developed 
(Coakley et al., 1997, Wilson, 1935). However, a rapid assay for screening starter 
strains against antimicrobial agents would be very useful to the dairy industry.  
With this in mind, we set out to construct a new lux plasmid (pRH001lux) capable of 
continuously expressing the lux genes in a Gram positive host. This plasmid was 
transformed into a variety of cheese starter culture strains to produce a bank of 
bioluminescent stable starter strains. These strains could potentially be used within 
the cheese industry to monitor bulk milk samples for the presence of antimicrobial 
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agents, such as antibiotics. However it is important to note that due to their 
genetically modified status the lux-tagged starter strains developed in this study are 
only suitable for use as a research or monitoring tool for the dairy industry. The lux-
tagged strains are unsuitable for direct use in cheese production where the non-lux-
tagged counterparts would continue to be used.   
Initial experiments focused on determining whether the lux genes in p16Slux plasmid 
could be expressed in L. lactis strains. The p16Slux plasmid contains luxABCDE 
genes derived from Photorhabdus luminescens and the E. coli DH10B 16S rRNA 
genes. However, this plasmid does not contain the necessary elements for plasmid 
transfer by conjugation and so it was not suitable for application in this study. 
However, p16Slux could be sucessfully transformed into L. lactis MG1363 and L. 
lactis IL1403 by electroporation, indicating the lux genes can be expressed in L 
lactis. Previous attempts by Riedel et al. (2006a) to transform this plasmid into L. 
lactis NZ9000 were also successful; however attempts to integrate the plasmid into 
the bacterial chromosome failed. Replacement of the 16S sequence (from p16Slux) 
with a 16S sequence from a Gram positive bacterium did not promote integration of 
the plasmid (p16SLlalux). Riedel postulated that Gram positive bacteria are more 
sensitive to the disruption of the 16S rRNA gene than Gram negative bacteria (Riedel 
et al., 2007a). Based on these finding, no attempts were made to construct a 
chromosomal integration vector based on the 16S rRNA gene during this study.  
Next we set out to develop a bank of bioluminescent starter culture strains capable of 
being monitored in real-time in whole milk. In order to develop pRH001lux, the 
native Lactococcus plasmid pMRC01 was exploited due to its self-transmissible 
nature. Plasmid pMRC01 is a 63-kb conjugative Lactococcus plasmid which encodes 
bacteriophage resistance genes as well as genes encoding production of and 
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immunity to the broad spectrum bacteriocin Lacticin 3147. This plasmid was 
previously identified as containing putative genes for conjugal transfer of the plasmid 
and an origin of transfer region (oriT) (Ryan et al., 1996). In its current form, 
pMRC01 was deemed inappropriate for this study due to the absence of lux genes 
and the presence of bacteriophage resistance genes. However, by combining the oriT 
from pMRC01 with pCI372 (a high copy number E. coli-Lactococcus shuttle vector) 
and ligating it with the lux cassette the resulting plasmid can be successfully 
mobilised into starter culture strains (Hickey et al., 2001). 
In terms of molecular construction of the new conjugative-lux plasmid, the Phelp 
promoter plus the luxABCDE cassette, derived from P. luminescens, was cloned from 
p16Slux into a 6-kb broad range host vector known as pRH001. This plasmid 
consists of 5.7-kb plasmid pCI372 and the 0.3-kb oriT derived from pMRC01. As 
well as being the original host of the oriT, pMRC01 also contain a 19.6-kb region 
which includes putative genes for conjugal transfer of the plasmid and genes 
necessary for bacteriocin production (Hickey et al., 2001, Coakley et al., 1997). In 
the presence of the mobilization genes (oriT) and pMRC01, the new lux plasmid 
could be transferred by filter matings and expressed in Gram positive bacteria. Up to 
nine starter strains were transformed in this manner with all transconjugates 
exhibiting strongly bioluminescent phenotypes, confirming that the lux genes can be 
expressed in Lactococcus.  
To prevent co-mobilising pMRC01, the bacteriocin selective pressure during the 
filter mating was relieved by the addition of proteinase K to the filter (Hickey et al., 
2001). Co-mobilizing pMRC01 would result in bacteriophage resistant 
transconjugates which would not be suitable for this study but would be useful if 
constructing a bank of lux-tagged bacteriophage resistant starter culture strains.  
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In the event that transformation by conjugation was not possible (perhaps due to 
incompatibility with a resident plasmid or difficulties replicating efficiently in the 
recipient), strategies to transform the plasmid by electroporation were also 
established (Coakley et al., 1997). Electroporation is commonly used as a means of 
plasmid transfer (Dupont et al., 2004, Coakley et al., 1997); however, in many 
countries it is not regarded as a food grade approach and was not always possible 
during the course of this work. In some instances, the transformation efficiency into 
Lactococcus was very low or the plasmid simply would not transform. We speculate 
that this was at least in part due to the relatively large plasmid size.   
We also investigated whether luminescence was affected by pH when the lux-tagged 
starter strains were left to ferment in milk overnight. Previously Jiang et al. (2006) 
had determined that media components influenced the reaction of the luminescent 
cultures to pH. The mechanisms by which media components affected the lux-tagged 
L. lactis response to pH are unknown. However, the bioluminescent L. lactis could 
emit a strong luminescent signal within a large pH range (approximately 2.5–9.5) 
thereby increasing the usefulness of lux-tagged L. lactis as reporters in different 
foods and under different environmental conditions; for example, in milk or during 
cheese production (Jiang et al., 2006). In this study, acidity was determined by 
measuring pH values after milk cultures were incubated at 30° C. After 24 hours pH 
values were measured and it was determined that light could be emitted between 
pH’s of 4.1 and 6.6, confirming that luminescence can be emitted in mildly acidic 
environments.  
To our surprise, challenging the lux-tagged starter strains with bacteriophage yielded 
an increase in luminescence despite a reduction in cell number being recorded when 
plate counts were performed. This occurred even when the strain was not susceptible 
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to the added phage (e.g. Tuc2009). This response does not occur when the tagged 
strains are exposed to another bactericidal agent such as an antibiotic. The increased 
bioluminescence must result from either (i) an increase in cell numbers, (ii) an 
increase in enzyme levels or (iii) and increase in enzyme activity. We were able to 
rule out an increase in cell numbers and speculate that this increase in luminescence 
is most probably as a result of increased activity, perhaps due to an increase in ATP 
levels in the presence of bacteriophage. It may well be that bacteria respond to phage 
attack by increasing metabolic activity to respond to the threat posed by the 
bacteriophage. However, it is unusual that the same response was observed in the 
presence of a phage which does not inhibit the luminescent strain. Despite extensive 
research, we have found no other explanation in the literature to support this finding. 
Further research will be necessary to confirm and/or explain this finding. While our 
initial hypothesis was that bacteriophage disruption would be detected by a decrease 
in luminescence, an increase would be equally useful for detection purposes 
however, we will have to establish if this is a general phenomenon. In the case of 
antibiotic residue detection, the strategy worked as originally envisaged, in that the 
presence of antibiotics prevents the development of a bioluminescent signal. The 
current study demonstrates a rapid method of monitoring the action of antibiotic 
residues on growth of bioluminescent cheese starter culture strains, in real time. This 
assay highlights the speed and ease at which biomonitoring assays can be performed 
when compared to plate assays.  
Using bioluminescent-based technology to monitor starter culture strains has many 
advantages. It is a rapid method of monitoring growth of the lux tagged strains when 
compared to other conventional methods such as plate counts. The latter requires 
serial dilutions of samples and plating on previously prepared agar plates which, in 
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the case of large sample loads, can be slow and labour intensive. Bioluminescent 
output can be measured in real-time and the result is instantaneous. Bioluminescent 
reporters give an accurate representation of starter strain growth given that there is no 
significant difference in growth rates between lux-tagged and wild-type strains (P-
value < 0.05). These reporters allow results to be tracked in real-time, at intervals 
determined by the researcher and over long or short time frames. In this study and in 
chapter II, it was shown that bioluminescence techniques may be used to monitor 
growth of bacteria in opaque environments such as whole milk (Morrissey et al., 
2011). This is very useful as opaque liquids are not conducive to optical density 
measurements and require other indirect methods of measurement such as measuring 
pH or cell counts.  
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Conclusion 
In brief, we have developed a method of transformation of the lux genes into 
Lactococcus strains to produce starters with a stable luminescent phenotype. These 
strains can be constructed using conjugation or electroporation and the physiological 
characteristics (growth, stability and acid resistance) of these strains were not 
significantly affected. The newly developed plasmid pRH001lux was successfully 
transformed into several industrially important starter culture strains by 
electroporation and conjugation and all transformants exhibited the luminescent 
phenotype. The plasmid pRH001lux was suitable for expressing luxABCDE genes in 
starter culture strains and tagged strains capable of being used as biomonitoring 
reporters for the dairy industry. Though it was not possible to monitor the presence 
of bacteriophage in milk, these reporters were used sucessfully to monitoring 
antibiotic residues in milk. These reports cannot be used for product manufacture as 
there are GMO’s (genetically modified organisms); however they could be beneficial 
to the dairy industry as an important research tool prior to the production of cheese. 
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Chapter IV 
Use of Bioluminescence-Based assays to test the 
Activity of Bioengineered Nisin Derivatives M21V 
and S29A against Foodborne Pathogens in 
Laboratory Media and Selected Foods 
 
 
 
 
 
 
 
A manuscript based on this chapter is in preparation 
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Abstract 
Nisin A is the best known bacteriocin and has been the subject of much research in 
particular with regard to its protective role in foods. It is also the only commerically 
available bacteriocin to date. Nisin is a 34- amino acid lantibiotic peptide, 
characterised by the presence of post translationally modified amino acids including 
lanthionine and/or methyllanthionine groups. Several Nisin variants with enhanced 
activity against Gram positive and negative bacteria have been identified. With this 
in mind, we set out to examine the effect of Nisin and two recently bioengineered 
Nisin variants (V and S29A) on a number of luciferase-tagged foodborne pathogens 
both in vitro and in food models at room temperature. We used bioluminescent 
reporter strains and modified agarose-based assays to quantitatively assess how each 
of these peptides performed against a range of foodborne pathogens, under sub-
optimal conditions. We also used a bioluminescent-based assay to test how well each 
of the peptides preformed in a model food system when combined with a an 
antimicrobial agent (EDTA). For the first time, we report the enhanced bioactivity of 
Nisin V against Gram negative bacteria (Escherichia coli and Cronobacter 
sakazakii) in agarose assays and laboratory media (E. coli). However, further 
analysis of Nisin V against Gram negative bacteria in powdered infant formula (PIF), 
apple juice and liquid whole egg revealed no such inhibitory effect. The enhanced 
bioactivity of Nisin S29A and V against Listeria monocytogenes in a commercially 
produced frankfurter maintained under sub-optimal conditions is also reported. In 
this instance, we demonstrated that Nisin V outperforms both the wild-type Nisin and 
S29A with respect to controlling growth of Listeria over a 24 hour period. Finally, 
we report that combinations of variants (M21V & S29A) with EDTA displayed 
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enhanced bioactivity against C. sakazakii in PIF, when compared to the wild-type 
nisin. 
Introduction 
Nisin A is easily the most extensively characterised lantibiotic and was the first 
approved as an antimicrobial agent in food by the Joint FAO/WHO expert committee 
on food additives in the late sixties (Delves-Broughton, 2005, Molloy et al., 2012). 
Since then, it has been used as a food preservative in over 50 countries worldwide 
and in europe has been given the food additive number E234 (Piper et al., 2009, 
Delves-Broughton, 2005). It functions by a distinctive dual mode of action involving 
binding of Nisin to lipid II, an essential precursor of the bacterial cell wall, followed 
by insertion into the membrane of the target cell to form a pore (Piper et al., 2009, 
Cotter et al., 2005, Wiedemann et al., 2006, Breukink et al., 1999, Field et al., 2008). 
In recent years and facilitated by the gene-encoded nature of lantibiotics, 
bioengineered Nisin A derivatives with enhanced bioactivity against Gram positive 
bacteria have been generated (Field et al., 2010a). Early attempts focussed on the 
generation of derivatives through targeted mutagenesis approaches in a bid to 
improve the solubility, stability and/or antimicrobial properties of Nisin A (Liu and 
Hansen, 1992, Kuipers et al., 1992, Rink et al., 2007, Rollema et al., 1995). Despite 
the large numbers of derivatives generated by these studies, relatively few Nisin 
variants were found with enhanced activity against pathogenic micro-organisms 
(Yuan et al., 2004, Rink et al., 2007, Kuipers et al., 1996). In recent years the 
combination of site-directed and non-targeted mutagenesis strategies, as well as 
specific targeting of a short 3 amino acid stretch in the peptide chain known as the 
hinge region, have resulted in the discovery of new derivatives with enhanced 
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activity against a range of pathogenic micro-organisms (Yuan et al., 2004, Field et 
al., 2008). Initial success was demonstrated through the generation of two hinge 
mutants, N20K and M21K, that only exhibited enhanced antimicrobial activity 
against Gram negative bacteria, including Shigella, Pseudomonas and Salmonella 
spp. (Yuan et al., 2004). However, four years later the goal of generating Nisin 
derivatives with enhanced activity against Gram positive pathogens was achieved via 
a non-targeted approach (Field et al., 2008). The screening of a large bank of 
randomly mutated Nisin mutants led to the discovery of one variant which encoded a 
K22T change (located within the hinge-region) that yielded a Nisin variant with 
enhanced activity against several Gram positive pathogens. A more in depth 
randomization of the hinge residues (Asn20-Met21-Lys22) led to the identification 
of further derivatives of note including N20P, M21V and K22S (Field et al., 2008). 
Of these, Nisin M21V, subsequently renamed Nisin V, was noteworthy by virtue of 
its enhanced antimicrobial activity against a wide range of Gram positive targets, 
including medically significant pathogens (heterogeneous vancomycin-intermediate 
S. aureus, methicillin-resistant S. aureus and vancomycin resistant enterococci), as 
well as Clostridium difficile, Streptococcus agalactiae (a human and bovine 
pathogen)  and Listeria monocytogenes (Field et al., 2008, Field et al., 2010b). 
The first instance of a Nisin derivative showing simultaneous enhanced activity 
against both Gram positive and Gram negative bacteria was reported in 2012 (Field 
et al., 2012). Using a targeted mutagenesis approach, derivatives of Nisin modified 
Serine 29, namely S29G, S29A, S29D and S29E, were found to possess superior 
antimicrobial activity against a range of Gram positive drug resistant clinical, 
veterinary and food pathogens. In addition, a number of the Nisin S29 derivatives 
displayed superior antimicrobial activity to Nisin A when assessed against a range of 
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Gram negative food-associated pathogens, including Escherichia coli, Salmonella 
enterica serovar Typhimurium and Cronobacter sakazakii.  
Increasing consumer demand for minimally processed foods and ingredients ensures 
that Nisin A remains the most commercially important bacteriocin. To date, much of 
the work demonstrating the antimicrobial activity of Nisin A has been carried out in 
the form of food trials (Chollet et al., 2008, Davies et al., 1999, Murray, 1997). 
However, the activity of Nisin A variants in different food matrices has not been 
comprehensively examined, with the exception of two recent studies. Rouse et al. 
(2012) demonstrated the enhanced activity of the Nisin hinge variants SVA and 
NAK compared to Nisin A in controlling the growth of L. monocytogenes in 
chocolate milk stored under varying conditions. Field et al. (2010b) also examined 
the impact of the Nisin variant V compared to wild type Nisin A on L. 
monocytogenes in frankfurter meat stored at 37°C for 1 h.   
With this in mind, we set out to compare the bioactivity of Nisin A and the most 
promising lead variants V and S29A against Gram positive and Gram negative 
bacteria, in laboratory media and food matrices stored under sub-optimal conditions 
(representing temperature abuse situations). Once the potency of each peptide was 
established in agarose, we used lux-tagged foodborne pathogens to determine 
whether the enhanced activity of the Nisin derivatives could be replicated in 
laboratory media and in food matrices stored under sub-optimal conditions.   
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Materials and methods 
Bacterial strains and growth conditions  
A summary of the Nisin producing strains and lux-tagged bacterial strains used in 
this study are listed in Table 1. Luria-Bertani (LB) broth (Merck, Darmstadt, 
Germany) was used to grow E. coli, S. enterica and C. sakazakii cultures. 
Microbiological agar (Merck, Darmstadt, Germany) was added to LB broth when 
solid agar was required. Lactococcus lactis strains were grown in M17 broth (Oxoid, 
Basingstokes, UK) supplemented with 0.5% glucose, GM17 (Sigma-Aldrich, MO, 
USA) or GM17 agar (Oxoid, Basingstoke, UK) at 30°C. Listeria strains were grown 
in brain heart infusion (BHI) broth or BHI agar (Oxoid, Basingstoke, UK) at 37°C. 
E. coli and C. sakazakii cultures were grown at 37°C, while S. enterica cultures were 
grown at 37°C. When required, antibiotics were used where indicated at the 
following concentrations: chloramphenicol (Sigma-Aldrich, MO, USA) 7.5 mg/ml
-1
 
for Listeria and 10 mg/ml
-1
 for L. lactis and erythromycin (Sigma-Aldrich, MO, 
USA) at 500 mg/ml
-1
 for E. coli, C. sakazakii, and S. Typhimurium. Stock soltions of 
1 M EDTA (Sigma-Aldrich, MO, USA) was prepared in 100% ethanol.  
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Table 1. List of Nisin-producing strains, lux-tagged bacterial strains used in this study, 
including relevant  
characteristics and references.  
Strains/Lux-tagged bacteria Relevant characteristics 
or source of strains 
Reference 
Lactococcus lactis Nisin A (UCC 
5010) 
Wild-type Nisin-producing strain (Field et al., 2008) 
Lactococcus lactis Nisin V (UCC 
5012)  
Wild-type Nisin-producing strain 
+ alteration at position 21 on 
peptide chain 
(Field et al., 2010b) 
Lactococcus lactis NZ9800 
PCI372-NisA S29A 
Wild-type Nisin-producing strain 
+ alteration at position 29 on 
peptide chain 
(Field et al., 2012) 
Listeria monocytogenes:: F2365 
::pPL2lux -Phelp 
Isolated from cheese and 
transformed with pPL2lux-Phelp 
plasmid 
UCC culture collection 
Cronobacter sakazakii NCTC 
8155::p16Slux -Phelp 
Isolated from dried milk powder 
and transformed with p16Slux- 
Phelp plasmid 
UCC culture collection 
(Chapter II) 
Escherichia coli 0157:H7 TUV 
93-0:p16Slux- Phelp 
Derived from strain EDL933 and 
transformed with p16Slux-Phelp 
plasmid 
This study 
Salmonella Typhimurium UK-
1::p16Slux -Phelp 
Chicken-passaged isolate of a 
highly virulent S. Typhimurium 
strain, originally isolated from 
infected horse. Transformed with 
p16Slux- Phelp plasmid 
UCC culture collection 
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Nisin purification 
L. lactis Nisin A (UCC 5010) or the mutant nisin strains of interest, L. lactis NZ9800 
PCI372-nisA S29A (S29A) and L. lactis Nisin V (UCC 5012) (V) were sub-cultured 
twice in GM17 broth at 1% at 30°C before use. Two liters of modified Tryptic yeast 
broth was inoculated with the culture at 0.5% and incubated at 30°C overnight. The 
culture was centrifuged at 3,287 X g for 20 min at 4 ˚C. The cell pellet was re-
suspended in 300 ml of 70% isopropanol (IPA) containing 0.1% trifluoroacetic acid 
(TFA) and stirred at room temperature for approximately 3 h. Cell debris was 
removed by centrifugation at 3,287 g for 20 min and the supernatant was retained. 
The isopropanol was evaporated from the supernatant using a rotary evaporator 
(Buchi) and the pH was adjusted to 4.5 before applying to a 10 g (60 ml) Varian C-
18 Bond Elut Column (Varian, Harbor City, CA) pre-equilibrated with methanol and 
water. The column was washed with 100 ml of 30% ethanol and the inhibitory 
activity was eluted in 100 ml of 70% IPA 0.1% TFA. Aliquots (10 ml) were 
concentrated to 2 ml through the removal of IPA by rotary evaporation. Aliquots (1.5 
ml) were applied to a Phenomenex (Phenomenex, Cheshire, UK) C12 reverse phase 
(RP)-HPLC column (Jupiter 4u proteo 90 Å, 250 x 10.0 mm, 4 µm) previously 
equilibrated with 25% IPA, 0.1% TFA. The column was subsequently developed in a 
gradient of 30% IPA containing 0.1% TFA to 60% IPA containing 0.1% TFA from 
10 to 45 min at a flow rate of 1.2 ml min
-1
. 
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Mass spectrometry 
For colony mass spectrometry analysis, bacteria was collected with sterile plastic 
loops and mixed with 50 ml of 70% isopropanol adjusted to pH 2 with HCl. The 
suspension was vortexed, the cells were spun down in a benchtop centrifuge at 
13,148 x g for 2 min and the supernatant was removed for analysis. Mass 
spectrometry in all cases was performed with an Axima CFR plus matrix-assissted 
laser desorption/ionisation Time-of-flight (MALDI TOF) mass spectrometer 
(Shimadzu Biotech, Manchester, UK). A 0.5 ml aliquot of matrix solution [alpha-
cyano-4-hydroxy cinnamic acid (CHCA), 10 mg ml
-1
 in 50% acetonitrile-0.1% (v/v) 
TFA] was placed onto the target and left for 1–2 min before being removed. The 
residual solution was then air dried and the sample solution (re-suspended 
lyophilized powder or colony mass spectrometry supernatant) was positioned onto 
the pre-coated sample spot. Matrix solution (0.5 ml) was added to the sample and 
allowed to air dry. The sample was subsequently analyzed in positive-ion reflectron 
mode. 
 
Well diffusion assays for antimicrobial activity 
Agarose-based deferred antagonism assays were carried out as follows: Underlay 
agar (0.03%) was prepared with 10 mM sodium phosphate buffer (SPB) at pH 7.4 
and agarose (1% w/v) was added, autoclaved and cooled to 50 °C. Bacteria grown to 
mid-logarithmic phase (OD595nm ~ 0.5nm) were harvested by centrifugation and 
washed with 10 mM SPB at pH 7.4. Bacterial cells were then added to 15 ml cooled 
underlay medium to obtain a concentration of 2 × 10
7
 colony-forming units 
(CFU)/ml. The inoculated medium was rapidly transferred into sterile Petri dishes, 
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allowed to solidify and dried. Wells (4.6mm in diameter) were then made in the 
seeded plates. Freeze dried purified Nisin A and mutants was weighed and 
resuspended in BHI/LB broth to a final concentration of 60 µM for Gram negative 
bacteria and 30 µM for Gram positive bacteria. Ten microliters of these resuspended 
Nisin peptides were then added to the wells and the plates were incubated at 37 °C 
(Gram positive strains) or room temperature (Gram negative strains) for 3 hours. The 
plates were then overlaid with 15 ml of autoclaved double strength BHI/LB agarose 
(1% w/v agarose) overlay medium pre-cooled to 50 °C. The plates were then 
incubated overnight (~ 16 h) at the relevant temperature. 
 
Minimum inhibitory concentration assays 
Minimum inhibitory concentration (MIC) determinations for Gram positive 
organisms were carried out in triplicate in microtitre plates (Sarstedt, Numbrecht, 
Germany). Ninety-six well microtitre plates were pre-treated with bovine serum 
albumin (BSA) (Sigma-Aldrich, MO) prior to addition of the peptides. Briefly, to 
each well of the microtitre plate 200 μl of phosphate buffered saline (PBS) (Gibco, 
Paisley, UK) containing 1% (w/v) bovine serum albumin (PBS/BSA) was added and 
incubated at 37 °C for 30 min. The wells were washed with 200 μl PBS and allowed 
to dry. Target strains (Table 1) were grown overnight using the appropriate 
conditions and broth medium, sub-cultured into fresh broth and allowed to grow to 
an OD595 of ~ 0.5 and diluted to a final concentration of 10
5
 CFU/ml. Wild type 
Nisin and Nisin mutant peptides were adjusted to a 7.5 μM (L. monocytogenes) 
starting concentration and 2-fold serial dilutions of each peptide were added to the 
wells containing the target strain. After incubation for 16 h at 37°C the MIC was 
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determined as the lowest peptide concentration causing inhibition of visible growth. 
For Gram negative bacteria (E. coli, C. sakazakii and S. Typhimurium), strains were 
grown to mid-logarithmic phase and then harvested by centrifugation, washed with 
10 mM SPB at pH 7.4, and diluted to 2 × 10
5
  CFU/ml in SPB. Nisin and Nisin 
derivative purified peptides were resuspended in sterile HPLC water and 50 μl 
aliquots were added to wells containing 2 × 10
5
 CFU of bacteria in a volume of 50 
µl. Plates were incubated at room temperature for 2 hours with agitation. Double 
strength LB broth (100 μl) was added and plates were incubated at room temperature 
overnight (~ 16 h). The MIC was taken as the lowest concentration of peptide at 
which growth was inhibited. All assays were carried out in triplicate. 
 
Food models 
Infant milk formula Trial with C. sakazakii 
Commerically available powdered infant formula (PIF) was prepared according to 
manufacturers instructions, brought to room temperature and the pH of the milk was 
determined. An overnight culture of C. sakazakii NCTC 8155::lux was diluted and 
inoculated into reconstituted PIF at a final concentration of 1 x 10
5
 CFU/ml. To this, 
Nisin A or the Nisin variants were added at a concentration of 160.1 mg/L (48 µM). 
Reconstituted PIF inoculated with the pathogen alone and PIF containing neither 
pathogen nor peptide served as contols for the experiment. One hundred microliters 
of test and control samples were transferred to a 96-well white plate (Nunc, Thermo 
Fisher Scientific, Roskilde, Denmark) and bioluminescence measurements were 
recorded every hour for 24 h at sub-optimal temperature in relative light units (RLU) 
by a Luminoskan luminometer automatic plate reader (Thermo Fisher Scientific, 
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Roskilde, Denmark). C. sakazakii counts levels were determined through dilution 
and plating of samples on LB and DFI agar. The experiments was carried out in 
triplicate. 
 
Apple Juice trial with E. coli 0157:H7 
Commerically available apple juice was brought to room temperature and the pH of 
the juice determined. An overnight culture of E. coli:0157:H7::lux was diluted and 
inoculated into the juice at a final concentration of 1 x 10
5
 CFU/ml. To this, Nisin A 
or the Nisin variants were added at a concentration of 160.1 mg/L (48 µM). Apple 
juice inoculated with the pathogen alone and juice containing neither pathogen nor 
peptide served as controls for the experiment. One hundred microliters of test and 
control samples were transferred to a 96-well white plate and bioluminescence 
measurements were recorded every hour for 24 h at ambient temperature in relative 
light units (RLU) by a Luminoskan luminometer automatic plate reader. E. coli 
0157:H7 counts were determined through dilution and plating of samples on LB 
agar. The experiment was carried out in triplicate. 
 
Egg trial with S. Typhimurium 
Large Grade A eggs were purchased from a local supermarket and egg shells were 
washed with 70% ethanol and allowed to air dry. The sanitised eggs were aseptically 
broken, transferred into a sterile stomacher bag (Seward, UK) and homogenised for 2 
mins in a stomacher (Alvarez et al., 2007). The liquid egg (yolk plus white) was 
stored at 4 °C until required. The pH of the liquid egg was determined. An overnight 
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culture of S. Typhimurium::lux was diluted and inoculated into liquid egg at a final 
concentration of 1 x 10
5
 CFU/ml. To this, Nisin A or the Nisin variants were added 
at a concentration of 160.1 mg/ml (48 µM). Egg inocultaed with the pathogen alone 
and egg containing neither pathogen or peptide, served as controls for the 
experiment. One hundred microliters of both test and control samples were 
transferred to a 96-well white plate and bioluminescence measurements were 
recorded every hour for 24 h at ambient temperatures in relative light units (RLU) by 
a Luminoskan luminometer automatic plate reader. S. Typhimurium counts were 
determined through dilution and plating of samples on LB agar. The experiment was 
carried out in triplicate.  
 
Frankfurter meat trial with Listeria monocytogenes 
Thirty-five grams of frankfurter meat (78% pork meat and 12% pork fat) was 
weighed and placed into a sterile blender and homogenized on full speed for 30 s 
with 35 ml of PBS. One ml of the meat homogenate was placed into sterile 1.5 ml 
eppendorf tubes. The samples were then inoculated with approximately 1x10
5
 
CFU/ml L. monocytogenes F2365lux. To this, Nisin A or the Nisin variants were 
added at a concentration of 7.5 mg/L (2.24µM). The effect of Nisin against Listeria 
was examined by two techniques: 200 µl of treated homogenate was transferred to 
96-well plates and kill of Listeria monitored by bioluminescence using the 
Luminoskan Luminometer. Similarly, 200 µl of treated homogenate was transferred 
to a sterile eppendorf tube, incubated at ambient temperature and Listeria counts 
were monitored by serial dilution and plate count technique using BHI and listeria 
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selective (LSA) agar (Oxoid, Basingstoke, UK). Samples were withdrawn and plated 
after 1, 3, 5 and 24 h. The test was conducted in triplicate (Field et al., 2010b). 
 
Infant milk formula Trial with C. sakazakii and EDTA 
Commerically available powdered infant formula (PIF) was prepared according to 
manufacturers instructions, brought to room temperature and the pH of the milk was 
determined. An overnight culture of C. sakazakii NCTC 8155::lux was diluted and 
inoculated into reconstituted PIF at a final concentration of 1 x 10
5
 CFU/ml. To this, 
Nisin A or the Nisin variants were added at a concentration of 160.1 mg/L (48 µM). 
EDTA at a concentration of 20 Mm was also added. Reconstituted PIF inoculated 
with the pathogen alone, PIF containing neither pathogen nor peptide and PIF 
containing EDTA served as controls for the experiment. One hundred microliters of 
test and control samples were transferred to a 96-well white plate (Nunc, Thermo 
Fisher Scientific, Roskilde, Denmark) and bioluminescence measurements were 
recorded every hour for 24 h at sub-optimal temperature in relative light units (RLU) 
by a Luminoskan luminometer automatic plate reader (Thermo Fisher Scientific, 
Roskilde, Denmark). C. sakazakii counts levels were determined through dilution 
and plating of samples on LB and DFI agar. The experiments was carried out in 
triplicate. 
Note: Growth curves examining lux-tagged Listeria monocytogenes, Cronobacter 
sakazakii, Escherichia coli and Staphylococcus aureus at various pH’s and salt 
concentrations were carried out. Result of this work can be found in the appendix. 
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Interpretation of data and statistical analysis.  
All experiments were performed in triplicate from three separate cultures (i.e. three 
biological repeats) and repeated at least twice. The results shown represent the means 
+/- standard deviations (error bars) for one particular experiment. Mean and standard 
deviations were calculated using a basic Excel programme. Statistical significance 
was determined via Sigma plot t-test. In all cases, a P-value less than or equal to 0.05 
was considered to be statistically significant. 
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Results 
Nisin purification and Mass spectrometry 
Previously Field et al. (2010a) generated Nisin variants (V and S29A) with enhanced 
activity through alterations of single amino acid residues (Fig. 1A). Following 
purification and freeze drying of these Nisin variants, colony mass spectrometry 
(CMS) analysis was performed. Peptide masses of 3,321 Da, 3,336 Da and 3,353 Da 
were obtained for Nisin peptides V, S29A and Nisin A, respectively, confirming the 
correct mass and purity of each peptide (Fig. 1B). 
 
Bioassays for antimicrobial activity and minimum inhibitory concentration 
(MIC) 
The antimicrobial activity of each peptide was initially determined by means of a 
modified agarose diffusion assay using equimolar concentrations of the purified 
peptides as previously described (Field et al., 2012). The peptides were assessed 
against a range of targets which included L. monocytogenes, C. sakazakii, E. coli and 
S. Typhimurium (Table 2). Results revealed that the Nisin variant V displayed 
enhanced activity when compared to wild-type Nisin A, when assessed against L. 
monocytogenes (16.13mm and 13.16mm, respectively), E. coli (13.70 and 12.32mm, 
respectively) and C. sakazakii (13.99mm and 12.25mm, respectively). Notably, the V 
variant was not enhanced against S. Typhimurium. In contrast, the Nisin S29A 
derivative exhibited enhanced bioactivity against all the pathogens tested when 
compared to the wild-type peptide. 
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Fig. 1 (A) The structure of Nisin A (wild-type). Red circles indicate where amino 
acids were altered resulting in the generation of Nisin variants with enhanced 
activity. (B) Colony Mass Spectrometry analysis of Nisin A (3352.6 Da), V (3320.76 
Da) and Nisin S29A (3336.6 Da) producing strains utilized in this study.   
 
 
WT             V             S29A
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Strains/Plasmids   Nisin A  V  S29A 
    mm
2
   mm
2 
  mm
2
  
L. monocytogenes F2365::pPL2lux 13.16±0.17 16.13±0.19 14.73±0.16  
      (p=0.0003) (p=0.002)  
C. sakazakii NCTC 8155::p16Slux 12.25±0.24 13.99±0.36 13.39±.078  
      (p=0.017) (p=0.015) 
E. coli 0157:H7 TUV 93-0::p16Slux 12.32±0.18 13.70±0.14 13.51±0.20 
      (p=0.004) (p=0.012)  
S. Typhimurium UK-1::p16Slux 9.70±0.17 9.64±0.28 10.28±0.12 
      (p=0.86)  (p=0.05) 
 
 
Table 2. Activity of purified peptides of Nisin A, V and S29A against C. sakazakii, 
E. coli and S. Typhimurium (60 µM) and L. monocytogenes (30 µM) as determined 
by agarose gel diffusion assay. Results are expressed as total area of inhibitory zone 
expressed in mm
2
. p -values represent statistical difference between Nisin variants 
and wild type Nisin A. Values in bold reached statistical significance compared to 
the Nisin A control (Student’s t-test: p ˂ 0.05). 
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To further confirm the specific activity of the peptides, and to ensure that these 
results were not simply a result of improved solubility in solid agar, broth-based MIC 
determination assays were also carried out using purified peptides against the same 
Gram positive and Gram negative targets (Table 3). The lower the MIC recorded, the 
higher the activity of the peptide. The results closely matched the results obtained 
using the agarose-based diffusion assays. S29A exhibited at least a two-fold increase 
in specific activity against all of the pathogen targets tested. In the case of Nisin V, 
enhanced specific activity compared to Nisin A was observed for L. monocytogenes 
(1.87µM and 3.75µM, respectively) and notably E. coli (3.75µM and 7.50µM, 
respectively). In contrast to the agar-diffusion assays however, the specific activity of 
Nisin V was comparable to Nisin A when examined against C. sakazakii and S. 
Typhimurium. These results demonstrate for the first time the enhanced activity of 
Nisin V against a Gram negative strain (E. coli) in a broth-based MIC assay. 
 
Strains/Plasmids   Nisin A  V  S29A 
    mg/L (µM) mg/L (µM) mg/L (µM) 
L. monocytogenes F2365::pPL2lux 25.14(7.5) 12.57(3.75) 6.28(1.87)  
C. sakazakii NCTC 8155::p16Slux 12.57(3.75) 12.57(3.75) 6.28(1.87)  
E. coli 0157:H7 TUV 93-0 p16Slux 25.14(7.5) 12.57(3.75) 12.57(3.75) 
S. Typhimurium UK-1:: p16Slux 25.14(7.5) 25.14(7.5) 12.57(3.75) 
 
Table 3. MIC of purified Nisin A, V and S29A against representative Gram negative 
strains & one Gram positive strain. Results are expressed (in mg/L and µM) as the 
mean of triplicate assays. Values in bold reached statistical significance compared to 
the Nisin control (Student’s t-test: p ˂ 0.05). 
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Food Trials 
Having established the potency of Nisin V and S29A against Gram positive and 
negative bacteria in both agar and broth, we set out to determine if the observed 
enhanced antimicrobial activity could translate to different food matrices stored at 
ambient temperature to simulate a temperature abuse situation. In food trials using 
reconstituted PIF (pH ~ 6.68) spiked with C. sakazakii, we observed that addition of 
wild-type Nisin A and the Nisin variants (V and S29A) had no inhibitory effect on 
bacterial growth (measured in RLU) over the time course of the assay (Fig. 2). In 
fact, samples containing Nisin A shared a similar growth pattern to samples 
containing either Nisin A or S29A. Viable plate counts taken at regular intervals 
support these findings (data not shown). 
When apple juice samples containing E. coli were spiked with wild-type Nisin A, V 
and S29A it was noted that no inhibitory effect on bacterial growth was observed for 
any of the samples tested (Fig. 3). Samples containing Nisin A peptide showed 
similar results to samples containing either Nisin A or S29A. Due to the low pH 
associated with apple juice (pH of apple juice ~ 3.16), it was not possible to monitor 
bacterial growth using bioluminescence. This was confirmed when higher inocula 
were also added to apple juice and luminescence was monitored. Instead viable plate 
counts were performed.  
In food trials using liquid whole egg (pH ~ 6.9) spiked with S. Typhimurium, we 
observed that addition of wild-type Nisin A and Nisin variants (V and S29A) had no 
inhibitory effect on bacterial growth (measured in RLU) over the time course of the 
assay (Fig. 4). Again samples containing Nisin A shared a similar growth pattern to 
samples containing either Nisin A or S29A. Viable plate counts taken at regular 
intervals support these findings (data not shown). 
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Fig. 2 Growth of lux-tagged C. sakazakii (1 x 10
5
 CFU/ml) in PIF alone (●) and in 
plus 48 µM wild-type Nisin (o), and in PIF plus 48 µM V variant (■), plus 48 µM 
S29A (□) at room temperature as measured for 24 h on the luminoskan luminometer. 
(*) represents control containing PIF alone. Error bars represent the standard 
deviations of triplicate experiments (Students T-test: p < 0.05). 
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Fig. 3 Growth of lux-tagged E. coli (1 x 10
5
 CFU/ml) in apple juice, and in apple 
juice plus 48 µM wild-type Nisin, and in apple juice plus 48 µM V variant, or in 
apple juice plus 48 µM S29A, at ambient temperature and measured after 2 h. Error 
bars represent the standard deviations of triplicate experiments (students t-test 
p<0.05).  
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Fig. 4 Growth of lux-tagged S. Typhimurium (1 x 10
5
 CFU/ml) in liquid egg alone 
(●), and in liquid egg plus 48 µM wild-type Nisin (o), and in liquid egg plus 48 µM 
V variant (■), and in liquid egg plus 48 µM S29A (□), at room temperature and 
measured for 24 h on the luminoskan luminometer. (*) represents control of egg 
alone. Error bars represent the standard deviations of triplicate experiments 
(student’s t-test p< 0.05). 
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Having established the potency of Nisin V and S29A against L. monocytogenes in 
broth and agar, we sought to determine whether the enhanced bioactivity could be 
observed in a meat model at a sub-optimal temperature. When variants were assessed 
in frankfurters meat spiked with 2 x 10
5 
CFU/ml of L. monocytogenes and Nisin V 
peptide at sub-optimal temperature, a significant reduction (P < 0.05) in Listeria 
counts was observed in samples taken after 1, 3, 5 and 24 h (Fig. 5). A significant 
difference was also observed in samples containing S29A after 1 and 3 h (p < 0.05) 
when compared to wild-type Nisin A samples. Plate count analysis of samples after 5 
and 24 h revealed that samples containing S29A demonstrated recovery of Listeria 
and a 2 Log increase in bacterial numbers. Due to the low initial inoculum of Listeria 
used and the reduced levels of luminescence emitted from Gram positive bacteria it 
was not possible to monitor bacterial growth using bioluminescence. However, the 
assay demonstrates that Nisin V provided significantly enhanced protection against 
L. monocytogenes relative to the control peptide and S29A under the temperature 
abuse circumstances outlined above. Previous investigations carried out with Nisin V 
and A involved monitoring growth of Listeria in a model food system for just 1 h 
and at 37°C.  In addition, for the first time, S29A has been shown to demonstrate 
enhanced activity relative to the control peptide in frankfurter meat against L. 
monocytogenes for approximately 5 h. Notably, Listeria numbers regrew in both the 
Nisin A and S29A samples to levels equivalent to the control containing no peptide 
after 24 h. In contrast, Listeria levels in the sample containing Nisin V remained 
unchanged at all time points. 
 
 
 
119 
 
 
(A)                                         (B) 
F2365 alone WT M21V S29A
L
o
g
 C
F
U
/m
l
3
4
5
6
F2365 alone WT M21V S29A
L
o
g
 C
F
U
/m
l
3
4
5
6
7
 
 
                             (C) 
F2365 alone WT M21V S29A
L
o
g
 C
F
U
/m
l
3
4
5
6
7
8
 
 
Fig. 5 Growth of lux-tagged (1 x 10
5
 CFU/ml) L. monocytogenes f2365-lux in 
frankfurter mix plus 7.5 µg/ml wild-type Nisin, in frankfurter mix plus 7.5 µg/ml 
Nisin V, in frankfurter mix plus 7.5 µg/ml S29A, at room temperature and measured 
after 1 h (A), 3 h (B) and 24 h (C). Error bars represent the standard deviations of 
triplicate experiments. (*) represents Nisin variants statistically enhanced against the 
wild-type control (p <0.05). 
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Having established that Nisin V and S29A alone had no enhanced antimicrobial 
effect on C. sakazakii growth in food models, we sought to determine whether an 
antimicrobial effect would be observed in a food model containing Nisin variants in 
combination with EDTA. When variants were assessed in reconstituted PIF spiked 
with C. sakazakii, Nisin V peptide and EDTA at a sub-optimal temperature, a 
significant reduction (P < 0.05) in Cronobacter counts was observed in samples 
taken after 8 h (Fig. 6). A significant difference was also observed in samples 
containing S29A and EDTA after 8 h (p < 0.05) when compared to wild-type Nisin 
A samples. Plate count analysis of samples after 24 h revealed that samples 
containing M21V and S29A plus EDTA demonstrated recovery of Cronobacter and 
an increase in bacterial numbers.  
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Fig. 6 Growth of lux-tagged (1 x 10
5
 CFU/ml) C. sakazakii in reconstituted PIF, in 
PIF plus 20 mM EDTA, in PIF plus 48 µM wild-type Nisin and 20 mM EDTA,  in 
PIF plus 48 mM Nisin V and 20 mM EDTA, in PIF plus 48 mM Nisin S29A and 20 
Mm EDTA, at room temperature and measured after 8 h. Error bars represent the 
standard deviations of triplicate experiments. (*) represents Nisin variants 
statistically enhanced against the wild-type control (p <0.05). 
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Discussion 
Ensuring a safe food supply is a major challenge for the food industry. Consumers 
are continually demanding safe, minimally processed ready to eat convenience foods 
which will cater for all demographics and life-styles. A plethora of new methods and 
preservatives aimed at reducing microbial food spoilage have been identified and 
developed (Devlieghere et al., 2004). These include high hydrostatic pressure, pulsed 
electric fields, modified atmosphere packaging, natural antimicrobial compounds and 
bacteriocinogenic and non-bacteriocinogenic cultures. In terms of natural 
preservatives, antimicrobial agents which are food grade and therefore acceptable for 
use in the food industry are hugely important. The use of preservatives such as Nisin 
provide a useful preservation technology which can replace older techniques leading 
to food products which retain their flavour, nutrition and most of all are safe and 
natural for the consumer (Devlieghere et al., 2004). With Nisin increasingly being 
used as a preservative in a variety of foods, (permitted for use in over 50 countries) 
the potential for Nisin variants as preservatives in specific foods in the future is 
enormous (Delves-Broughton, 2005). The fact that these variants often differ from 
the wild-type Nisin A by only one amino acid suggests that these variants are more 
likely to become legally accepted preservatives in the future (Field et al., 2010b).  
To date, Nisin A has been used in a wide variety of foods (reviewed by Delves-
Broughton et al., 2005) and previous studies have shown that Nisin A can be 
influenced by a wide range of factors within foodstuffs including fat content, 
proteolytic degradation, partitioning into polar or nonpolar food components and 
sodium chloride concentrations. For example, Chollet and co-workers investigated 
the antimicrobial effect of sodium chloride, fat and proteolytic enzymes on the 
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concentration of Nisin in Emmental cheese and its subsequent antimicrobial activity 
(Chollet et al., 2008). Agarose-based assays determined that increased anhydrous 
milk concentrations caused a decrease in Nisin concentrations by a factor of 1.6 and 
a subsequent significant decrease in Nisin activity. Increasing sodium chloride 
concentrations was found to increase Nisin bioactivity. This work indicated that 
Nisin interacts with fat globules in the cheese matrix and was not affected by 
proteases. Another study by Jung et al. (1992) investigated the influence of fat and 
emulsifiers on the efficacy of Nisin at inhibiting L. monocytogenes in fluid milk 
(Jung et al., 1992). Results showed that Nisin activity (50 U/ml) decreased by about 
33% when it was added to skim milk and by more than 88% when added to milk 
containing 12.9% fat. In half-and-half milk or milk containing 12.9% milk fat, Nisin 
was far less effective at inhibiting L. monocytogenes. A review by Galvez et al. 
(2007) suggests that the efficacy of bacteriocins in food is in fact much lower when 
compared to results obtained in culture media. In some instances, up to ten-fold 
higher bacteriocin concentrations must be added to foods in order to achieve the 
same inhibitory effect seen in culture media (Gálvez et al., 2007). This is due to a 
number of limiting factors such as the target bacteria and food related factors such as 
pH, storage, processing conditions and the presence of enzymes or additives (Gálvez 
et al., 2007). The microbiota of the food is also an important factor. In the presence 
of a complex food microbiota, the efficacy of bacteriocins may be reduced due to the 
antimicrobial binding to insensitive bacteria such as Gram negative bacteria (Gálvez 
et al., 2007). During the course of this study, more than ten times the MIC for Nisin 
V (48 µM) was used in food trials involving Gram negative bacteria. Despite this 
high concentration no inhibitory affect was observed. By comparison, much less 
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peptide was needed to confer an antimicrobial effect on the Gram positive bacterium 
Listeria.   
To date, two studies have investigated the efficacy of Nisin variants in model food 
systems (Rouse et al., 2012, Field et al., 2010b). The study by Rouse et al. (2012) 
used two Nisin variants (SVA and NAK) to investigate whether the enhanced 
activity observed in carrageenan based agar but not in MIC based assays could be 
replicated in a carrageenan containing food containing 10
5
 or 10
4
 CFU/ml of L. 
monocytogenes. Results showed that both peptides dramatically outperformed Nisin 
A with respect to controlling L. monocytogenes in commercially produced chocolate 
milk containing carrageenan when stored at 22 °C and 4 °C for 3 days. Similarly, a 
study by Field et al. (2010b) used Nisin variants V and T to investigate whether 
either peptide showed enhanced activity against 10
7
 CFU/ml of lux-tagged L. 
monocytogenes in frankfurter meat over a 1 h. Results revealed that in the presence 
of Nisin A and T, bioluminescence increased whereas the corresponding nisin V 
treated sample showed a marked decrease in bioluminescence following 1 hour 
incubation at 37 °C. In the present study, we found that both Nisin V and for the first 
time S29A, significantly reduced growth of L. monocytogenes in a model food 
system using a low initial inoculum (1 x 10
5
 CFU/ml) and storage at ambient 
temperature over 24 h and 3 h respectively. It is evident from results obtained that 
the enhanced potency of Nisin V can be maintained for up to 24 h within a complex 
and high-fat food such as frankfurter meat. The performance of the Nisin V peptide 
under these ‘abusive’ conditions suggests that were it to be combined with good 
manufacturing processes and other hurdle technologies, this derivative could be a 
very effective anti-listerial food preservative. Although it is also evident that S29A 
can control L. monocytogenes growth initially and for up to 5 h, the antimicrobial 
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effect is not maintained for as long as that of M21V. However, we should recognise 
that levels of contamination in real food systems are usually much lower than the 
levels used in these experiments. 
Given that S29 derivatives displayed superior antimicrobial activity to Nisin A when 
assessed against a range of Gram negative food-associated pathogens (Field et al., 
2012), we investigated whether the enhanced activity of either V or S29A in broth 
could translate to liquid-based foods such as reconstituted PIF, apple juice or liquid 
whole egg. Despite the activity observed when Nisin was added to laboratory media, 
no antimicrobial effect was observed in PIF, apple juice or liquid egg for Nisin A, 
Nisin V or S29A despite the fact that almost 13-fold the concentration of Nisin V or 
S29A needed for MICs in broth was applied.  
The various limiting factors previously discussed combined with the fact that Gram 
negative bacteria have a more resistant cell envelope, may offer an explanation as to 
why Nisin has not been found to inhibit Gram negative pathogens in food matrices. 
One possible solution to this problem could involve the use of chemical substances 
or other microbial substances in conjunction with Nisin. Galves et al. (2007) states 
that chelators and other compounds can permeabilise the outer membrane of Gram 
negative bacteria by extracting Ca
2+
 and Mg
2+ 
ions that stabilise the 
lipopolysaccharide part of the structure, thereby allowing certain bacteriocins to 
reach the inner cytoplasmic layer (Gálvez et al., 2007). Oshima et al. (2012) 
investigated a variety of anti-microbial agents alone and in combination to determine 
their bacteriostatic or bactericidal effect on C. sakazakii. Results showed that the 
addition of Nisin (at a concentration of 8000 AU ml
-
1) had no inhibitory effect when 
present as a single compound, however the combination of Nisin with the 
lactoperoxidase system (LPOS) inhibited outgrowth of C. sakazakii at 37 °C for 8 h 
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(Oshima et al., 2012). In the present study, we found for the first time that both Nisin 
V and S29A, when combined with EDTA, significantly reduced growth of C. 
sakazakii in reconstituted PIF over an 8 h period. These results demonstrate that the 
addition of Nisin variants alone had no inhibitory effect when present as a single 
compound, however combinations of Nisin variants with EDTA significantly 
reduced C. sakazakii levels for 8 h. Further food trials would be necessary to 
determine where this combined effect would be observed in other liquid-based food 
models and whether other antimicrobial agents or chelators could be used along with 
Nisin variants to exhibit an enhanced antimicrobial effect on bacteria. It has also 
been suggested that prior exposure of cells to sub-lethal heat, osmotic shock or 
freezing in conjunction with Nisin use may overcome the difficulties encountered by 
bacteriocins when trying to traverse the Gram negative bacterial cell wall (Gálvez et 
al., 2007). However, further investigations would be necessary to determine which 
treatments or combinations of antibacterial agents could be used along with Nisin A 
variants to inhibit Gram negative pathogens in liquid-based food matrices.  
Experiments carried out in this chapter highlight the importance of bioluminescence-
based assays to the food industry. These experiments show it is possible to monitor 
the impact of various antimicrobial agents on a number of bacteria in many food 
systems over the time course of an assay. Bioluminescent imaging is a faster and less 
labour intensive method of monitoring strain growth than conventional methods. 
However, this work has also identified limitations of bioluminescent imaging. Low 
acid environments such as those in apple juice do not allow light to be emitted and so 
bioluminescence can not be used successfully in all types of food systems. Similarly, 
lux-tagged microorganism must emit high levels of light over long time periods in 
order for luminescences to be sucessfully detected. 
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Conclusion 
In summary, we have examined the activity of Nisin derivatives V and S29A against 
foodborne pathogens in laboratory media and selected foods. For the first time, we 
report the enhanced bioactivity of Nisin V against Gram negative bacteria in agarose-
based assays and laboratory media. We have also demonstrated the enhanced 
bioactivity of Nisin S29A and V against Listeria monocytogenes in commercially 
produced frankfurter meat maintained under sub-optimal conditions showing that 
Nisin V outperforms both the wild-type Nisin and S29A with respect to controlling 
growth of Listeria over a 24 h period. We also report the enhanced antimicrobial 
effect of Nisin V and S29A in combination with EDTA, against lux-tagged C. 
sakazakii in reconstituted PIF over a 8 h period. This study highlights the usefulness 
of bioluminescence-based assays over conventional  methods of monitoring 
bacterium growth. The study also confirms the importance of rigorously testing 
novel antimicrobial compounds in model food systems and under a variety of 
conditions to examine their effectiveness in more ‘real life’ situations.  
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Thesis summary 
 
 
 
 
 
 
 
 
 
129 
 
Bioluminescence technology has many potentially beneficially uses in the area of 
food microbiology. Lux-based assays offer a sensitive and real-time method for 
monitoring the presence, quantity and the metabolic state of bacteria in laboratory 
media as well as complex food systems.   
In particular, bioluminescence assays can aid in the development of Powdered Infant 
Formula (PIF) and provide information on Cronobacter infections associated with 
ingestion of contaminated PIF. The risk of Cronobacter infections poses a serious 
threat to PIF manufacturers and attempts are constantly being made to not only 
understand the factors affecting its growth and survival in PIF, but also to develop 
more effective control strategies during production. With this in mind, chapter II of 
this thesis examines the potential of using a lux-tagged C. sakazakii strain to monitor 
growth of the bacterium in various liquids. Our study demonstrates that 
bioluminescent imaging facilitates culture-independent real-time tracking of C. 
sakazakii, in opaque food matrices such as PIF, which are not conducive to optical 
density measurements. When the lux-labelled strain was examined under laboratory 
controlled conditions, growth of the tagged strain was found to be similar to that of 
the non–tagged counterpart and the integrated plasmid was found to be stable for up 
to 24 h. This suggests that the tagged strain is a suitable substitute for the wild-type. 
When examining the influence of added ingredients (e.g. antimicrobial agents) on the 
growth of C. sakazakii, it was found that the impact of these ingredients could be 
monitored using bioluminescence as a reporter.  
Following on from this work, Flaherty et al. (2013) lux-labelled a further nine 
Cronobacter spp. and determined that their growth could also be easily monitored in 
real-time by means of light emissions. It was also determined that while all PIF’s 
tested were able to support the growth of each of the Cronobacter strains, differences 
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were observed between the brands. Variations in light emissions were also noted for 
individual Cronobacter strains. The monitoring of light emissions by a combination 
of two strains that produced higher and lower than average RLU readings was found 
to be a good surrogate for the entire collection of lux-tagged strains (Flaherty et al., 
2013). Assays with mixes of strains demonstrated that a cocktail of two lux-tagged 
Cronobacter strains provides a good representation of the average growth of all ten 
strains in IMF. This means that rather than performing future growth analyses in IMF 
with all ten strains, the use of two strains would reduce the amount of work and 
samples required (Flaherty et al., 2013). 
Oshima et al. (2012) also examined the potential use of bioluminescent Cronobacter 
spp. in high-throughput assays aimed at monitoring the effects of various PIF 
compositions on growth of the bacterium. In particular, Oshima et al. (2012) 
examined the efficacy of organic acids, bacteriocins and the lactoperoxidase system 
(LPOS) in inhibiting growth of Cronobacter spp. in rehydrated PIF. Results showed 
that in the presence of LPOS and Lacticin 3147, growth of Cronobacter spp. was 
inhibited for up to 12 h when PIF was rehydrated at 40 or 50°C. Each of these studies 
demonstrates the potential industrial applications of lux technology to the PIF 
industry.   
Chapter III of this thesis involves investigation of a bioluminescence based ‘early-
warning’ system for starter culture disruption by antimicrobial agents such as 
antibiotic residues. To achieve this, we developed a new lux-plasmid and 
successfully introduced this lux plasmid into Lactococcus strains to produce stable 
luminescent phenotypes. The strains were constructed using either conjugation or 
electroporation procedures and the physiological characteristics (growth, stability 
and acid resistance) of the strains were not negatively affected. The newly developed 
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plasmid pRH001lux was successfully transformed into several L. lactis and L. 
cremoris strains and all transformants exhibited the luminescent phenotype. Using 
these strains, we established an assay capable of rapidly monitoring the antimicrobial 
activity of selected antibiotics in milk, thereby making these strains useful 
biomonitoring reporters for the dairy industry. However, these strains were not 
suitable for bacteriophage detection assays. 
Chapter IV examined the effect of bioengineered Nisin variants (Nisin V and S29A) 
on a number of luciferase-tagged foodborne pathogens, in vitro and in food models at 
room temperature (representative of a temperature abuse situation) when compared 
to the wild-type Nisin. Bioluminescent reporter strains and modified agarose-based 
assays were used to quantitatively assess how well each of the peptides performed 
against a range of foodborne pathogens under stressed conditions. For the first time, 
we observed the enhanced bioactivity of Nisin V against Gram negative bacteria 
(Escherichia coli, Salmonella Typhimurium and Cronobacter sakazakii) in agarose 
assays and laboratory media (E. coli). However, further analysis of Nisin V against 
Gram negative bacteria in PIF, apple juice and liquid whole egg revealed no 
inhibitory effect.  
The enhanced bioactivity of S29A and Nisin V against Listeria monocytogenes in 
commercially produced frankfurter meat maintained under sub-optimal temperature 
is also reported. In this instance, we demonstrated that Nisin V outperforms both the 
wild-type Nisin and S29A, with respect to controlling growth of Listeria over a 24 
hour period. The generation of Nisin variants in a food-grade manner provides an 
important industrial application of these peptides as enhanced food preservatives 
particularly in the area of minimally processed foods. From this work, we determined 
that the use of bioluminescence-based technology provides a useful method of 
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tracking the effectiveness of these food grade peptides in both laboratory media and 
liquid based food systems. Future work may involve investigating Nisin variants in 
combination with other antimicrobial peptides, acids and bacteriocins to identify 
combinations which would inhibit Gram negative bacteria in model food systems. 
 
In conclusion, this body of work shows that lux-tagged microorganisms have 
numerous potential food industry-related applications and could offer many 
advantages over the existing traditional reporter methods. Bioluminescent strains 
may be of benefit to the area of food safety by examining the growth and survival of 
pathogens in various foods and under a variety of food storage conditions. 
Examining the effects of different food compositions on the ability of pathogens to 
cause disease can result in assays which optimise processing regimes. These assays 
could also lead to the identification of novel preventatives and control strategies 
which will in turn lead to a safer food supply. Bioluminescence-based assays may 
also have potential applications in the dairy industry, in particular during cheese 
production and the production of probiotics. The development of large banks of lux-
tagged starter culture strains could help identify even more strains suitable for starter 
strain rotation strategies and prevent starter culture failure or the development of 
slow cheese production vats in the future.  
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Supplementary Information for Chapter II   
 
During this chapter we examined the potential of using a lux-tagged Cronobacter 
sakazakii strain to monitor growth of the bacterium in various liquids. The figures 
presented below represent a correlation curve of the lux-tagged C. sakazakii strain, 
an optical density curve comparing the wild-type and lux-tagged strain, a growth 
curve of the lux-tagged C. sakazakii at varying inoculums in PIF and a growth curve 
of the lux-tagged strain grown in the presence of competing bacteria. 
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Fig. 1 Comparison of RLU (relative light units) and Log CFU per milliliter for lux-
tagged C. sakazakii. (R
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Fig. 2 Growth curve of lux-tagged C. sakazakii in PIF. Varying initial inoculums 
were used: 1 Log CFI/ml (♦), 2 Log CFU/ml (x), 3 Log CFU/ml (□), 4 Log CFU/ml 
(◊), 5 Log CFU/ml (■), 6 Log CFU/ml (Δ), and 7 Log CFU/ml. 
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Fig. 3 Growth curve of lux-tagged C. sakazakii (●) and non-tagged C. sakazakii (o), 
in LB broth following 24 h of growth in the absence of antibiotic. Data are 
represented as OD595nm ± standard deviations.  
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Fig. 4 Growth curve of lux-tagged C. sakazakii (●) plus Escherichia coli (▲), 
Salmonella Typhimurium (Δ), Listeria monocytogenes (o) and E. coli, S. 
Typhimurium and L. monoctyogenes all together (□) in LB broth during 24 h of 
growth in the absence of antibiotic. Data are represented as mean RLU’s ± standard 
deviations.  
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Supplementary Information for Chapter III 
The aim of this study was to construct a bank of bioluminescent Lactococcus starter 
culture strains using a conjugative vector which would then be able to monitor the 
action of antimicrobial agents in laboratory media and whole milk. The figures 
presented below represent a correlation curve of lux-tagged 5250 (measuring RLU’s 
and CFU’s), stability assays, growth curves of lux-tagged starter strains grown in 
PIF, growth curves of lux-tagged and non-tagged starter strains grown in GM17, 
growth curve of lux-tagged strains transformed by electroporation and conjugation 
and bioluminescence growth curves measuring the antimicrobial activity of 
antibiotics in whole milk. 
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Fig. 1 Correlation of RLU (relative light units) and average Log CFU per milliliter 
(Log CFU/ml) for lux-tagged Starter culture 5250. (R
2
 ~ 0.8885) 
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Fig. 2 Growth of each lux-tagged starter culture strain, 158 (●), 4272 (o), WM1 (■), 
4935 (□), 5250 (+), 5101 (X), 745 (▲), 743 (Δ), 275 (♦), in reconstituted PIF broth at 
30 °C. Bioluminescence was measured in RLU by a Luminoskan luminometer. 
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Fig. 3 Growth of lux-tagged (●) and non-tagged (o) starter strain L. lactis 745 in 
GM17 broth at 30 °C (electroporation). Data are represented as average Log CFU per 
millilitre ± standard deviations for three biological repeats. 
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Fig. 4 Stability of pRH001lux in L. lactis 158 represented as a percentage of 
chloramphenicol resistant colonies following 24 h of growth in the absence of 
antibiotic (electroproration). 
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Fig. 5 Stability of pRH001lux in L. lactis 275 represented as a percentage of 
chloramphenicol resistant colonies following 24 h of growth in the absence of 
antibiotic (electroporation). 
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Fig. 6 & 7 Stability of pRH001lux in L. lactis 5101 transformed by conjugation (top) 
and by electroporation (bottom) represented as a percentage of chloramphenicol 
resistant colonies following 24 h of growth in the absence of antibiotic. 
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Fig. 8 & 9 Stability of pRH001lux in L. lactis 275 transformed by conjugation (top) 
and by electroporation (bottom) represented as a percentage of chloramphenicol 
resistant colonies following 24 h of growth in the absence of antibiotic. 
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Fig. 10 & 11 Stability of pRH001lux in L. lactis WM1 transformed by 
electroporation (top) and L. lactis WM1 transformed by conjugation (bottom) 
represented as a percentage of chloramphenicol resistant colonies following 24 h of 
growth in the absence of antibiotic. 
 
   o/n Culture      P1            P2               P3                P4           P5  
   o/n Culture       P                 P2               P                 P                 P5  
143 
 
158- lux (Electroporation)
Time (h)
0 1 2 3 4 5
%
 C
m
 r
es
is
ta
n
ce
 c
o
lo
n
ie
s
0
20
40
60
80
100
 
 
158-lux (Conjugation)
Time (h)
0 1 2 3 4 5
%
 R
if
 &
 C
m
 r
es
is
ta
n
t 
co
lo
n
ie
s
0
20
40
60
80
100
 
Fig. 12 & 13 Stability of pRH001lux in L. lactis 158 transformed by electroporation 
(top) and 158 transformed by conjugation (bottom) represented as a percentage of 
chloramphenicol resistant colonies following 24 h of growth in the absence of 
antibiotic. 
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Fig. 14 Growth curve of L. lactis 275lux transformed by electroporation (●) and 
conjugation (o) in GM17 broth following 24 h of growth in the absence of antibiotic. 
Data are represented as average Log CFU per millilitre ± standard deviations (p < 
0.05). 
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Fig.15 Growth curve of L. lactis 5250lux transformed by electroporation (●) and 
conjugation (o) in GM17 broth following 24 h of growth in the absence of antibiotic. 
Data are represented as average Log CFU per millilitre ± standard deviations  
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Fig. 16 Growth curve of L. lactis 158lux transformed by electroporation (●) and 
conjugation (o) in GM17 broth following 24 h of growth in the absence of antibiotic. 
Data are represented as average Log CFU per millilitre ± standard deviations  
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Fig. 17 Growth curve of L. lactis WM1lux transformed by electroporation (●) and 
conjugation (o) in GM17 broth following 24 h of growth in the absence of antibiotic. 
Data are represented as average Log CFU per millilitre ± standard deviations.  
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Fig. 18 Growth curve of L. lactis WM1lux alone (□), transformed by electroporation 
(●) and by conjugation (o) in GM17 broth following 24 h of growth in the absence of 
antibiotic. Data are represented as OD595nm millilitre ± standard deviations  
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Fig. 19 Bioluminescence as a measure of the antimicrobial activity of Ampicillin in 
whole milk as determined by the luminoskan luminometer over 20 h. (●) represents 
5250lux, (o) represents L. lactis 5250lux plus 5 µg/ml of Ampicillin. RLU = Relative 
Light Units. 
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Fig. 20 Plaque assay demonstrating the effect of Tuc2009 (left) and c2 phage (right) 
on growth of the lux-tagged starter culture strain L. lactis 5250lux as determined 
using a conventional technique. 
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Supplementary Information for Chapter IV 
Chapter IV of this thesis examines the activity of Nisin derivatives V and S29A 
against foodborne pathogens in laboratory media and selected foods. The figures 
presented below represent growth curves of lux-tagged Listeria monocytogenes, 
Cronobacter sakazakii, Escherichia coli and Staphylococcus aureus at various pH’s 
and salt concentrations. 
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Fig. 1 Growth curve of lux tagged L. monocytogenes (●), C. sakazakii (o), E. coli (■) 
and S. aureus (□) in broth at pH 4 over a 24 h period. Data are represented as average 
Log CFU/ml ± standard deviations. 
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Fig. 2 Growth curves of lux tagged L. monocytogenes (●), C. sakazakii (o), E. coli 
(■) and S. aureus (□) in broth at pH 7 over 24 h of growth. Data are represented as 
average RLU ± standard deviations. 
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Fig. 3 Growth curve of lux tagged L. monocytogenes (●), C. sakazakii (o), E. coli (■) 
and S. aureus (□) in broth at pH 10 over 24 h of growth. Data are represented as 
average RLU ± standard deviations. 
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Fig. 4 Growth curve of lux tagged L. monocytogenes (●), C. sakazakii (o), E. coli (■) 
and S. aureus (□) in broth at pH 7 over 24 h of growth. Data are represented as 
average Log CFU/ml ± standard deviations. 
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Fig. 5 Growth curve of lux-tagged C. sakazakii in LB broth (●), plus 2% salt (■), 4% 
(♦), 6% (▲) and 10% (x) over 24 h of growth. Data are represented as OD595nm 
millilitre ± standard deviations.  
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Fig. 6 Growth curve of lux-tagged L. monocytogenes in LB broth (●), plus 2% salt 
(■), 4% (♦), 6% (▲) and 10% (x) over 24 h of growth. Data are represented as 
OD595nm millilitre ± standard deviations.  
 
Time (h)
0 5 10 15 20 25
O
D
5
9
5
n
m
0.2
0.4
0.6
0.8
1.0
1.2
 
Fig. 7 Growth curve of lux-tagged E. coli in LB broth (●), plus 2% salt (■), 4% (♦), 
6% (▲) and 10% (x) over 24 h of growth. Data are represented as OD595nm 
millilitre ± standard deviations.  
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Fig. 8 Growth curve of lux-tagged S. aureus in LB Broth (●), plus 2% salt (■), 4% 
(♦), 6% (▲) and 10% (x) over 24 h of growth. Data are represented as OD595nm 
millilitre ± standard deviations.  
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Fig. 9 Growth curve of lux-tagged L. monocytogenes in LB broth (●), plus 2% salt 
(■), 4% (♦), 6% (▲) and 10% (x) over 24 h of growth. Data are represented as RLU 
± standard deviations.  
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Fig. 10 Growth curve of lux-tagged C. sakazakii in LB broth (●), plus 2% salt (■), 
4% (♦), 6% (▲) and 10% (x) over 24 h of growth. Data are represented as RLU ± 
standard deviations.  
 
 
 
 
 
 
 
 
154 
 
 
 
 
Bibliography 
 
 
 
 
 
 
 
 
 
 
155 
 
AHMAD, K. A. & STEWART, G. 1991. The production of bioluminescent Lactic 
Acid Bacteria suitable for the rapid assessment of starter culture activity in 
milk. Journal of Applied Microbiology, 70, 113-120. 
AHMAD, K. A. & STEWERT, G. S. A. B. 1988. Cloning of the lux genes into 
Lactobacillus casei and Streptococcus lactis: phosphate-dependent light 
production. Biochemical Society Transactions, 16, 1068. 
AL-HOLY, M. A., CASTRO, L. F. & AL-QADIRI, H. M. 2010. Inactivation of 
Cronobacter spp. (Enterobacter sakazakii) in infant formula using lactic acid, 
copper sulfate and monolaurin. Letter in Applied Microbiology, 50, 246-51. 
ALLEN, K. J. & GRIFFITHS, M. W. 2001. Use of luminescent Campylobacter 
jejuni ATCC 33291 to assess eggshell colonization and penetration in fresh 
and retail eggs. Journal of Food Protection, 64, 2058-2062. 
ALLOUSH, H. M., LEWIS, R. J. & SALISBURY, V. C. 2006. Bacterial 
bioluminescent biosensors: Applications in food and environmental 
monitoring. Analytical Letters, 39, 1517 - 1526. 
ALVAREZ, I., NIEMIRA, B. A., FAN, X. & SOMMERS, C. H. 2007. Inactivation 
of Salmonella Enteritidis and Salmonella Senftenberg in Liquid Whole Egg 
Using Generally Recognized as Safe Additives, Ionizing Radiation, and Heat. 
Journal of Food Protection, 70, 1402-1409. 
ANDREU, N., ZELMER, A., FLETCHER, T., ELKINGTON, P. T., WARD, T. H., 
RIPOLL, J., PARISH, T., BANCROFT, G. J., SCHAIBLE, U., 
ROBERTSON, B. D. & WILES, S. 2010. Optimisation of Bioluminescent 
Reporters for Use with Mycobacteria. PLoS One, 5, e10777. 
156 
 
ATAMER, Z., DIETRICH, J., NEVE, H., HELLER, K. J. & HINRICHS, J. 2010. 
Influence of the suspension media on the thermal treatment of mesophilic 
Lactococcal bacteriophages. International Dairy Journal, 20, 408-414. 
BACHMANN, H., SANTOS, F., KLEEREBEZEM, M. & VAN HYLCKAMA 
VLIEG, J. E. T. 2007. Luciferase Detection during Stationary Phase in 
Lactococcus lactis. Applied and Environmental Microbiology, 73, 4704-4706. 
BACK, S., JIN, H. & LEE, S. 2009. Inhibitory effect of organic acids against 
Enterobacter sakazakii in laboratory media and liquid foods. Journal of Food 
Control, 20, 867-872. 
BAKER, J. M., GRIFFITHS, M. W. & COLLINS -THOMPSON, D. L. 1992. 
Bacterial bioluminescence: Applications in food microbiology. Journal of 
Food Protection, 55, 62 - 70. 
BEGLEY, M. Unpublished data. Unpublished data. 
BOWEN, A. & BRADEN, C. 2006. Invasive Enterobacter sakazakii disease in 
infants. Emerging Infectious Diseases, 12, 1185-1189. 
BREEUWER, A., LARDEAU, P. & JOOSTEN, H. 2003. Desiccation and heat 
tolerance of Enterobacter sakazakii. Journal of Applied Microbiology, 95, 
967-973. 
BREUKINK, E., WIEDEMANN, I., KRAAIJ, C. V., KUIPERS, O. P., SAHL, H.-G. 
& DE KRUIJFF, B. 1999. Use of the cell wall precursor lipid II by a pore-
forming peptide antibiotic. Science, 286, 2361-2364. 
BRON, P. A., MONK, I. R., CORR, S. C., HILL, C. & GAHAN, C. G. M. 2006. 
Novel luciferase reporter system for In vitro and organ-specific monitoring of 
differential gene expression in Listeria monocytogenes. Applied and 
Environmental Microbiology, 72, 2876-2884. 
157 
 
BROVKO, L., MINIKH, O., PIEKNA, A. & GRIFFITHS, M. 2011. Bioluminescent 
high throughput assay for the bacteria adherence to the tissue culture cells. 
Biotechnology and bioengineering, 108, 1628-33. 
BURNS-GUYDISH, S. M., OLOMU, I. N., ZHAO, H. U. I., WONG, R. J., 
STEVENSON, D. K. & CONTAG, C. H. 2005. Monitoring age-related 
susceptibility of young mice to oral Salmonella enterica Serovar 
Typhimurium infection using an In vivo murine model. Pediatric Research, 
58, 153-158. 
CALVERT, R. M., HOPKINS, H. C., REILLY, M. J. & FORSYTHE, S. J. 2000. 
Caged ATP - an internal calibration method for ATP bioluminescence assays. 
Letters in Applied Microbiology, 30, 223-7. 
CAWTHORN, M., BROTHA, M. & WITTHUHN, R. 2008. Evaluation of different 
methods for the detection and identification of Enterobacter sakazakii 
isolated from South African infant formula milks and the process 
environment. International Journal of Food Microbiology., 127. 
CHANG, C. H., CHIANG, M. L. & CHOU, C. C. 2010. The effect of heat shock on 
the response of Cronobacter sakazakii to subsequent lethal stresses. 
Foodborne Pathogen Disease, 7, 71-6. 
CHEN, J. & GRIFFITHS, M. W. 1996a. Luminescent Salmonella strains as real time 
reporters of growth and recovery from sublethal injury in food. International 
Journal of Food Microbiology, 31, 27 - 43. 
CHEN, J. & GRIFFITHS, M. W. 1996b. Salmonella detection in eggs using lux+ 
bacteriophages. Journal of Food Protection 59, 908-914. 
CHOLLET, E., SEBTI, I., MARTIAL-GROS, A. & DEGRAEVE, P. 2008. Nisin 
preliminary study as a potential preservative for sliced ripened cheese: NaCl, 
158 
 
fat and enzymes influence on nisin concentration and its antimicrobial 
activity. Food Control, 19. 
CHOPIN, M.-C., CHOPIN, A. & BIDNENKO, E. 2005. Phage abortive infection in 
Lactococci: variations on a theme. Current Opinion in Microbiology, 8, 473-
479. 
CHUMKHUNTHOD, P., SCHRAFT, H. & GRIFFITHS, M. 1998. Rapid 
monitoring method to assess efficacy of sanitizers against Pseudomonas 
putida biofilms. Journal of Food Protection, 61, 1043-6. 
CIARCIAGLINI, G., HILL, P. J., DAVIES, K., MCCLURE, P. J., KILSBY, D., 
BROWN, M. H. & COOTE, P. J. 2000. Germination-induced 
bioluminescence, a route to determine the inhibitory effect of a combination 
preservation treatment on bacterial spores. Applied and Environmental 
Microbiology, 66, 3735-42. 
COAKLEY, M., FITZGERALD, G. & ROS, R. P. 1997. Application and evaluation 
of the phage resistance- and bacteriocin-encoding plasmid pMRC01 for the 
improvement of dairy starter cultures. Applied and Environmental 
Microbiology, 63, 1434-40. 
CODEX ALIMENTARIUS COMMISSION 2008. Code of hygienic practice for 
powdered infant formulae for infants and young children. Available at: 
http://www.codexalimentarius.net/ Codex Alimentarius Commission. 
COTTER, P. D., DRAPER, L. A., LAWTON, E. M., DALY, K. M., GROEGER, D. 
S., CASEY, P. G., ROSS, R. P. & HILL, C. 2008. Listeriolysin S, a novel 
peptide haemolysin associated with a subset of lineage I Listeria 
monocytogenes. PLoS pathogens, 4, e1000144. 
159 
 
COTTER, P. D., HILL, C. & ROSS, R. P. 2005. Bacteriocins: developing innate 
immunity for food. Nature Reviews Microbiology, 3, 777-788. 
CRONIN, M., SLEATOR, R., HILL, C., FITZGERALD, G. & VAN SINDEREN, 
D. 2008. Development of a luciferase-based reporter system to monitor 
Bifidobacterium breve UCC2003 persistence in mice. BMC Microbiology, 8, 
161. 
DAVIES, E., MILNE, A., BEVIS, C. H. E., POTTER, H., HARRIS, J., WILLIAMS, 
G., THOMAS, L. & DELVES-BROUGHTON, J. 1999. Effective use of 
Nisin to control Lactic Acid Bacteria spoilage in vacuum-packed bologna-
type sausage. Journal of Food Protection, 62, 1004-1010. 
DELVES-BROUGHTON, J. 2005. Nisin as a food preservative. Food Australia, 57, 
525-532. 
DEVEAU, H., LABRIE, S. J., CHOPIN, M.-C. & MOINEAU, S. 2006. Biodiversity 
and Classification of Lactococcal Phages. Applied and Environmental 
Microbiology, 72, 4338-4346. 
DEVLIEGHERE, F., VERMEIREN, L. & DEBEVERE, J. 2004. New preservation 
technologies: Possibilities and limitations. International Dairy Journal, 14, 
273-285. 
DOMMEL, M. K., FRENZEL, E., STRASSER, B., BLOCHINGER, C., SCHERER, 
S. & EHLING-SCHULZ, M. 2010. Identification of the main promoter 
directing cereulide biosynthesis in emetic Bacillus cereus and its application 
for real-time monitoring of ces gene expression in foods. Applied and 
Environmental Microbiology, 76, 1232-1240. 
160 
 
DOSTALEK, P. & BRANYIK, T. 2005. Prospects for rapid bioluminescent 
detection methods in the food industry – a Review. Czech Journal of Food 
Science, 23, 85-92. 
DOWD, G. C., JOYCE, S. A., HILL, C. & GAHAN, C. G. M. 2011. Investigation of 
the mechanisms by which Listeria monocytogenes grows in porcine gall 
bladder bile. Infection and Immunity, 79, 369-379. 
DRUDY, D., MULLANE, N., QUINN, T., WALL, P. & FANNING, S. 2006. 
Enterobacter sakazakii: an emerging pathogen in powdered infant formula. 
Clinical Infectious Diseases, 42, 996-1002. 
DUFFY, G., ELLISON, A., ANDERSON, W., COLE, M. B. & STEWART, G. S. 
1995. Use of bioluminescence to model the thermal inactivation of 
Salmonella typhimurium in the presence of a competitive microflora. Applied 
and Environmental Microbiology, 61, 3463-5. 
DUNCAN, S., GLOVER, L. A., KILLHAM, K. & PROSSER, J. I. 1994. 
Luminescence-based detection of activity of starved and viable but 
nonculturable bacteria. Applied and Environmental Microbiology, 60, 1308-
1316. 
DUPONT, K., JANZEN, T., VOGENSEN, F. K., JOSEPHSEN, J. & STUER-
LAURIDSEN, B. 2004. Identification of Lactococcus lactis genes required 
for bacteriophage adsorption. Applied and Environmental Microbiology, 70, 
5825-5832. 
DURMAZ, E. & KLAENHAMMER, T. R. 1995. A starter culture rotation strategy 
incorporating paired restriction/ modification and abortive infection 
bacteriophage defenses in a single Lactococcus lactis strain. Applied and 
Environmental Microbiology, 61, 1266-1273. 
161 
 
EATON, T. J., SHEARMAN, C. A. & GASSON, M. J. 1993. The use of bacterial 
luciferase genes as reporter genes in Lactococcus: regulation of the 
Lactococcus lactis subsp. lactis lactose genes. Journal of General 
Microbiology, 139, 1495-1501. 
ELLISON, A., PERRY, S. & STEWART, G. 1991. Bioluminescence as a real-time 
monitor of injury and recovery in Salmonella typhimurium. International 
Journal of Food Microbiology, 12, 323-32. 
ENGEBRECHT, J., SIMON, M. & SILVERMAN, M. 1985. Measuring gene 
expression with light. Science, 227, 1345-7. 
FABRICANT, J. D., CHALMERS, J. H., JR. & BRADBURY, M. W. 1995. 
Bioluminescent strains of E. coli for the assay of biocides. Bulletin of 
Environmental Contamination and Toxicology, 54, 90-5. 
FAN, J., CROOKS, C. & LAMB, C. 2008. High-throughput quantitative 
luminescence assay of the growth in planta of Pseudomonas syringae 
chromosomally tagged with Photorhabdus luminescens luxCDABE. The 
Plant Journal, 53, 393-399. 
FAO/WHO 2001. Evaluation of Health and Nutritional Properties of Powder Milk 
with Live Lactic Acid Bacteria. Report from FAO/WHO Expert Consultation, 
1–4 October 2001, Cordoba, Argentina. 
FARMER, J., ASBURY, M., HICKMANN, F. & BRENNER, D. 1980. Enterobacter 
sakazakii: a new species of ‘‘Enterobacteriaceae’’ isolated from clinical 
specimens. International Journal of Systematic Bacteriology, 30, 569-584. 
FIELD, D., BEGLEY, M., O’CONNOR, P. M., DALY, K. M., HUGENHOLTZ, F., 
COTTER, P. D., HILL, C. & ROSS, R. P. 2012. Bioengineered Nisin A 
162 
 
derivatives with enhanced activity against both Gram positive and Gram 
negative pathogens. PLoS One, 7, e46884. 
FIELD, D., CONNOR, P. M., COTTER, P. D., HILL, C. & ROSS, R. P. 2008. The 
generation of nisin variants with enhanced activity against specific gram-
positive pathogens. Mol Microbiol, 69, 218-30. 
FIELD, D., HILL, C., COTTER, P. D. & ROSS, R. P. 2010a. The dawning of a 
‘Golden era’ in lantibiotic bioengineering. Molecular Microbiology, 78, 
1077-1087. 
FIELD, D., QUIGLEY, L., O'CONNOR, P. M., REA, M. C., DALY, K., COTTER, 
P. D., HILL, C. & ROSS, R. P. 2010b. Studies with bioengineered Nisin 
peptides highlight the broad-spectrum potency of Nisin V. Microb 
Biotechnol, 3, 473-486. 
FIELD, D., QUIGLEY, L., O'CONNOR, P. M., REA, M. C., DALY, K., COTTER, 
P. D., HILL, C. & ROSS, R. P. 2010c. Studies with bioengineered Nisin 
peptides highlight the broad spectrum potency of Nisin V. Microbial 
Biotechnology, 3, 473-486. 
FLAHERTY, C., BEGLEY, M. & HILL, C. 2013. Investigation of the use of a 
cocktail of Lux-tagged Cronobacter strains for monitoring growth in infant 
milk formulae Journal of Food Protection, 76, 1359-1365. 
FORSYTHE, S. 2009. Bacteriocidal preparation of powdered infant formula. Food 
Standard Agency, York, UK. Available at: 
http://www.foodbase.org.uk/results.php?f_category_id~&f_report_ id~395. 
Accessed 30 March 2010. 
163 
 
FRACKMAN, S., ANHALT, M. & NEALSON, K. H. 1990. Cloning, organization 
and expression of the bioluminescence genes of Xenorhabdus luminescens. 
Journal of Bacteriology, 172, 5767 - 5773. 
FRANCIS, J. D., BELLINGER-KAWAHARA, C., HAWKINSON, M. J., 
PURCHIO, T. F. & CONTAG, P. R. 2000. Monitoring bioluminescent 
Staphylococcus aureus infections in living mice using a novel luxABCDE 
construct. Infection and Immunity, 68, 3594 - 3600. 
FRATAMICO, P. M., DENG, M. Y., STROBAUGH, T. P. & PALUMBO, S. A. 
1997. Construction and characterization of Escherichia coli O157: H7 strains 
expressing firefly luciferase and green fluorescent protein and their use in 
survival studies. Journal of Food Protection, 60, 1167-1173. 
GÁLVEZ, A., ABRIOUEL, H., LÓPEZ, R. L. & OMAR, N. B. 2007. Bacteriocin-
based strategies for food biopreservation. International Journal of Food 
Microbiology, 120, 51-70. 
GARNEAU, J. & MOINEAU, S. 2011. Bacteriophages of Lactic Acid Bacteria and 
their impact on milk fermentations. Microbial Cell Factories, 10, S20. 
GEOFFROY, M.-C., GUYARD, C., QUATANNENS, B., PAVAN, S., LANGE, M. 
& MERCENIER, A. 2000. Use of Green Fluorescent Protein To Tag Lactic 
Acid Bacterium Strains under Development as Live Vaccine Vectors. Appl. 
Environ. Microbiol., 66, 383-391. 
GRIFFITHS, M. W. 2000. How novel methods can help discover more information 
about foodborne pathogens. Canadian Journal of Infectious Diseases, 11, 143 
- 153. 
164 
 
GUINEE, T. P. & O’BRIEN, B. 2010. The Quality of Milk for Cheese Manufacture. 
In: LAW, B. & TAMIME, A. Y. (eds.) Technology of Cheesemaking. 2 ed.: 
A John Wiley & Sons, Ltd. 
GURTLER, J. B. & BEUCHAT, R. L. 2007. Growth and survival of Enterobacter 
sakazakii in reconstituted infant formula as affected by composition and 
temperature. Journal of Food Protection, 2095–2103. 
GUTIÉRREZ, D., MARTÍNEZ, B., RODRÍGUEZ, A. & GARCÍA, P. 2010. 
Isolation and characterization of bacteriophages infecting Staphylococcus 
epidermidis. Current Microbiology, 61, 601-608. 
HARDY, J., FRANCIS, K., DEBOER, M., CHU, P., GIBBS, K. & CONTAG, C. 
2004. Extracellular replication of Listeria monocytogenes in the murine gall 
bladder. Science, 303, 851-3. 
HARDY, J., MARGOLIS, J. J. & CONTAG, C. H. 2006. Induced biliary excretion 
of Listeria monocytogenes. Infection and Immunity, 74, 1819-1827. 
HAYES, M., BARRETT, E., ROSS, P., FITZGERALD, G., HILL, C. & STANTON, 
C. 2009. Evaluation of an antimicrobial ingredient prepared from a 
Lactobacillus acidophilus casein fermentate against Enterobacter sakazakii. 
J. Food Prot. 72:340–345. Journal of Food Protection, 72, 340-345. 
HEAP, H. A. & LAWRENCE, R. C. 1976. The selection of starter strains for 
cheesemaking. New Zealand Journal of Dairy Science and technology, 11-16. 
HIBMA, A. M., JASSIM, S. A. A. & GRIFFITHS, M. W. 1996. In vivo 
bioluminescence to detect the attachment of L-forms of Listeria 
monocytogenes to food and clinical contact surfaces. International Journal of 
Food Microbiology, 33, 157-167. 
165 
 
HICKEY, R. M., TWOMEY, D. P., ROSS, R. P. & HILL, C. 2001. Exploitation of 
plasmid pMRC01 to direct transfer of mobilizable plasmids into commercial 
Lactococcal starter strains. Appl. Environ. Microbiol., 67, 2853-2858. 
HILL, P. J., HALL, L., VINICOMBE, D. A., SOPER, C. J., SETLOW, P., WAITES, 
W. M., DENYER, S. & STEWART, G. 1994. Bioluminescence and spores as 
biological indicators of inimical processes. Journal of Applied Microbiology, 
76, 129S-134S. 
HILL, P. J., SWIFT, S. & STEWART, G. 1991. PCR based gene engineering of the 
Vibrio harveyi lux operon and the Escherichia coli trp operon provides for 
biochemically functional native and fused gene products. Molecular and 
General Genetics MGG, 226, 41-48. 
HOLO, H. & NES, I. F. 1989. High-frequency transformation, by electroporation, of 
Lactococcus lactis subsp. cremoris grown with glycine in osmotically 
stabilized media. Applied and Environmental Microbiology, 55, 3119-3123. 
HOWE, K., KARSI, A., GERMON, P., WILLS, R., LAWRENCE, M. & BAILEY, 
R. 2010. Development of stable reporter system cloning luxCDABE genes 
into chromosome of Salmonella enterica serotypes using Tn7 transposon. 
BMC Microbiology, 10, 197. 
HUDSON, L. M., CHEN, J., HILL, A. R. & GRIFFITHS, M. W. 1997. 
Bioluminescence: a rapid indicator of Escherichia coli O157: H7 in selected 
yogurt and cheese varieties. Journal of Food Protection, 60, 891-897. 
HURRELL, E., KUCEROVA, E., LOUGHLIN, M., CAUBILLA-BARRON, J. & 
FORSYTHE, S. J. 2009. Biofilm formation on enteral feeding tubes by 
Cronobacter sakazakii, Salmonella serovars and other Enterobacteriaceae. 
International Journal of Food Microbiology, 136, 227-31. 
166 
 
IMMONEN, N. & KARP, M. 2007. Bioluminescence-based bioassays for rapid 
detection of Nisin in food. Biosensors and Bioelectronics, 22, 1982-7. 
IVERSEN, C., DRUGGAN, P. & FORSYTHE, S. 2004. A selective differential 
medium for Enterobacter sakazakii, a preliminary study. International 
Journal of Food Microbiology, 96, 133-139. 
IVERSEN, C., DRUGGAN, P., SCHUMACHER, S., LEHNER, A., FEER, C., 
GSCHWEND, K., JOOSTEN, H. & STEPHAN, R. 2008. Development of a 
novel screening method for the isolation of "Cronobacter" spp. (Enterobacter 
sakazakii). Appl Environ Microbiol, 74, 2550-3. 
IVERSEN, C. & FORSYTHE, S. 2003. Risk profile of Enterobacter sakazakii, an 
emergent pathogen associated with infant milk formula. Trends in Food 
Science and Technology, 14, 443-454. 
IVERSEN, C., LEHNER, A., MULLANE, N., BIDLAS, E., CLEENWERCK, I., 
MARUGG, J., FANNING, S., STEPHAN, R. & JOOSTEN, H. 2007. The 
taxonomy of Enterobacter sakazakii: proposal of a new genus Cronobacter 
gen. nov. and descriptions of Cronobacter sakazakii comb. nov. Cronobacter 
sakazakii subsp. sakazakii, comb. nov., Cronobacter sakazakii subsp. 
malonaticus subsp. nov., Cronobacter turicensis sp. nov., Cronobacter 
muytjensii sp. nov., Cronobacter dublinensis sp. nov. and Cronobacter 
genomospecies 1. BMC Evol Biol, 7, 64. 
JACOBS, M. F., TYNKKYNEN, S. & SIBAKOV, M. 1995. Highly bioluminescent 
Streptococcus thermophilus strain for the detection of diary-relevant 
antibiotics in milk. Applied Microbiology and Biotechnology, 44, 405-12. 
167 
 
JIANG, A., WANG, H., LEE, N., YANG, G. & GRIFFITHS, M. W. 2006. 
Biological characteristics of luminescent Lactococcus lactis transformed with 
lux genes. Food Research International, 39, 426-432. 
JUNG, D.-S., BODYFELT, F. W. & DAESCHEL, M. A. 1992. Influence of fat and 
emulsifiers on the efficacy of Nisin in inhibiting Listeria monocytogenes in 
fluid milk. Journal of Dairy Science, 75, 387-393. 
KANDHAI, M. C., REIJ, M. W., GORRIS, L. G. M., GUILLAUME-GENTIL, O. & 
M. VAN SCHOTHORST, M. 2004. Occurrence of Enterobacter sakazakii in 
the food production environments and households. Lancet, 363, 39-40. 
KANDHAI, M. C., REIJ, M. W., GROGNOU, C., VAN SCHOTHORST, M., 
GORRIS, L. G. M. & ZWIETERING, M. H. 2006. Effects of preculturing 
conditions on lag time and specific growth rates of Enterobacter sakazakii in 
reconstituted powdered infant formula. Applied and Environmental 
Microbiology, 72, 2721-2729. 
KARSI, A., HOWE, K., KIRKPATRICK, T., WILLS, R., BAILEY, R. H. & 
LAWRENCE, M. 2008. Development of bioluminescent Salmonella strains 
for use in food safety. BMC Microbiology, 8, 10. 
KIM, H., RYU, J.-H. & BEUCHAT, L. R. 2006. Attachment of and biofilm 
formation by Enterobacter sakazakii on stainless steel and enteral feeding 
tubes. Applied and Environmental Microbiology, 72, 5846-5856. 
KIM, H., RYU, J.-H. & BEUCHAT, L. R. 2007a. Effectiveness of disinfectants in 
killing Enterobacter sakazakii in suspension, dried on the surface of stainless 
steel, and in a biofilm. Applied and Environmental Microbiology, 73, 1256-
1265. 
168 
 
KIM, K. P., KLUMPP, J. & LOESSNER, M. J. 2007b. Enterobacter sakazakii 
bacteriophages can prevent bacterial growth in reconstituted infant formula. 
International Journal of Food Microbiology, 115, 195-203. 
KUCEROVA, E., CLIFTON, S. W., XIA, X. Q., LONG, F., PORWOLLIK, S., 
FULTON, L., FRONICK, C., MINX, P., KYUNG, K., WARREN, W., 
FULTON, R., FENG, D., WOLLAM, A., SHAH, N., BHONAGIRI, V., 
NASH, W. E., HALLSWORTH-PEPIN, K., WILSON, R. K., 
MCCLELLAND, M. & FORSYTHE, S. J. 2010. Genome sequence of 
Cronobacter sakazakii BAA-894 and comparative genomic hybridization 
analysis with other Cronobacter species. PLoS One, 5, e9556. 
KUHN, J., SUISSA, M., WYSE, J., COHEN, I., WEISER, I., REZNICK, S., 
LUBINSKY-MINK, S., STEWART, G. & ULITZUR, S. 2002. Detection of 
bacteria using foreign DNA: the development of a bacteriophage reagent for 
Salmonella. International Journal of Food Microbiology, 74, 229-238. 
KUIPERS, O. P., BIERBAUM, G., OTTENWALDER, B., DODD, H. M., HORN, 
N. & METZGER, J., ET AL. 1996. Protein engineering of lantibiotics. 
Antonie Van Leeuwenhoek 69. 
KUIPERS, O. P., ROLLEMA, H. S., YAP, W. M., BOOT, H. J., SIEZEN, R. J. & 
DE VOS, W. M. 1992. Engineering dehydrated amino acid residues in the 
antimicrobial peptide Nisin. Journal of Biological Chemistry, 267, 24340-
24346. 
KUMAR, C. G. & ANAND, S. K. 1998. Significance of microbial biofilms in food 
industry: a review. International Journal of Food Microbiology, 42, 9-27. 
169 
 
LAMPEL, K. A. & CHEN, Y. 2009. Method for the isolation and detection of 
Enterobacter sakazakii (Cronobacter) from powdered infant formula. Int J 
Food Microbiol, 136, 179-84. 
LEDEBOER, A. M., BEZEMER, S., DE HAARD, J. J. W., SCHAFFERS, I. M., 
VERRIPS, C. T., VAN VLIET, C., DÜSTERHÖFT, E. M., ZOON, P., 
MOINEAU, S. & FRENKEN, L. G. J. 2002. Preventing phage lysis of 
Lactococcus Lactis in cheese production using a neutralizing heavy-chain 
antibody fragment from Llama. Journal of Dairy Science, 85, 1376-1382. 
LEE, Y.-S. & JIN, H. H. 2008. Inhibitory activity of natural antimicrobial 
compounds alone or in combination with Nisin against Enterobacter 
sakazakii. Letters in Applied Microbiology, 47, 315-321. 
LIU, L., O’CONNER, P., COTTER, P. D., HILL, C. & ROSS, R. P. 2008. 
Controlling Listeria monocytogenes in Cottage cheese through heterologous 
production of enterocin A by Lactococcus lactis. Journal of Applied 
Microbiology, 104, 1059-1066. 
LIU, W. & HANSEN, J. N. 1992. Enhancement of the chemical and antimicrobial 
properties of subtilin by site-directed mutagenesis. Journal of Biological 
Chemistry, 267. 
LIU, Y., GAO, Q., ZHANG, X., HOU, Y., YANG, J. & HUANG, X. 2006. PCR and 
oligonucleotide array for detection of Enterobacter sakazakii in infant 
formula. Mol. Cell. Probes, 20, 11-17. 
LOESSNER, M., LESCHNER, S., ENDMANN, A., WESTPHAL, K., WOLF, K., 
KOCHRUEBE, K., MILOUD, T., ALTENBUCHNER, J. & WEISS, S. 2009. 
Drug-inducible remote control of gene expression by probiotic Escherichia 
170 
 
coli Nissle 1917 in intestine, tumor and gall bladder of mice. Microbes and 
Infection, 11, 1097-1105. 
LOESSNER, M., REES, C. E., STEWART, G. S. & SCHERER, S. 1996. 
Construction of luciferase reporter bacteriophage A511::luxAB for rapid and 
sensitive detection of viable Listeria cells. Applied and Environmental 
Microbiology, 62, 1133-1140. 
LOESSNER, M., RUDOLF, M. & SCHERER, S. 1997. Evaluation of luciferase 
reporter bacteriophage A511:: luxAB for detection of Listeria monocytogenes 
in contaminated foods. Applied and Environmental Microbiology, 63, 2961. 
MADERA, C., GARCı, AMP, X, A, P., JANZEN, T., RODRı, GUEZ, A. & 
SUÁREZ, J. E. 2003. Characterisation of technologically proficient wild 
Lactococcus lactis strains resistant to phage infection. International Journal 
of Food Microbiology, 86, 213-222. 
MAHONY, J., MCGRATH, S., FITZGERALD, G. F. & VAN SINDEREN, D. 
2008. Identification and characterization of Lactococcal-prophage-carried 
superinfection exclusion genes. Applied and Environmental Microbiology, 
74, 6206-6215. 
MAOZ, A., MAYR, R., BRESOLIN, G., NEUHAUS, K., FRANCIS, K. P. & 
SCHERER, S. 2002. Sensitive in situ monitoring of a recombinant 
bioluminescent Yersinia enterocolitica reporter mutant in real-time on 
Camembert cheese. Applied and Environmental Microbiology, 68, 5737-
5740. 
MARSHALL, K. C. 1992. Biofilms: an overview of bacterial adhesion activity and 
control at surfaces. American Society of Microbiology News, 58, 202-207. 
171 
 
MARVIG, C. L., AIDEH, B., NEVE, H., HELLER, K. J., KNØCHEL, S. & 
VOGENSEN, F. K. 2011. Heat tolerance of dairy Lactococcal c2 phages. 
International Dairy Journal, 21, 556-560. 
MCGRATH, S., SEEGERS, J. F. M. L., FITZGERALD, G. F. & VAN SINDEREN, 
D. 1999. Molecular characterization of a phage-encoded resistance system in 
Lactococcus lactis. Applied and Environmental Microbiology, 65, 1891-1899. 
MEIGHEN, E. A. 1993. Bacterial bioluminescence: organization, regulation, and 
application of the lux genes. The FASEB Journal, 7, 1016. 
MOINEAU, S., BORKAEV, M., HOLLER, B. J., WALKER, S. A., KONDO, J. K., 
VEDAMUTHU, E. R. & VANDENBERGH, P. A. 1996. Isolation and 
characterization of Lactococcal bacteriophages from cultured buttermilk 
plants in the United States. Journal of Dairy Science, 79, 2104-2111. 
MOLLOY, C., CAGNEY, C., O'BRIEN, S., IVERSEN, C., FANNING, S. & 
DUFFY, G. 2009. Surveillance and characterisation by pulsed-field gel 
electrophoresis of Cronobacter spp. in farming and domestic environments, 
food production animals and retail foods. Int J Food Microbiol, 136, 198-203. 
MOLLOY, E. M., ROSS, R. P. & HILL, C. 2012. Bac’ to the future: bioengineering 
lantibiotics for designer purposes. Biochemical Society Transactions, 40, 
1492-1497. 
MORRISSEY, R., BEGLEY, M., OSHIMA, S., REA, M., ROSS, R. P. & HILL, C. 
2011. Real-time monitoring of luciferase-tagged Cronobacter sakazakii in 
reconstituted infant milk formula. Journal of Food Protection, 74, 573-579. 
MORRISSEY, R., HILL, C. & BEGLEY, M. 2013. Shining light on food 
microbiology; applications of Lux-tagged microorganisms in the food 
industry. Trends in Food Science & Technology, 32, 4-15. 
172 
 
MOULTON, K., RYAN, P., LAY, D. & WILLARD, S. 2009. Photonic plasmid 
stability of transformed Salmonella Typhimurium: A comparison of three 
unique plasmids. BMC Microbiology, 9, 152. 
MULLANE, N., GAORA, P. O., MALLY, J. E., IVERSEN, C., WHYTE, P., 
WALL, P. G. & FANNING, S. 2008a. Molecular analysis of the 
Enterobacter sakazakii o-antigen gene locus. Applied and Environmental 
Microbiology, 74, 3783-3794. 
MULLANE, N., HEALY, B., MEADE, J., WHYTE, P., WALL, P. G. & FANNING, 
S. 2008b. Dissemination of Cronobacter spp. (Enterobacter sakazakii) in a 
powdered milk protein manufacturing facility. Applied and Environmental 
Microbiology, 74, 5913-7. 
MURRAY, M. R., JEAN A. 1997. Comparative study of the antilisterial activity of 
Nisin A and pediocin AcH in fresh ground pork stored aerobically at 5°C. 
Journal of Food Protection, 60, 1534-1540. 
MURRAY, N. E. 2000. Type I restriction systems: sophisticated molecular machines 
(a legacy of Bertani and Weigle). Microbiology and molecular biology 
reviews, 64, 412-434. 
MUYTJENS, H. L., ROELOFS-WILLEMSE, H. & JASPAR, G. H. J. 1988. Quality 
of powdered substitutes for breast milk with regard to members of the family 
Enterobacteriaceae. Journal of Clinical Microbiology, 26, 743-746. 
NAIR, M. K. M., J. JOY, J. & VENKITANARAYANAN, K. S. 2004. Inactivation 
of Enterobacter sakazakii in reconstituted infant formula by monocaprylin. 
Journal of Food Protection, 67, 2815-2819. 
NAIR, M. K. M., JOY, J., VASUDEVAN, P., HINCKLEY, L., HOAGLAND, T. A. 
& VENKITANARAYANAN, K. S. 2008. Antibacterial effect of caprylic 
173 
 
acid and monocaprylin on major bacterial mastitis pathogens. Journal of 
Dairy Science, 88, 3488-3495. 
NAZAROWEC-WHITE, M. & FARBER, J. M. 1997. Incidences, survival, and 
growth of Enterobacter sakazakii in infant formula. Journal of Food 
Protection, 60, 226-230. 
OH, S. W. & KANG, D. H. 2005. Rapid enumeration of Enterobacter sakazakii in 
reconstituted milk formula by fluorogenic mostprobable- number assay using 
96-well microtiter plate. Journal of Rapid Methods Automation in 
Microbiology, 13, 318-328. 
OSHIMA, S., REA, M. C., LOTHE, S., MORGAN, S., BEGLEY, M., O'CONNOR, 
P. M., FITZSIMMONS, A., KAMIKADO, H., WALTON, R., ROSS, R. P. & 
HILL, C. 2012. Efficacy of organic acids, bacteriocins, and the 
lactoperoxidase system in inhibiting the growth of Cronobacter spp. in 
rehydrated infant formula. Journal of Food Protection, 75, 1734-1742. 
PARASION, S., KWIATEK, M., MIZAK, L., GRYKO, R., BARTOSZCZE, M. & 
KOCIK, J. 2012. Isolation and characterization of a novel bacteriophage φ4D 
lytic against Enterococcus faecalis strains. Current Microbiology, 65, 284-
289. 
PARK, S. F., STEWART, G. S. A. B. & KROLL, R. G. 1992. The use of bacterial 
luciferase for monitoring the environmental regulation of expression of genes 
encoding virulence factors in Listeria monocytogenes. Journal of General 
Microbiology, 138, 2619-2627. 
PINGOUD, A., FUXREITER, M., PINGOUD, V. & WENDE, W. 2005. Type II 
restriction endonucleases: structure and mechanism. Cellular and molecular 
Life Science, 62, 685-707. 
174 
 
PIPER, C., DRAPER, L. A., COTTER, P. D., ROSS, R. P. & HILL, C. 2009. A 
comparison of the activities of Lacticin 3147 and Nisin against drug-resistant 
Staphylococcus aureus and Enterococcus species. Journal of Antimicrobial 
Chemotherapy, 64, 546-551. 
QAZI, S., COUNIL, E., MORRISSEY, J., REES, C. E. D., COCKAYNE, A., 
WINZER, K., CHAN, W. C., WILLIAMS, P. & HILL, P. J. 2001. agr 
expression precedes escape of internalized Staphylococcus aureus from the 
host endosome. Infection and immunity, 69, 7074. 
QUIBERONI, A., TREMBLAY, D., ACKERMANN, H. W., MOINEAU, S. & 
REINHEIMER, J. A. 2006. Diversity of Streptococcus thermophilus phages 
in a large-production cheese factory in Argentina. Journal of Dairy Science, 
89, 3791-3799. 
RAMSARAN, H., CHEN, J., BRUNKE, B., HILL, A. & GRIFFITHS, M. W. 1998. 
Survival of bioluminescent Listeria monocytogenes and Escherichia coli 
O157: H7 in soft cheeses. Journal of Dairy Science, 81, 1810. 
RICE, J., FOWLER, R., ARRAGE, A., WHITE, D. & SAYLER, G. 1995. Effects of 
external stimuli on environmental bacterial strains harboring analgD-lux 
bioluminescent reporter plasmid for the study of corrosive biofilms. Journal 
of Industrial Microbiology & Biotechnology, 15, 318-328. 
RIEDEL, CASEY, P., MULCAHY, H., O'GARA, F., GAHAN, C. G. M. & HILL, 
C. 2007a. Construction of p16Slux, a novel vector for improved 
bioluminescent labeling of Gram-negative bacteria. Applied and 
Environmental Microbiology, 73, 7092-7095. 
RIEDEL, MONK, I., CASEY, P., MORRISSEY, D., O'SULLIVAN, G., 
TANGNEY, M., HILL, C. & GAHAN, C. 2007b. Improved luciferase 
175 
 
tagging system for Listeria monocytogenes allows real-time monitoring In 
vivo and In vitro. Applied and Environmental Microbiology, 73, 3091-3094. 
RINK, R., WIERENGA, J., KUIPERS, A., KLUSKENS, L. D., DRIESSEN, A. J., 
KUIPERS, O. P. & MOLL, G. N. 2007. Dissection and modulation of the 
four distinct activities of Nisin by mutagenesis of rings A and B and by C-
terminal truncation. Applied and Environmental Microbiology, 73. 
ROBINSON, G. M., TONKS, K. M., THORN, R. M. S. & REYNOLDS, D. M. 
2011. Application of bacterial bioluminescence to assess the efficacy of fast-
acting biocides. Antimicrobial Agents and Chemotherapy, 55, 5214-5220. 
ROLLEMA, H. S., KUIPERS, O. P., BOTH, P., DE VOS, W. M. & SIEZEN, R. J. 
1995. Improvement of solubility and stability of the antimicrobial peptide 
Nisin by protein engineering. Applied and Environmental Microbiology, 61, 
2873-8. 
ROSS, R. P., DESMOND, C., FITZGERALD, G. F. & STANTON, C. 2005. 
Overcoming the technological hurdles in the development of probiotic foods. 
Journal of Applied Microbiology, 98, 1410-1417. 
ROUSE, S., FIELD, D., DALY, K. M., O'CONNOR, P. M., COTTER, P. D., HILL, 
C. & ROSS, R. P. 2012. Bioengineered Nisin derivatives with enhanced 
activity in complex matrices. Microbial Biotechnology, 5, 501-508. 
RYAN, M. P., REA, M. C., HILL, C. & ROSS, R. P. 1996. An application in 
cheddar cheese manufacture for a strain of Lactococcus lactis producing a 
novel broad-spectrum bacteriocin, Lacticin 3147. Applied and Environmental 
Microbiology, 62, 612-9. 
SANTOS, T. M. A., GILBERT, R. O., CAIXETA, L. S., MACHADO, V. S., 
TEIXEIRA, L. M. & BICALHO, R. C. 2010. Susceptibility of Escherichia 
176 
 
coli isolated from uteri of postpartum dairy cows to antibiotic and 
environmental bacteriophages. Part II: In vitro antimicrobial activity 
evaluation of a bacteriophage cocktail and several antibiotics. Journal of 
Dairy Science, 93, 105-114. 
SANZ, P., TEEL, L. D., ALEM, F., CARVALHO, H. M., DARNELL, S. C. & 
O'BRIEN, A. D. 2008. Detection of Bacillus anthracis spore germination In 
vivo by bioluminescence Imaging. Infection and Immunity, 76, 1036-1047. 
SHANER, N. C., STEINBACH, P. A. & TSIEN, R. Y. 2005. A guide to choosing 
fluorescent proteins. Nature methods, 2, 905-909. 
SHEEHAN, B. J., FOSTER, T. J., DORMAN, C. J., PARK, S. & STEWART, G. 
1992. Osmotic and growth-phase dependent regulation of the eta gene of 
Staphylococcus aureus: a role for DNA supercoiling. Molecular and General 
Genetics MGG, 232, 49-57. 
SHIMIZU, T., OHTA, Y., TSUTSUKI, H. & NODA, M. 2011. Construction of a 
novel bioluminescent reporter system for investigating Shiga toxin expression 
of enterohaemorrhagic Escherichia coli. Gene, 478, 1-10. 
SING, W. D. & KLAENHAMMER, T. R. 1993. A strategy for rotation of different 
bacteriophage defenses in a Lactococcal single-strain starter culture system. 
Applied and Environmental Microbiology, 59, 365. 
SIRAGUSA, G., NAWOTKA, K., SPILMAN, S., CONTAG, P. & CONTAG, C. 
1999. Real-time monitoring of Escherichia coli O157:H7 adherence to beef 
carcass surface tissues with a bioluminescent reporter. Applied and 
Environmental Microbiology, 65, 1738-45. 
SMALLA, K., OSBURNE, A. M. & WELLINGTON, E. M. H. 2000. Isolation and 
characterization of plasmids from bacteria., Harwood Academic Publishers. 
177 
 
STEWART, G. S. 1990. In vivo bioluminescence: new potentials for microbiology. 
Letters in Applied Microbiology, 10, 1-8. 
TERZAGHI, B. E. & SANDINE, W. E. 1975. Improved medium for Lactic 
Streptococci and their bacteriophages. Applied and Environmental 
Microbiology, 29, 807. 
TOMICKA, A., CHEN, J., BARBUT, S. & GRIFFITHS, M. W. 1997. Survival of 
bioluminescent Escherichia coli O157: H7 in a model system representing 
fermented sausage production. Journal of Food Protection, 60, 1487-1492. 
TÜKEL, Ç. L., ŞANLIBABA, P., ÖZDEN, B. & AKÇELIK, M. 2006. Identification 
of adsorption inhibition, restriction/modification and abortive infection type 
phage resistance systems in Lactococcus lactis strains. Acta Biologica 
Hungarica, 57, 377-385. 
TURPIN, P., MAYCROFT, K., BEDFORD, J., ROWLANDS, C. & 
WELLINGTON, E. 1993. A rapid luminescent phage based MPN method for 
the enumeration of Salmonella typhimurium in environmental samples. 
Letters in Applied Microbiology, 16, 24-27. 
ULITZUR, S. 1986. Determination of antibiotic activities with the aid of luminous 
bacteria. Methods in Enzymology, 133, 275-284. 
ULITZUR, S. & KUHN, J. 1987. Introduction of lux genes into bacteria, a new 
approach for specific determination of bacteria and their antibiotic 
susceptibility, In: Schlomerich J, Andreesen R, Kapp A, et al, eds, Chichester: 
John Wiley and Sons. 
WAIDMANN, M., BLEICHRODT, F., LASLO, T. & RIEDEL, C. 2011. Bacterial 
luciferase reporters: The Swiss army knife of molecular biology. 
Bioengineered Bugs, 2, 1-9. 
178 
 
WALLACE, W., FLEMING, J., WHITE, D. & SAYLER, G. 1994. An algD-
bioluminescent reporter plasmid to monitor alginate production in biofilms. 
Microbial ecology, 27, 225-239. 
WIDDER, E. A. 2010. Bioluminescence in the ocean: origins of biological, 
chemical, and ecological diversity. Science, 328, 704-8. 
WIEDEMANN, I., BÖTTIGER, T., BONELLI, R. R., WIESE, A., HAGGE, S. O., 
GUTSMANN, T., SEYDEL, U., DEEGAN, L., HILL, C., ROSS, P. & 
SAHL, H.-G. 2006. The mode of action of the lantibiotic Lacticin 3147 – a 
complex mechanism involving specific interaction of two peptides and the 
cell wall precursor lipid II. Molecular Microbiology, 61, 285-296. 
WILLIS, J. & ROBINSON, J. E. 1988. Enterobacter sakazakii meningitis in 
neonates. Pediatric Infectious Disease Journal, 7, 196-199. 
WILSON, G. S. 1935. The bacteriological grading of milk . Medical Research 
Council, Special Rep. 
XU, X., MILLER, S. A., BAYSAL-GUREL, F., GARTEMANN, K. H., 
EICHENLAUB, R. & RAJASHEKARA, G. 2010. Bioluminescence imaging 
of Clavibacter michiganensis subsp. michiganensis infection of tomato seeds 
and plants. Applied and Environmental Microbiology, 76, 3978-88. 
YUAN, J., ZHANG, Z. Z., CHEN, X. Z., YANG, W. & HUAN, L. D. 2004. Site-
directed mutagenesis of the hinge region of NisinZ and properties of NisinZ 
mutants. Journal of Applied Microbiology, 64. 
 
 
 
 
179 
 
 
 
 
 
 
Acknowledgements 
180 
 
I would like to take this opportunity to sincerely thank my supervisors, Prof. Colin 
Hill and Dr. Máire Begley, for all their advice, kindness and patience during my time 
in Lab 4.23. Thank you for giving me this opportunity and helping me throughout the 
years. Thank you so much for your contributions to the writing not only of this thesis 
but to the writing of my published papers.  
I wish to thank all in the Microbiology Department, particularly Margaret and Máire 
for placing all my last minute orders and assisting me with all my consumable needs. 
Thanks to Julianne for all the great peptide pictures, Dan for keeping my PC in tip-
top condition and Paddy for helping with all the freeze-drying. Thank you.   
I wish to thank all past and present members of lab 4.23. To name a few, G, Heather, 
Eamonn, Pat, Joanne, Kiera, Eileen, James, Ciara, Mohammad and Neasa. In 
particular I’d like to thank Eamonn for keeping things calm around the lab. It’s been 
a total pleasure sitting next to you (I hope I wasn’t talking to much). I’d like to thank 
Eileen for all her kindness when we were living on the Lough. For all the Friday and 
Saturday nights you and Philip kept me company, thanks. I really appreciate it. 
Thanks to Kiera for all her advice, lifts and sponge cakes throughout the years, thank 
you so much! Thanks to Sinead for all our lovely lunches, chats and support during 
the tough times. I really appreciate it. You’re an inspiration. Thanks to Lisa Q and 
Sarah for all the lovely chats and visits. You guys are the best. 
We wish to thank Paula O Connor for carrying out mass spectrometry analysis 
during this study. I’d like to also thank James and Jen in Lab 3.40 for all the phage 
advice. To everyone in lab 3.37 (especially Des Brian, Lorraine, Karen, and Evelyn) 
for all your help with prep work and the HPLC work. Thanks to Tanya and Therese 
in the FHI for all you kindness and chats (also for all the fab buns). I’d especially 
like to thanks Claire for all her kindness during the PhD. You are the best running 
181 
 
partner I’ve ever had and you have been so kind to me particularly in the last few 
months when things went from bad to worse.  I will never forget your support and 
words of encouragement. Thank you.  
Finally, I would like to take this opportunity to deeply thank my family. To my mom 
and Dad, thank you for all the support (financial and emotional) and all the great 
words of encouragement! I don’t know how you put up with me! Thanks to my sister 
and brother, Elaine and Michael. Thanks for all the craic, understanding, (false) 
interest and motivational speeches. I couldn’t wish for a better family. 
 
Ruth   
 
 
 
 
 
 
 
 
 
 
182 
 
 
